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Abstract 
 
Human cytomegalovirus (HCMV) is a human pathogen that can cause severe 
disease in immunocompromised or immunosupressed individuals and also in 
newborns infected in utero.  Transcription of the viral genome occurs by a process 
in which three classes of HCMV genes, immediate early, early and late are 
expressed in a regulated temporal cascade.  The HCMV protein pp71, encoded by 
gene UL82, is located in the tegument of the HCMV virion and is delivered to cells 
immediately upon infection.  This protein has been identified as a transactivator of 
viral immediate early gene expression.  It also stimulates expression from a 
number of heterologous promoters by a mechanism that is not promoter sequence 
specific.  Protein pp71 has multiple properties; it can increase the infectivity of 
transfected viral DNA, modulate the cell cycle and interact with the retinoblastoma 
family of proteins.  Within the cell nucleus, pp71 co-localises with the cellular 
proteins PML and hDaxx at sub-cellular structures named nuclear domain 10 
(ND10).  The interaction of pp71 with hDaxx is believed to promote the 
degradation of hDaxx, resulting in relief of repression at the HCMV major 
immediate early promoter.  Protein pp71 has also been reported to have the 
unusual property of mediating long-term expression of reporter genes cloned into 
a herpes simplex virus type 1 (HSV-1) vector.  This study describes a comparison 
of pp71 with the non-human UL82 homologues from simian CMV, baboon CMV, 
rhesus CMV and chimpanzee CMV, named S82, B82, RH82 and Ch82, 
respectively. 
  
Plasmids expressing all of the UL82 homologues as enhanced yellow fluorescent 
protein (EYFP) or myc-tagged proteins were constructed and analysed for 
expression by transfection into HFFF2 cells.  The EYFP-tagged UL82 homologues 
all directed β−gal expression in short-term assays, while only pp71 directed both 
short-term and long-term gene expression.  Only myc-tagged pp71 was observed 
to direct gene expression in both the short-term and long-term assays.  
 
The EYFP-tagged proteins and myc-tagged pp71 and Ch82 were cloned into a 
mutated HSV-1 vector to produce recombinant viruses.  Functional assays in 
human glioblastoma (U373) cells confirmed that all of the EYFP-tagged and 
myc-tagged non-human UL82 homologues were able to direct short-term Tanya Chaudry 2008    Abstract   1
expression but only EYFP- and myc-tagged pp71 directed long-term gene 
expression, confirming results obtained in transfection assays.   
 
In agreement with previous reports, pp71 was shown to promote the resumption of 
gene expression from quiescent HSV-1 genomes.  Comparison of the pp71 and 
Ch82 homologues indicated that pp71 is unique in its ability to do so.  No 
reactivation was observed in cells infected with an HSV-1 recombinant that 
expressed EYFP-tagged Ch82. 
 
In order to establish the region of pp71 responsible for mediating long-term gene 
expression six plasmids encoding EYFP-tagged hybrid proteins were constructed.  
The C-terminus, N-terminus and mid-regions of pp71 were substituted for the 
equivalent Ch82 regions using homologous restriction sites in both coding 
sequences.  All EYFP-tagged hybrids mediated short-term gene expression, while 
only one protein, with the mid region of pp71 inserted between the C- and N-
terminal regions of the Ch82 homologue, appeared to stimulate long-term gene 
expression.  However, levels of expression were significantly lower than that 
achieved by pp71.  A HSV-1 recombinant expressing the hybrid protein was used 
to confirm results from transfection assays, suggesting that the mid-region of pp71 
may be involved in mediating its long-term properties.  Given the significantly 
lower degree of gene expression directed by the hybrid protein in short-term 
assays it was concluded that alterations to pp71 may result in structural changes 
that prevent normal function of the protein. 
 
Immunofluorescence studies revealed further differences between the non-human 
UL82 homologues and pp71.  In confirmation of previously published findings, in 
the majority of HFFF2 cells infected with a HSV-1 recombinant expressing 
EYFP-tagged pp71, this protein localised to discrete punctate ND10 foci at all 
times tested.  In cells infected with a HSV-1 recombinant expressing S82 a pattern 
distinct from that of pp71 was observed.  S82 exhibited a punctate/diffuse pattern 
of fluorescence, which became increasingly diffuse at later times post-infection.  
The remaining non-human UL82 homologues, despite localising to the discrete 
punctate foci characteristic of pp71 at early times post-infection, all showed 
nuclear distribution patterns akin to that of S82 at later times, in cells infected with 
the HSV-1 recombinants expressing EYFP-tagged Ch82, B82 and Rh82.  All non-
human UL82 homologues, like pp71, co-localised with the endogenous cellular Tanya Chaudry 2008    Abstract   1
proteins hDaxx and PML at the times tested.  Interestingly, however, at later times 
post-infection, the S82 protein appeared to disperse hDaxx throughout the 
nucleus, a feature that was not observed with the remaining UL82 homologues.  
Examination of the hybrid protein observed to stimulate long-term gene expression 
revealed that, like pp71, it localised to discrete punctate foci, and co-localised with 
both PML and hDaxx at all times post-infection.  In contrast to other published 
studies, it was not possible to demonstrate pp71-mediated hDaxx degradation, by 
either pp71 or the non-human UL82 homologues. 
 
The work presented in this thesis confirms the previous observation that pp71 
directs long-term gene expression, reactivates quiescent genomes and 
co-localises in the nucleus with hDaxx and PML.  It also characterises the non-
human UL82 homologues of pp71.  This study shows that, while each non human 
UL82 homologue shares some characteristics with pp71, subtle functional 
differences exist between these proteins.   
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Abbreviations used in this study 
 
AP     assembly  protein 
APS     ammonium  persulphate 
BCMV     baboon  cytomegalovirus 
BDGF     Bio-Gene  Finder 
bp     base  pair 
β-gal     β-galactosidase 
BSA     bovine  serum  albumin 
C        carboxy (-terminal end of protein) 
CCMV     chimpanzee  cytomegalovirus 
CENP-C    centromere  protein  C 
CIP     calf  intestinal  phosphatase 
CLTs     cytomegalovirus  latency-specific  transcripts 
CTCF     CCCTC-binding  factor 
DC     dendritic  cells 
dH20     distilled  water 
DID     Daxx  interaction  domain 
DMEM      Dulbeccos modified Eagles medium 
DMSO   dimethylsulphoxide 
DNA     deoxyribonucleic  acid 
E     Early 
EBV     Epstein-Barr  virus 
EC     endothelial  cells 
E.coli     Escherichia coli 
ECL     enhanced  chemiluminescence 
EDTA     ethylenediaminetetra-acetic  acid 
EGFR     epidermal  growth  factor  receptor 
ER     endoplasmic  reticulum 
EYFP     enhanced  yellow  fluorescent  protein 
FCS     foetal  calf  serum 
GAG     glycosaminoglycan 
GMPs     granulocyte  macrophage  precursors 
GST     glutathione  S-transferase 
HCF     host  cellular  factor 
HCMV     human  cytomegalovirus Tanya Chaudry 2008    Abbreviations used in this study  14
HDAC     histone  deacetylase 
HFFF     human  foetal  foreskin  fibroblasts 
HHV-6   human  herpesvirus  type  6 
HHV-7   human  herpesvirus  type  7 
HIV     human  immunodeficiency  virus 
HMBA     hexamethylbisacrylamide 
HP1     histone  deacetylase  1 
hr     hours 
HRP     horse  radish  peroxidase 
HSV-1        herpes simplex virus type 1 
HSV-2        herpes simplex virus type 2 
HVEM     herpes  virus  entry  mediator 
ICP     infected  cell  protein 
IE     immediate  early 
Ig     immunoglobulin 
ITE     immediate  transcript  environment 
KHSV     Kaposi’s  sarcoma-associated  herpesvirus 
L     Late 
LAT     latency  associated  transcript 
LTR     long-terminal  repeat 
LSM     laser  scanning  microscope 
mcBP     minor  capsid  binding  protein 
MCMV   murine  cytomegalovirus 
MCP     major  capsid  protein 
mcP     minor  capsid  protein 
MCS     multiple  cloning  site 
MHC     major  histocompatibility  complex 
MIEP     major  immediate  early  promoter 
min     minutes 
MOI     multiplicity  of  infection 
mRNA     messenger  RNA 
MUP     4-methylumbelliferyl  phosphate 
N     amino  (-terminal  of  protein) 
NBCS     newborn  calf  serum 
ND10     nuclear  domain  10 
NLS     nuclear  localisation  signal Tanya Chaudry 2008    Abbreviations used in this study  15
NPC     nuclear  pore  complex 
NP40     Nonidet  p40 
NT2D1   teratocarcinoma  cells 
ORF     open  reading  frame 
orilyt     origin  of  lytic  replication 
PAGE     polyacrylamide  gel  electrophoresis 
PBS     phosphate  buffered  saline 
PBST     phosphate  buffered  saline+Tween  20 
PCR     polymerise  chain  reaction 
pfu     plaque  forming  unit 
PML     promyelocytic  leukaemia 
Rb     retinoblastoma  protein 
RhCMV    rhesus  cytomegalovirus 
rpm     revolutions  per  minute 
RL     long  inverted  repeat  region 
RS     short  inverted  repeat  region 
SCMV     simian  cytomegalovirus 
SCP     small  capsid  protein 
SEAP     secreted  alkaline  phosphatase 
ShRNA    short  hairpin  RNA 
SiRNA   small  inhibitory  RNA 
SIM     SUMO-interaction  motif 
SIV     simian  immunodeficiency  virus 
SUMO-1    small  ubiquitin-like  modifier 
TAP     transporter  associated  with  antigen  presentation 
TBP     TATA-binding  protein 
TEMED    N’-N’-N’-N’-tetramethylethylethylenediamine 
TF     transcription  factor 
THP1     myelomonocytic  cells 
TK     thymidine  kinase 
Tris     tris  (hydroxymethyl)  aminomethane 
ts     temperature  sensitive 
TSA     trichostatin  A 
Tween  20    polyoxyethylene-sobitanmonolaurate 
UL     unique  long  region 
US     unique  short  region Tanya Chaudry 2008    Abbreviations used in this study  16
USP7     ubiquitin specific protease 
UV     ultra-violet 
v/v     volume/volume 
VZV     varicella-zoster  virus 
w/v     weight/volume 
X-gal     5’bromo-4-chloro-3-indoyl-β-D-galactosidase 
YFP     yellow  fluorescent  protein 
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1. Introduction to herpesviruses 
 
1.1. Herpesviridae classification 
 
Herpesviruses constitute a large group of viruses classified as the family 
Herpesviridae, containing over 120 members (Roizman, 2001).  Herpesviruses 
differ widely in their pathogenic potential, but following primary infection can 
remain latent within the host.  The Herpesviridae fall into three sub-families, 
Alphaherpesvirinae, Betaherpesvirinae and Gammaherpesvirinae.  Classification 
of these sub-families is based on their biological characteristics such as the length 
of the viral replication cycle, host cell range, cytopathology and the disease 
resulting from productive infection (Roizman & Baines, 1991, Roizman, 2001). 
 
1.1.1. Alphaherpesvirinae 
 
Viruses in the sub-family Alphaherpesvirinae typically exhibit variable host range in 
vitro, a rapid reproductive cycle, and the capacity to establish latent infection within 
sensory ganglia.  They are further divided into two genera; the Simplexviruses and 
Varicelloviruses.  The Simplexviruses include herpes simplex virus type 1 (HSV-1), 
which typically infects mucosal tissue of the mouth resulting in cold sores, and 
herpes simplex virus type 2 (HSV-2), which infects genital mucosal epithelia 
causing genital lesions.  The Varicelloviruses include varicella-zoster virus (VZV), 
which causes chickenpox during primary infection (Roizman, 2001). 
 
1.1.2. Betaherpesvirinae 
 
Viruses within the sub-family Betaherpesvirinae demonstrate a restricted host 
range and slow growth in cell culture models (Mocarski, 2001).  Latency is 
established in lymphoreticular cells, and secretory glands (Sinclair & Sissons, 
2006).  This sub-family is further divided into three genera; the Cytomegaloviruses, 
Roseloviruses and Muromegaloviruses.  Infection with human cytomegalovirus 
(HCMV) of the Cytomegalovirus  genera poses a significant risk to 
immunocompromised individuals resulting in diseases such as retinitis and 
pneumonitis (Mocarski, 2001). HHV-6 and HHV-7 are both are both members of 
the Roselovirus genus of the Betaherpesvirinae.  HHV-6 is associated with febrile 
disease in children and has been implicated in the aetiology of chronic fatigue 
syndrome and multiple sclerosis (Ablashi et al., 2000).  HHV-7 has been Tanya Chaudry 2008    Chapter 1  18
associated with post-transplant disease in immunosupressed organ recipients.  It 
has been reported that gastric mucosal cells are the site at which latent HHV-7 
DNA is found (Gonelli et al., 2001).  The murine cytomegalovirus (MCMV) of the 
Muromegalovirus genra is utilised as a model for both productive and persistent 
HCMV infection (Keil et al., 1984). 
 
1.1.3. Gammaherpesvirinae 
 
These viruses have variable host cell range, and duration of replication (Roizman, 
2001).  Members of this family replicate in lymphoblastoid cells some types of 
epithelioid and fibroblastic cells, and establish latency in either T or B lymphocytes 
(Roizman, 2001).  Gammaherpesviruses are further divided into two genera; 
Lymphocryptoviruses (EBV) and Rhadinoviruses (HHV-8).  HHV-8 is also known 
as Karposi’s sarcoma-associated herpesvirus (KSHV), and infection can result in 
Karposi’s sarcoma, primary effusion lymphoma or muliticentric Castleman’s 
disease in immunosupressed patients (Roizman, 2001).  
 
1.2. HSV biology 
 
The herpes simplex viruses consist of two serotypes, HSV-1 and HSV-2, and were 
the first of the human herpesviruses to be discovered.  Due to their ease of growth 
in culture both are amongst the most intensely investigated (Roizman, 2001).   
HSV-1 has a complex lytic life cycle (Roizman, 2001) and is able to establish life 
long latency in sensory neurons.  This strategy secures the long-term survival of 
the virus as it is able to evade the host immune system during latent infection 
(Efstathiou & Preston, 2005). 
 
1.2.1. HSV-1 virion and genome structure 
 
As with other herpesviruses, the HSV-1 virion consists of four distinct components; 
the DNA core (contained within the capsid), capsid, tegument, and envelope 
(Adamson et al., 2006, Roizman, 2001).  The HSV-1 capsid is icosohedral in 
shape with a diameter of 1,250 Ǻ (Saad et al., 1999).  Capsids are considered to 
exist in three forms, B-capsids, which contain scaffolding proteins, C-capsids, 
which contain viral DNA, and A-capsids that are empty capsids (Rixon, 1993).   
Capsids are composed of 162 capsomeres, which can be divided into three types: Tanya Chaudry 2008    Chapter 1  19
150 hexons, 11 pentons and one portal.  The hexons form the faces and edges of 
the capsid and the pentons form eleven of the twelve vertices.  Triplexes of UL18 
and UL38 hold the capsomeres together (Garner, 2003, Newcomb et al., 2005, 
Newcomb et al., 2006, Newcomb et al., 2003).  A linear double stranded DNA 
genome of 152 kb is packaged into the capsids.  It has been reported that the 
packaged DNA appears to exist in a liquid crystalline state, similar to that 
suggested for the double stranded DNA bacteriophages λ and T4 (Booy et al., 
1991, Rixon, 1993). The capsid is surrounded by a tegument layer that contains at 
least 15 viral proteins including the HSV-1 immediate early (IE) proteins 
(McLauchlan & Rixon, 1992, Rixon et al., 1992).  The outer surface of the virion is 
a tri-laminar viral lipid envelope with a diameter of 170-200 nm, containing 
embedded viral glycoproteins, which are seen as spikes under an electron 
microscope (Mettenleiter, 2002).  A schematic representation of a herpes virion is 
presented in figure 1.1 
. 
The initial sequence of the HSV-1 genome, strain 17, was finally determined in 
1988 by McGeoch et al. when the complete DNA sequence of the long unique 
region of HSV-1 was obtained (McGeoch et al., 1988).  Prior to this the complete 
sequence of the unique short region (US) (McGeoch et al., 1985), and the 
complete sequence of the short inverted repeat region (RS) (Davison & Wilkie, 
1981, Murchie & McGeoch, 1982) were published.  The complete sequence of the 
long inverted repeat (RL) region was later published by Perry and McGeoch in 
1988 (Perry & McGeoch, 1988), thus the complete sequence of HSV-1 was 
believed to contain 152260 residues in each strand with a base composition of 
68% G+C (McGeoch et al., 1988).  The sequence of HSV-1 was later updated and 
currently stands at 152261 base pairs (bp) (Dolan et al., 1998).  The HSV-1 
genome therefore consists of the UL and US regions that are in turn flanked by 
inverted repeat sequences RL and RS.  HSV-1 genes are distributed throughout 
the genome on both DNA strands; genes located within the inverted repeats are 
present in two copies (Weir, 2001).  Three of the IE genes are located near the 
termini of the RL and RS regions of the genome.  The IE genes encoding ICP0 and 
ICP4, are contained within the inverted repeats RL and RS, and therefore occur 
twice within the genome.  The early (E) and late (L) genes are found throughout 
the unique regions (Roizman, 2001).  Figure 1.2 shows the genome arrangement 
of HSV-1. 
 Capsid
Tegument
DNA Core
Envelope
Figure 1.1  Cartoon illustrating the structure of a herpes virion 
Schematic representation of the structure of an HSV-1 virion. It shows 
the double-stranded DNA core enclosed within the icosahedral capsid, 
surrounded by a proteinaceous tegument and enclosed within a 
lipoprotein membrane. TRL
U L
TRS
U S a ‘a’ a
IRL IRS
0
0
Figure 1.2 Genome arrangement of HSV-1
The genome has two unique regions, each of which is flanked by an inverted repeat.  The repeat regions IRL/TRL and 
IRS/TRS, flanking UL and US respectively. An  additional  repeat element the ‘a’ sequence, is found at both genomic 
termini and at the junction between the internal repeats (IRL and IRS).  Both the UL and US segments show a high 
frequency of inversion. 
Adapted from Davison and McGeoch (1995).
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1.3. HSV infection 
 
The prevalence of both HSV-1 and HSV-2 infections varies markedly by country, 
region within country and population sub-group.  The percentage of adults infected 
with HSV-1 is thought to be 60-90% in non-high risk groups, a rise from 40% at 15 
years old (Smith & Robinson, 2002).  Infection occurs when HSV is excreted from 
infected individuals to seronegative individuals via intimate personal contact.   
Infection occurs at mucosal surfaces or abraded skin (Whitley, 2001).  The most 
common consequence of HSV-1 infection is cold sores, however severe infection 
with HSV-1 can result in stromal keratitis (infection of the cornea) and it is also the 
most common causative agent of viral encephalitis and, more rarely of 
meningoencephalitis (Whitley, 2001), while HSV-2 infection is the main cause of 
genital herpes (Roizman, 2001).  Following infection HSV-1 can enter two modes 
of infection: lytic or latent (Efstathiou & Preston, 2005). 
 
1.4. Lytic infection 
 
1.4.1. Viral attachment and penetration into the cell 
 
HSV-1 host cell entry is mediated by glycoproteins B (gB), gC, gD, gH, gJ, gK, gL, 
gM, and gN which are components of the viral envelope (Spear, 2004).  Only gB, 
gD, gH, and gL are believed to be essential for cell fusion and entry (Spear, 2004).  
The virus initially binds to glycosaminoglycan (GAG) heparan sulphate on the host 
cell surface via gB and gC (Herold et al., 1994).  Fusion of the viral envelope with 
the cell membrane is triggered by gD interaction with one of three cellular 
receptors: herpes virus entry mediator (HVEM), nectin-1 or nectin-2 (Spear, 2002). 
 
1.4.2. Virion transport and genome insertion to the nucleus 
 
Following internalisation the majority of tegument proteins dissociate from the 
capsids.  However, tegument proteins that remain associated with the HSV-1 
capsid are thought to assist in microtubule dependent transport, as is the case for 
pseudorabies virus (Granzow et al., 2005).  The HSV-1 nucleocapsid is 
transported to the nuclear pore complex (NPC) via the microtubule network and 
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Translocation of HSV-1 DNA into the nucleus occurs following capsid docking at 
the NPC, a process mediated by the one or more of the tegument proteins. The 
empty capsid remains in the cytoplasm (Ojala et al., 2000, Roizman, 2001).   
Shanin et al. (2006) suggested that the HSV-1 genome translocates through the 
nuclear pore in a condensed rod like structure.  For this to occur the NPC is 
thought to dilate to allow entry (Shahin et al., 2006).  Following entry of the 
genome into the nucleus it is thought to circularise (Roizman, 2001). 
 
1.4.3. HSV-1 viral IE proteins 
 
HSV-1 gene expression involves a sequential cascade of three sets of genes, IE, 
E and L, which are classified according to their time of expression during 
replication (Roizman, 2001).  The IE genes are the first genes expressed, these 
are: ICP4, ICP27, ICP0, ICP22 and ICP47 (Efstathiou & Preston, 2005).   
Expression of the IE genes is stimulated by binding of a tripartite complex, 
composed of the tegument protein VP16, and two cellular proteins Oct-1 and host 
cellular factor (HCF), to DNA elements containing the TAATGARAT sequence 
(where R is a purine) upstream of each of the IE gene promoters (Nicholl & 
Preston, 1996, Preston et al., 1988).  Each component of the complex plays a 
specific role in the activation of IE gene expression (Weir, 2001).  Transcriptional 
activation is a function of the acidic carboxy-terminus of VP16; studies have shown 
that this acidic domain can be tethered to DNA binding domains to activate 
transcription.  Thus the target for VP16 activation is a component of the basal 
transcription machinery of the cell (Flint & Shenk, 1997). Oct-1 provides binding 
specificity, while HCF stabilises the tripartite complex and acts a nuclear import 
factor for VP16 (LaBoissiere & O'Hare, 2000).   
 
Of the five IE gene products only four play a role in regulating viral gene 
expression (Weir, 2001).  ICP0, ICP4, ICP22 and ICP27 are all involved in 
controlling gene expression, while ICP47 interferes with antigen presentation (York 
& Rock, 1996).  A schematic over-view of HSV-1 viral gene expression is 
presented in figure 1.3.  Below is a brief review of the HSV-1 IE proteins. 
 
 
 
 ICP0
IE Early Late
VP16 + Oct-1 + HCF
ICP27
ICP4
+ve -ve
Figure 1.3. Schematic view of the sequence of viral gene expression during HSV-1 infection.
A scheme of viral gene expression in HSV-1 infection.  VP16 activates IE gene expression upon forming a 
complex with Oct-1 and HCF.  The subsequent production of ICP4 and ICP0 activates expression of Early 
and Late viral genes.  Diagram adapted from Everett (2000).Tanya Chaudry 2008    Chapter 1  22
1.4.3.1. ICP4 
 
ICP4 has negative and positive effects upon transcription of viral genes and is 
composed of a number of discrete functional domains involved in transactivation, 
repression, dimerization, nuclear localisation and DNA binding (Gu et al., 1995).  
ICP4 acts as a transactivator of E and L gene expression (Weir, 2001) by 
promoting transcription by facilitating the formation of pre-initiation complexes 
through the recruitment of transcription factor (TF) IID (Grondin & DeLuca, 2000).  
It was also shown that ICP4 requires TFIIA to initiate transcription of the E genes 
(Zabierowski & DeLuca, 2004)  
 
ICP4 is able to repress its own expression by negatively regulating the ICP4 
promoter (Kuddus & DeLuca, 2007).  Repression is thought to require direct 
binding of ICP4 to specific DNA binding sites near the transcription start site.   
Specific ICP4 interactions with general transcription factors including the TATA-
binding protein (TBP) and TFIIB are involved in repression (Kuddus et al., 1995).  
Co-transfection experiments also showed that ICP4 acts to repress the latency 
associated promoter (LAP) by binding to the region spanning the LAP cap site 
sequences.  Deletion of LAP cap site sequences effectively abolished ICP4 
mediated repression (Batchelor et al., 1994). 
 
More recent studies suggest ICP4 is important for circularisation of the HSV-1 
genome, an event that may occur at a site where replication compartments later 
develop (Su et al., 2006). 
 
1.4.3.2. ICP22 
 
ICP22 is not required for virus replication in many cell systems. However, in 
certain rodent cell lines and primary human cells ICP22 is essential for efficient 
viral replication, expression of ICP0 and of a subset of viral L genes (Weir, 2001).  
It has been suggested that the primary role of ICP22 in lytic replication is to alter 
the expression, activity or post-translational modification of cellular proteins in 
order to provide a suitable environment for the expression of L genes (Orlando et 
al., 2006).  Orlando et al. (2006) demonstrated that an ICP22-null virus (22/n199), 
produced virions that were of abnormal composition.  Morphologically they 
contained reduced amounts of the L proteins, Us11 and gC, but increased Tanya Chaudry 2008    Chapter 1  23
amounts of ICP0 and ICP4, suggesting that ICP22 affects virion composition 
(Orlando et al., 2006).  
 
1.4.3.3. ICP27 
 
ICP27 is required for the switch between E and L viral gene expression, and for 
efficient DNA replication (Sacks et al., 1985). It has been shown to shuttle 
between the nucleus and the cytoplasm, suggesting a role for it in the nuclear 
export of viral transcripts and is also able to bind to intronless mRNAs (Sandri-
Goldin, 1998).  Koffa et al. (2001) proposed that ICP27 mediates viral mRNA 
transport by recruiting a TAP/NXF1 complex via an interaction with REF proteins 
(Koffa et al., 2001).  This allows the otherwise inefficiently exported viral mRNAs to 
access the TAP-mediated export pathway.  Studies have also shown that ICP27 
associates with polyribosomes and its C-terminus is involved in the stimulation of 
translation (Larralde et al., 2006).  ICP27 is able to interact with the C-terminus of 
RNA polymerase II (used by HSV-1 for viral gene transcription) to facilitate the 
recruitment of this cellular polymerase to sites of viral transcription (Dai-Ju et al., 
2006). 
 
1.4.3.4. ICP47 
 
The HSV-1 IE protein ICP47 is able to block the major histocompatibility complex 
(MHC) class I antigen presentation pathway by binding to the transporter 
associated with antigen presentation (TAP), thus blocking the supply of peptide for 
the correct assembly and trafficking of MHC class I molecules (York et al., 1994).  
As a consequence antigenic presentation is turned off and infected cells are 
hidden from the immune system, suggesting a role for ICP47 in the persistence of 
HSV-1 infection (York & Rock, 1996).  Recent studies in vivo showed that an 
ICP47-defective virus (ΔICP47, F strain) was less able to invade organs of adult 
female mice than the wild-type virus employed in the study, indicating that ICP47 
influences immune evasion (Burgos et al., 2006).  This group also demonstrated 
that the neuroinvasiveness of the ΔICP47 virus was recovered in TAP-deficient 
mice suggesting the TAP-ICP47 interaction is specific to neural tissues.  Thus 
ICP47 appears to be essential for immune evasion, playing a role in infection while 
TAP production is regulated during viral challenge (Burgos et al., 2006). 
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1.4.3.5. ICP0 
 
ICP0 is considered to be a promiscuous transactivator as it activates transcription 
from HSV-1 (Cai & Schaffer, 1992, Chen & Silverstein, 1992) and heterologous 
promoter elements independently of a single cis-acting element (Everett et al., 
1991). 
 
The functional domains of ICP0 have been established via mutational analysis.  
These include a RING finger domain located near the N-terminus (Everett, 1988).  
Many functions of ICP0 are dependent on its RING finger domain (Everett, 2000, 
Harris et al., 1989).  ICP0 interacts with and can promote the degradation of 
various cellular proteins including the nuclear domain 10 (ND10) components 
(described in section 1.5.3.7), PML (Everett et al., 1998a), Sp100 (Parkinson & 
Everett, 2000), CENP-C (Everett et al., 1999a) and CENP-A (Lomonte et al., 
2001).  As ICP0 induces the accumulation of and co-localises with conjugated 
ubiquitin it is considered to be a part of the ubiquitin proteasome pathway and can 
act as a ubiquitin ligase (Boutell & Everett, 2003, Boutell et al., 2002).  Boutell et 
al. (2002) demonstrated that full length ICP0 and its isolated RING finger domain 
possess E3 ubiquitin ligase activity in vitro.  Furthermore, deletion of the RING 
finger domain resulted in an inactive protein  
 
1.4.3.6. ICP0 and USP7 
 
The 135 KDa protein, named ubiquitin-specific protease 7 (USP7) is a member of 
a family of proteins that cleave ubiquitinylated cellular proteins.  It interacts with 
ICP0 residues 594-633 (Everett et al., 1997, Meredith et al., 1995, Meredith et al., 
1994).  Studies have shown that ICP0 is able to induce its own ubquitination in 
vitro, however, this is abolished when ICP0 binds to USP7 (Canning et al., 2004).  
More recent studies have shown reciprocal activity between ICP0 and USP7, 
suggesting that rather than ICP0 mediating degradation of USP7 at low multiplicity 
infections, USP7 stabilises ICP0 during the initial stages of HSV-1 infection 
(Boutell et al., 2005). 
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1.4.3.7. ICP0 and PML 
 
ND10 domains are punctate nuclear structures (Ascoli & Maul, 1991), the major 
constituent of which is PML (Maul et al., 2000).  In HSV-1 infection one of the early 
events is the association of the HSV-1 genome with ND10 domains (Everett & 
Murray, 2005).  Various studies have linked ICP0 to the disruption of ND10 
domains (Everett et al., 1998a, Everett & Maul, 1994, Maul & Everett, 1994) in a 
process that is dependent on its RING finger.  Everett et al. (1998b) proposed 
during HSV-1 infection, ICP0 induces the loss of the high-molecular weight 
isoforms of PML, and the loss of these proteins is dependent on an active 
proteasome-dependent degradation pathway (Everett et al., 1998a).  In 2003, 
using a transfection based approach and a family of deletion and point mutations, 
Boutell et al. demonstrated that sequences in the C-terminus and the lysine 
residue at position 160 of PML were necessary for ICP0-induced degradation of 
ND10 domains (Boutell et al., 2003).  Initial infection with an ICP0-null virus 
showed the major ND10 components (PML, Sp100, and hDaxx) accumulating in 
replication compartments with ICP4 (Everett et al., 2004b).  Everett and Murray 
(2005) showed that associated ND10-like complexes are formed in these 
replication compartments when ND10 proteins are deposited to create new 
aggregates in association with viral complexes, rather than by migration of pre-
existing intact ND10 structures.  Therefore ND10 constituent proteins migrate to 
the viral genome where ICP0 induced disruption and degradation takes place 
(Everett & Murray, 2005). More recently work using an siRNA approach was 
carried out where cells were depleted of PML and infected with HSV-1 ICP0-null 
virus.  It was observed that depletion of PML increased the plaque forming and 
gene expression efficiencies of the ICP0-null HSV-1 mutants.  This suggests that 
PML may contribute to a repressive mechanism that targets HSV-1 genomes and 
is countered by the activities of ICP0 (Everett et al., 2006).  
 
1.4.3.8. ICP0 and ICP4 
 
Both ICP0 and ICP4 have been shown to be present in the tegument of purified 
virions (Yao & Courtney, 1989), suggesting that upon entry of newly infected cells, 
these proteins function in synergy to activate viral gene expression (Yao & 
Schaffer, 1994).  Using far-western blotting analysis and glutathione S-
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showed ICP0 to be capable of interacting directly and specifically with itself and 
ICP4.  GST-ICP0 fusion protein affinity chromatography showed ICP4 to interact 
preferentially with the C-terminal amino acid residues 395-775 of ICP0.  Further 
deletion analysis suggested amino acids 617-775 of ICP0 may represent the major 
domain for physical interaction of ICP4 and ICP0 (Yao & Schaffer, 1994). 
 
1.4.3.9. ICP0-null viruses 
 
In order to asses the biological activities of ICP0, an ICP0-null virus, dl1403, was 
constructed (Stow & Stow, 1986).  HSV-1 viruses mutated for ICP0 are viable, but 
they exhibit a multiplicity and cell cycle-dependent defect in the onset of viral 
infection (Sacks & Schaffer, 1987, Yao & Schaffer, 1995).  Cell type is also a 
complicating factor when working with ICP0-null viruses.  This mutant virus has 
been shown to replicate to normal levels in the permissive osteosarcoma cell line 
U20S (Yao & Schaffer, 1995).  In Vero (African green monkey) and BHK (baby 
hamster kidney), replication efficiency is reduced, while replication efficiency in 
human fibroblast cell lines is extremely poor (Everett et al., 2004a, Hancock et al., 
2006, Stow & Stow, 1986).  Hancock et al. (2006) suggested gene expression is 
inhibited via a multi-step anti-viral gene silencing pathway and that VP16 and ICP0 
act as inhibitors of separate steps in this pathway.  This gene silencing pathway 
may be inactive in U2OS cells, accounting for the ability of these cells to 
complement defects in these viral functions. 
 
Upon infecting non-permissive cell lines with ICP0-null viruses, at a low MOI, 
either quiescence or stalled infection is observed.  Stalled infection displays one of 
three possible phenotypes; stalled with an incomplete set of expressed IE genes, 
stalled at the IE stage, or stalled with the expression of some E genes (Everett et 
al., 2004a).  However, this inhibition of infection can be overcome at a high MOI, 
whereby infection proceeds normally even in the absence of ICP0 (Everett et al., 
2004a, Stow & Stow, 1986). 
 
1.4.4. Viral transcription and translation  
 
The E genes are expressed after the IE genes.  Transcription of this set of genes 
requires functional ICP4 (Watson & Clements, 1980) but not viral DNA synthesis 
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thymidine kinase.  UL29 is expressed shortly after the onset of the synthesis of the 
IE proteins, while UL23 is expressed with more significant delay following IE 
protein expression (Huszar & Bacchetti, 1981, Roizman, 2001). 
 
The final class of genes to be expressed are the L genes, the expression of which 
begins with the initiation of DNA replication (Weir, 2001), which can be divided into 
two individual classes leaky-late and true-late genes (Roizman, 2001).  The 
true-late genes (for example, UL38), require DNA replication for significant levels 
of protein expression, while leaky-late genes (for example, UL19) can be 
expressed in the absence of DNA replication (Roizman, 2001).  The L genes 
encode for structural proteins of the virion including scaffolding proteins. 
 
1.4.5. Capsid assembly, DNA replication, packaging and virion maturation 
 
HSV DNA replication takes place in the nucleus of infected cells (Becker et al., 
1968).  The herpes simplex virus genome contains both cis- and trans-acting 
elements which are important in viral DNA replication (Wu et al., 1988).  Three cis-
acting replication origins are thought to exist, consisting of two distinct but related 
DNA sequences, oriL of which there is one copy in the viral genome and oriS of 
which there are two copies (Spaete & Frenkel, 1982, Stow, 1982, Stow & 
McMonagle, 1983, Weller et al., 1983).  Studies have shown that plasmid DNAs 
containing either oriL or  oriS are replicated when they are introduced into 
HSV-infected cells (Spaete & Frenkel, 1982, Stow, 1982, Stow & McMonagle, 
1983, Weller et al, 1983), suggesting that oriL and oriS are sites at which viral DNA 
synthesis is initiated (Wu et al., 1988).  Challberg (1986) showed that five cloned 
restriction fragments of HSV-1 DNA together can supply all of the trans-acting 
functions needed for the replication of plasmids containing oriL or  oriS when 
co-transfected into Vero cells (Challberg, 1986).  Using this approach in 
conjunction with data from large scale sequence analysis of the HSV-1 genome 
Wu et al. (1988) identified seven HSV genes which are necessary for transient 
replication of plasmids containing either oriL or oriS, As shown previously, two of 
these genes encode the viral DNA polymerase (UL30) and single-stranded DNA-
binding protein (UL29)`.  Wu et al. (1988) propose that the seven genes essential 
for plasmid replication comprise a set of genes whose products are directly 
involved in viral DNA synthesis. 
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It has been suggested that replication is a two-stage process.  Initial theta 
replication is followed by rolling circle replication to generate, head to tail 
concatemers of double stranded viral DNA (Boehmer & Lehman, 1997).  After 
replication viral DNA is incorporated into preformed capsids (Stow, 2001).   
 
Capsids containing DNA leave the nucleus by a budding event at the inner nuclear 
membrane, a process involving UL34 and UL31.  This results in the formation of 
enveloped virions in the perinuclear space.  The primary envelope fuses with the 
outer part of the nuclear membrane releasing the nucleocapsids into the 
cytoplasm.  The final stages of envelopment, including acquisition of tegument and 
envelope glycoproteins, occurs by budding into Golgi derived vesicles.  Mature 
virions are released following fusion of the vesicle membrane with the membrane 
compartment of the cell (Mettenleiter, 2004).   
 
Another model proposes multiple routes of egress for HSV-1, including budding of 
the capsids at the inner nuclear membrane into the perinuclear space where the 
tegument and a thick viral envelope are acquired.  Virions travel via intraluminal 
transportation into the Golgi cisternae, where one or more of the virions are 
packaged into transport vacuoles.  Alternatively, capsids may gain direct access to 
the cytoplasm via impaired nuclear pores.  Cytoplasmic capsids may bud at the 
outer nuclear membrane, at membranes of the endoplasmic reticulum (ER), or at 
Golgi cisternae (Leuzinger et al., 2005). 
 
1.5. Latent infection 
 
A specific feature of all herpesviruses is their ability to establish life-long latency 
within their hosts (Efstathiou & Preston, 2005).  Latency occurs due to a failure of 
the virus to initiate productive lytic infection as all the lytic genes are switched off 
(Preston, 2000).  During HSV-1 infection, primary replication at oral mucosa 
results in the virus accessing sensory nerve terminals.  The virions are then 
transported to neuronal cell bodies by retrograde axonal transport to trigeminal 
ganglia.   The genome is maintained as a nucleosomal circular episome during 
latency (Efstathiou & Preston, 2005, Preston, 2000).   
 
Latency is established when the viral genome is delivered to the nucleus but IE 
gene expression is not activated.  IE gene activation fails if the three proteins 
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(Efstathiou & Preston, 2005).  Kristie et al. (1999) attributed the failure of IE gene 
expression to occur because VP16 does not reach the neuronal nucleus in 
sufficient amounts to mediate IE gene expression.  Other work suggests that HCF 
sequesters VP16 at the cytoplasm of sensory neurons thus restricting IE 
transcription (Kristie et al., 1999).  It has also been proposed that a number of 
proteins related to Oct-1 fail to complex with VP16 thus acting as repressors of IE 
gene expression (Efstathiou & Preston, 2005). 
 
During latency the expression of all IE genes is known to be switched off (Preston, 
2000).  However, this is not the only defining feature of latency as a set of viral 
transcripts known as the latency associated transcripts (LATs) accumulate 
(Margolis et al., 1992, Preston, 2000).  Two major LAT products are produced 
from a 8.3 Kb polyadenylated transcript, a 2 Kb intron which is spliced and a 1.5 
Kb product (Farrell et al., 1991, Margolis et al., 1992).  These are located to the 
neuronal nucleus, and are transcribed anti-sense to and partially complementary 
to the ICP0 coding sequences (Preston, 2000).  In 1988 Javier et al. demonstrated 
that a virus that was unable to express LAT could still establish latency in mice 
and was also able to be reactivated (Javier et al., 1988).  This was confirmed by 
Steiner et al. (1989) who used a HSV-1 LAT deletion virus to infect mice.  They 
showed that in explanted trigeminal ganglia, that LATs were not required for the 
maintenance of latency (Steiner et al., 1989).  More recent studies have created a 
mouse transgenic for the LAT 5’ exon and 2 Kb intron.  When these mice were 
infected with HSV-1, no difference in lytic replication or in the establishment and 
maintenance of latency was observed when compared to non-transgenic mice.   
This suggests that LATs have no effect on these functions when supplied in trans 
(Gussow et al., 2006).   
 
A number of studies have suggested that the LATS are effective at blocking virus 
induced apoptosis both in vitro and in the trigeminal ganglia of acutely infected 
rabbits (Inman et al., 2001, Perng et al., 2000).  Ahmed et al. (2002) propose that 
the region of the LAT that includes the 2 Kb intron exhibits an antiapoptotic 
function.  In cells transfected with a construct expressing the 2 Kb LAT as well as 
several LAT deletion constructs it was observed that the 5’ region of the 2 Kb LAT 
intron and the exon 1 region of the LAT were vital for protection from apoptosis 
(Ahmed et al., 2002).  It is possible that the proposed ability of the LATs to prevent 
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extensive neuronal damage and subsequent neuronal disorders (Perng et al., 
2000). 
 
HSV-1 latency is associated with chromatin modification and remodelling as the 
latent genomes are known to persist as circular episomes associated with histones 
(Deshmane & Fraser, 1989).  Further work using cultured sensory neurones 
showed that the ICP0 promoter was activated by the histone deacetylase inhibitor 
trichostatin A (TSA), indicating that the latent genomes respond to changes in the 
acetylation state of histones (Arthur et al., 2001).   
 
Studies have shown that during latency, the lytic regions of the virus exist in a 
hypoacetylated (transcriptionally non-permissive) state, while the LAT promoter 
and 5’ exon/enhancer remain hyperacetylated (transcriptionally permissive) (Kubat 
et al., 2004).  Amelio et al. (2006a) used latently infected dorsal root ganglia to 
assess relative levels of LAT and histone H3 acetylation of the LAT locus and 
ICP0 promoter at early time post-explant.  The increase in levels of acetylation at 
the ICP0 promoter after deacetylation of the LAT enhancer suggested that 
chromatin remodelling at both the LAT locus and the ICP0 promoter may be 
directly linked during reactivation.  Therefore the LAT could function to recruit a 
novel histone-modifying complex, which establishes and maintains active 
expression of the LAT during latency (Amelio et al., 2006a).  Amelio et al. (2006b) 
identified a 1.5 kb region containing a CTCF (CCCTC-binding factor) motif in the 
LAT region.  This motif was found to exhibit enhancer blocking and silencing 
activites by binding to motifs on the latent genome and insulating the LAT 
enhancer, thus suggesting that the CTCF motif may facilitate the formation of 
distinct chromatin boundaries during HSV-1 latency (Amelio et al., 2006b). 
 
1.5.1. Reactivation from latency 
 
Reactivation of a latent virus can be caused by a number of factors including 
immune suppression, emotional and physical stress and exposure to UV light 
(Wysocka & Herr, 2003).  Given that during latency the viral genome is associated 
with non-acetylated histones, it would appear that the virus must act to overcome 
this repressive effect exerted by histones to overcome latency.  Thus reactivation 
would employ a mechanism of IE gene activation that can be initiated in the 
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In vivo reactivation studies have previously shown various stressful stimuli can 
lead to reactivation from latency (Wang et al., 2005).  This induces changes in the 
physiological state of sensory neurons that contain the latent viral genome 
(Sawtell & Thompson, 2004).  Latent HSV-1 in mouse ganglia was shown to be 
reactivated upon infection of dissociated ganglia with adenoviruses expressing 
VP16, ICP0 or ICP4 (Halford et al., 2001).  These findings indicate that in the 
absence of ICP0, adenovirus directed expression of VP16 or ICP4 initiates 
reactivation in neurone based systems, possibly by exerting a general effect on 
the genome or by stimulating ICP0 production from the quiescent or latent 
genome.  However Halford et al. (2001) showed that reactivation by ICP0-null 
mutants is considerably less efficient than that observed with wild type viruses 
upon explantation of ganglia suggesting reactivation can occur in the absence of 
ICP0. 
 
Recent studies using wild type, revertant, ICP0-null or ICP0-mutant viruses have 
demonstrated that upon hyperthermic stress in mouse models, ICP0-defective 
viruses did not produce infectious virus, however, they did express ‘lytic-phase 
viral proteins’ at levels that were as easily detectable as in reactivating neurones 
infected with wild-type and revertant viruses. This suggested that ICP0 is not 
required for the initiation of reactivation, but instead is needed to activate 
productive infection once reactivation has been initiated (Thompson & Sawtell, 
2006). 
 
1.5.2. Reactivation of quiescent genomes 
 
Work by Harris and Preston (1991), Preston and Nicholl (1997) and Samaniego et 
al. (1998) showed that after infection with mutants defective for IE proteins the 
virus establishes a quiescent state, during which promoters which would be active 
in the context of the cellular genome become repressed when placed in the 
context of the virus (Preston, 2000, Preston & Nicholl, 1997).   
 
ICP0 was initially believed to be the HSV-1 protein involved in reactivation of 
quiescent viruses following studies carried out by Russell et al. (1987) whereby 
quiescent virus was observed to resume replication following super-infection of 
cultures with HSV-1, HSV-2 or HCMV (Russell et al., 1987).  However it was 
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HSV-2, thus suggesting a requirement for ICP0 in the reactivation of quiescent 
HSV (Preston, 2007).  This was further confirmed when it was found that the 
mutant virus dl1403 could be retained in a quiescent state in human fibroblasts, 
and super-infection of these cultures with wild-type HSV-1 resulted in reactivation 
(Stow & Stow, 1989).  Therefore, it is possible that ICP0 can influence the balance 
between lytic and latent infection in cultured cells. 
 
A further observation by Preston (2007) suggested quiescent HSV-1 genomes are 
reactivated by super-infection with the ICP0-null virus (dl1403) under appropriate 
conditions.  Human fibroblasts were infected with in1374 (HSV-1 recombinant 
mutated for VP16, ICP0 and ICP4) to establish quiescent infection.  When 
super-infected with dl1403 at various MOIs and stained with X-gal most plaques 
observed were β-gal positive at the lowest MOI.  To eliminate effects of DNA 
replication, quiescent infected cells were super-infected with in1330 (HSV-1 
recombinant deleted for ICP0 and a temperature sensitive mutation in ICP4) or 
dl1403 and maintained at 32
oC or 38.5
oC.  β-gal expression was activated at 32
oC, 
but only dl1403 was active at 38.5
oC therefore dl1403 is dependent on functional 
ICP4 but not on DNA replication.  It is possible that genomes retain different levels 
of silence and upon super-infection some are more susceptible to trans acting 
factors from dl1403, thus reactivation of some quiescent genomes is observed, 
and therefore highlights similarities between quiescence in fibroblasts and latency 
in neurons (Preston, 2007). 
 
1.6. HCMV Biology 
 
1.6.1. The HCMV genome 
 
The HCMV genome is the largest within the herpesvirus family, consisting of a 
linear double stranded DNA molecule of 235646 bp with a G+C content of 
approximately 56%.  It is organised into two segments, designated UL and US, 
which are in turn flanked on one side by terminal repeated sequences (TRL and 
TRS) and on the other by internal repeats (IRL and IRS) yielding the overall gene 
configuration of TRL-UL-IRL-IRS-US-TRS (Chee et al., 1990, Mocarski, 2001).  
 
The HCMV strain AD169 genome sequence, published in 1990, predicted 208 
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However in 1997 Dargan et al. (1997) identified a novel 929 bp sequence in 
HCMV strain AD169 representing the upstream portion of the gene UL42 and an 
adjacent downstream portion of gene UL43.  As the novel 929 bp sequence was 
observed to be present in most isolates of AD169, the revised sequence of AD169 
was proposed to have a total genome length of 230283 bp (Dargan et al., 1997).  
AD169 is extensively used as a laboratory strain as, not only is the sequence 
available but it also replicates more efficiently than clinical isolates (Cha et al., 
1996).  However, it differs from clinical isolates in terms of genomic structure and 
biology (Prichard et al., 2001).  For example AD169 lacks 19 ORFs that are 
present in clinical isolates and it fails to replicate in endothelial cells, which are 
permissive for replication of some clinical isolates (Murphy et al., 2003b).   
Comparisons of AD169 with data from other strains showed it to be a multiple 
mutant, containing frame shifts in three genes RL5A, RL13, and UL131A (Davison 
et al., 2003b). 
 
Early work by Chee et al. (1990) established that the HCMV genome sequence 
(AD169) stood at 229354 bp.  As laboratory strains have undergone deletions and 
re-arrangments during adaptation to growth in cell culture and since HCMV has 
not yet been sequenced directly from genetic material a full picture of the gene 
content of wild type HCMV is not available (Davison et al., 2003a).  In order to 
improve interpretation, the HCMV sequence was compared with a close genetic 
relative, as most of the essential protein coding regions are conserved during 
evolution.  The Chimpanzee CMV (ChCMV) genome was sequenced (the closest 
known relative of HCMV) and used to reassess the gene layout of HCMV.  Of the 
189 unique genes originally proposed in AD169 by Chee et al. (1990), 108 
remained unchanged as a result of subsequent reinterpretations, 46 genes were 
discounted as being unlikely to encode proteins and five new AD169 genes 
(UL15A, UL21A, UL128, UL131A and US34A) were identified.  Further 
comparison of the ChCMV genome with the HCMV Toledo strain confirmed that 
the AD169 sequence was correct.  However, the additional region at the right end 
of UL in Toledo (containing 19 genes absent from AD169) was found not to be co-
loinear with the corresponding part of the ChCMV genome (Davison et al., 2003a).  
Thus derivation of the ChCMV sequence showed both HCMV AD169 and ChCMV 
genomes to be co-linear, each possessing a few genes lacking in the other. The 
40 core genes inherited from the common ancestor of the Alpha-,  Beta- and 
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non-core genes located nearer the genome termini.  Genes nearer the genome 
termini generally exhibited higher levels of sequence divergence reminiscent of the 
two sub-species of HHV-6.  Davison et al. (2003) concluded that ChCMV encodes 
165 genes each present as single copies, while AD169 contains 145 genes, with 
four of these genes present in two copies in the RL elements.  Therefore, 
assuming that the wild type HCMV genome approximates to the AD169 genome 
plus a rearrangement of the additional genes at the right end of UL in Toledo a 
complement of 164-167 genes was inferred (Davison et al., 2003a).   
 
The coding potential of the HCMV AD169 genome was also re-evaluated by 
Murphy et al. in 2003 using a Bio-Gene Finder (BDGF) algorithm.  The gene-finder 
algorithm was used to assess the potential of an ORF to encode a protein based 
on matches to a database of amino acid patterns derived from a large collection of 
proteins.  The algorithm was used to score HCMV ORFs with the potential to 
encode polypeptides greater than 50 amino acids in length.  The genomes of 
chimpanzee, rhesus and murine cytomegalovirus were also analysed using BDGF 
to search for orthologues of predicted HCMV ORFs as a further test for 
functionality.  The analysis by Murphy et al. (2003) discounted 37 ORFs predicted 
by Chee et al. (1990), and further predicted 12 novel protein coding ORFs, 
predicting that the HCMV genome contains approximately 192 unique ORFs with 
the potential to encode a protein (Murphy et al., 2003a). 
 
The genetic content of the HCMV genome was further investigated by sequencing 
the 235645 bp genome of a low passage strain Merlin.  Comparative analyses with 
the genome of AD169 indicated that the strain Merlin accurately reflected the wild 
type complement of 165 genes (Dolan et al., 2004).  This study by Dolan et al. 
(2004) however, discounted the 12 novel protein coding ORFs predicted by 
Murphy et al. (2003) as only modest levels of discrimination were thought to be 
achieved using the BDGF, even for recognised genes. Therefore, without 
additional data it was considered premature to include these ORFs in the gene 
layout. 
 
The HCMV genome is densely packed with ORFs, but contains very few 
polyadenylation signals.  Thus, many spliced and non-spliced HCMV genes share 
polyadenylation signals, leading to the generation of 3’ co-terminal groups within 
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ORFs such as UL146/UL147A (Lurain et al., 2006), UL122/UL123 and UL37 
overlap (Adair et al., 2003, Awasthi et al., 2004). 
 
1.6.2. HCMV capsid 
 
Three types of HCMV capsids are produced: A capsids which are the products of 
abortive DNA packaging and lack the viral genome, B capsids which are 
precursors of fully mature particles, containing scaffolding proteins but again lack 
the DNA genome, and C capsids which are mature capsids containing the full 
length viral genome (Gibson et al., 1996). 
 
The study of HCMV capsids has focused on the B capsid, which is the pre-formed 
capsid prior to DNA encapsidation, tegument formation and envelopment.  It 
consists of proteins found in the capsid within the intact virus particle including an 
internal assembly protein (Chen et al., 1999).  The HCMV capsid consists of four 
structural components: the major capsid protein (MCP), the minor capsid protein 
(mcP), the minor capsid binding protein (mCBP) and the small capsid proteins 
(SCP) (Borst et al., 2001).  HCMV SCP is considered to be the homologue of 
HSV-1 VP26 and, similar to its HSV-1 counterpart, it is found located the tips of 
hexameric capsomers (Borst et al., 2001, Gibson et al., 1996).   
 
HCMV B capsids are larger in diameter than HSV-1 capsids (130 nm and 125 nm 
respectively), allowing the HCMV B capsid to accommodate a DNA molecule that 
is 60% larger than the HSV-1 genome (Butcher et al., 1998).  These differences in 
capsid size can be attributed to spacing and relative tilt of HCMV triplex proteins 
and the size of the scaffold core (Butcher et al., 1998).  Electron-cryomicroscopy 
was used to image full and empty HSV-1 and HCMV capsids.  Measurements 
obtained from images showed that the HCMV genome is packaged at a higher 
density, than the HSV-1 genome, with an inter-layer spacing of 23 Å compared to 
26 Å of HSV-1 (Bhella et al., 2000). 
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1.7. HCMV pathogenesis 
 
1.7.1. HCMV prevalence and disease 
 
HCMV is thought to be acquired at an early age.  In developed countries 
seroprevalence is thought to be around 30-70%.  However, in developing 
countries, the prevalence exceeds 90% in certain socioeconomic groups and 
homosexual men (Gandhi & Khanna, 2004).  The virus is transmitted via a number 
of routes that include sexual contact, saliva, placental transfer, breast-feeding, 
blood transfusion, solid organ transfer or haemopoietic stem cell transfer (Pass, 
2001). 
 
Infection with HCMV during pregnancy often results in severe consequences.   
Statistics show primary infection during gestation poses a 30-40% risk of clinical 
disease (Fisher et al., 2000). The risk to the infant is greatest if infection occurs 
during the first trimester of pregnancy (Gandhi & Khanna, 2004).  The infant can 
be infected via viral transmission through the placenta, during delivery from 
cervical secretions, blood or from the mother by breast milk (Fisher et al., 2000).  
 
Approximately 15% of women with primary HCMV infection during the early stages 
of pregnancy abort spontaneously (Griffiths & Baboonian, 1984).  It is the 
placenta, not the foetus that shows evidence of infection, suggesting the placenta 
is infected before the embryo or the foetus (Mostoufi-zadeh et al., 1984).  Recent 
studies by Fisher et al. (2000) used culture models of trophoblast populations from 
the maternal-foetal interface to observe HCMV infection of human placental cells 
in vitro.  They observed the placenta to be an ineffective barrier to HCMV 
transmission, with cytotrophoblasts becoming infected in several locations.  These 
locations suggest specific routes by which the virus reaches the foetus in utero.  
Currently no vaccine is available for HCMV infected infants, however, some 
studies have shown that administration of intravenous human immunoglobulin to a 
pregnant mother with a primary HCMV infection, could potentially protect the 
foetus (Malm & Engman, 2007). 
 
Ten to seventeen percent of infants with asymptomatic infection develop hearing 
defects or neurodevelopmental sequelae.  Furthermore 5-10% of congenitally 
infected neonates present with irreversible CNS involvement in the form of 
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psychomotor retardation (Boppana et al., 1992).  Infected newborn babies can 
also show other clinical features such as jaundice, petechiae and hepatitis, all of 
which tend to resolve without treatment.  However long-term studies have 
indicated that 80% of affected infants display serious life long neurological 
abnormalities with severe life threatening organ dysfunction and death in 10-20% 
of patients (Gandhi & Khanna, 2004). 
 
As HCMV can establish latent infections it is thought the foetus can in some cases 
become infected after reactivation of maternal infection.  In this case, less severe 
clinical disease is observed in the offspring (Gandhi & Khanna, 2004).   
 
Initial infection with HCMV results in a primary immune response, with subsequent 
establishment of long-term immunity preventing viral replication after reactivation 
from latency.  However long-term immunosupression can lead to uncontrolled 
replication of the virus in the host and can result in serious disease (Gandhi & 
Khanna, 2004).  In cases of solid organ transfer such as kidney transplantation, 
HCMV is the single most frequent infectious complication observed (Sagedal et 
al., 2005), with the risk of infection being heightened because the patient is 
immunosuppressed.  Those most at risk are serologically negative patients who 
receive organs from serologically positive donors.  Limited organ availability 
means matching seronegative donors and recipients is not always possible 
(Gandhi & Khanna, 2004).  HCMV associated disease in 
transplant/immunosupressed patients manifests itself in the transplanted organ 
(i.e. hepatitis arises in liver transplant patients, pancreatitis arises in pancreas 
transplant patients).  However, disease can spread rapidly leading to a host of 
other symptoms including pneumonitis, enteritis, retinitis and CNS involvement 
(Sagedal et al., 2005). 
 
One method of preventing HCMV disease is pre-emptive anti-HCMV therapy.  An 
antiviral agent is introduced at the first signs of HCMV antigenaemia (detection of 
HCMV pp65 antigen in leukocytes), positive HCMV PCR, or positive HCMV 
viraemia in the blood.  When compared with prophylaxis this method means fewer 
patients are exposed to anviral agents, resulting in less drug resistance (Sagedal 
et al., 2005).   
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1.7.2. HCMV latency and reactivation 
 
As mentioned previously latency and reactivation are the defining characteristics 
of herpesviruses and HCMV is no exception.  It is able to effectively establish 
lifelong persistence within the host following initial usually asymptomatic infection, 
by persisting in specific sites in the host.  However the viral genome retains the 
ability to reactivate in response to specific stimuli (Sinclair & Sissons, 2006). 
 
The presence of HCMV DNA in the peripheral blood leukocytes of healthy, HCMV 
seropositive individuals was only discovered by the technological advances of 
PCR (Stanier et al., 1992, Taylor-Wiedeman et al., 1991).  It was established that 
peripheral blood monocytes are the major site of carriage of HCMV DNA in healthy 
individuals by using sorted peripheral blood monocytes (Larsson et al., 1998, 
Smith et al., 2004, Taylor-Wiedeman et al., 1991).  Other studies have shown that 
HCMV DNA could be detected in CD34
+ bone marrow progenitors (Mendelson et 
al., 1996).  Although CD34
+ cells give rise to B cells, T cells and 
polymorphonuclear leukocytes (PMNLs) as well as monocytes no evidence of 
HCMV has been detected in the PMNL, T-cell or B-cell fractions of peripheral 
blood, in normal healthy carriers (Taylor-Wiedeman et al., 1991).  How the HCMV 
genome is maintained selectively in only particular sub-sets of cells arising from 
common CD34
+ stem cells carrying viral DNA is as yet not understood (Sinclair & 
Sissons, 2006).  Various studies have determined that in monocytic cells and their 
precursors, it appears that HCMV is carried in a true latent state, with little or no 
accompanying viral IE gene expression (Mendelson et al., 1996, Taylor-Wiedeman 
et al., 1994).   
 
Various latent model systems have been set up to try to identify HCMV latent viral 
transcripts.  Early work by Kondo et al. (1996) used infected granulocyte- 
macrophage precursors (GMPs) derived from foetal liver cells to identify HCMV 
transcripts expressed in the absence of virus production, termed cytomegalovirus 
latency-specific transcripts (CLTs).  The CLTs were found to include novel spliced 
and unspliced RNA transcripts that mapped to both strands of the HCMV major IE 
region (Kondo et al., 1996).  Some of these transcripts and antibodies to CLT 
ORFs were detected in healthy seropositive individuals, but many transcripts were 
also detected in infected cells in culture (Kondo et al., 1996), thus the true role of 
these transcripts remains to be established.  Goodrum et al. (2002) identified 
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production of infectious virions; many, if not all which were also detected in 
productive infection.  However, it was not determined whether any of these 
transcripts were detected in mononuclear cells of normal, healthy carriers 
(Goodrum et al., 2002).  Studies based on transcripts identified by Goodrum et al. 
(2002) identified viral RNA from monocytes of healthy seropositive carriers (Bego 
et al., 2005).  These RNA transcripts were observed to be antisense to the UL81-
82 region of the viral genome.  As these RNA transcripts were partially antisense 
to the viral UL82 gene, encoding pp71 a transcriptional transactivator of the MIEP, 
it has been suggested this transcript (or its protein product) maybe involved in 
restricting IE gene expression in order to maintain latency (Bego et al., 2005).  
 
It is generally considered that myeloid cells are an important site of true latency in 
vivo.  However, the possibility remains that in healthy carriers other sites of latency 
may occur, this is mainly due to a number of cell types becoming rapidly infected 
upon clinical reactivation (Sinclair & Sissons, 2006).  It was suggested that 
endothelial cells (ECs) may be a reservoir of latent virus as CD34
+ bone marrow 
derived cells may give rise to ECs (Jarvis & Nelson, 2002, Quirici et al., 2001).  
This however, was disputed by Reeves et al. (2005), as latent HCMV genomes 
were not detected in ECs of healthy seropostive individuals, despite HCMV DNA 
being readily detected in monocytes at the same time.  It is therefore possible that 
HCMV may persist in certain cells types, at a low level of productive infection 
(Sinclair & Sissons, 2006). 
 
After establishing latency within its host, sporadic reactivation events can occur, 
that are generally controlled by cell-mediated immunosurveillance.  However when 
reactivation occurs in immnocompromised or immunosuppressed individuals 
replication of the virus becomes uncontrolled leading to morbidity and mortality 
(Sinclair & Sissons, 2006).  As with the other herpesviruses (EBV and HSV-1), 
reactivation from latency is dependent upon expression of viral IE genes which 
determine commitment of the virus to lytic infection (Sinclair & Sissons, 2006). 
 
Myeloid cells appear to be classical sites of viral latency, in peripheral blood of 
healthy individuals carrying viral DNA no appreciable levels of infectious virus or 
lytic gene expression is observed (Mendelson et al., 1996, Taylor-Wiedeman et 
al., 1994).  It is believed that the undifferentiated nature of these cells is important 
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myeloid cells differentiate to macrophages and dendritic cells (DC) a fundamental 
change in their ability to support IE gene expression occurs (Taylor-Wiedeman et 
al., 1994).  Differentiation of these myeloid cells, generated from healthy 
seropositive carriers, reactivated HCMV and suggested that latency and 
reactivation in these cells maybe controlled by chromatin remodelling of the MIEP 
to regulate lytic gene expression (Reeves et al., 2005a).  Chromatin-mediated 
regulation of transcription is achieved by a number of post-translational 
modifications of histone N-terminal tails (Berger, 2002).  Histone acetylation 
causes chromatin to adopt an open structure allowing access of DNA-binding 
factors to the DNA template resulting in an increase in gene expression.  The 
recruitment of various silencing proteins e.g. heterochromatin protein 1 (HP1) or 
the deacetylation or methylation of histones causes a closed, transcriptionally 
silenced chromatin state preventing viral gene expression (Kouzarides, 2002). 
 
Reeves et al. (2005b) showed that in CD34
+ cells, the viral MIEP is associated 
with the HP-1 protein and not acetylated histones, consistent with CD34
+ cells 
being non-permissive for HCMV IE gene expression.  In contrast, differentiation of 
infected CD34
+ cells to mature CD34
+-derived DCs, ultimately resulted in 
reactivation of infectious virus.  This was observed to be preceded by chromatin 
remodelling of the MIEP such that it was associated with acetylated histones.   
Thus repression of the HCMV lytic gene expression after infection of CD34
+ cells 
correlates with the recruitment of repressive chromatin markers (HP1) to the MIEP 
promoter. The exact mechanism, however, remains unclear (Reeves et al., 
2005b). 
 
Murphy et al. (2002) showed using transformed human cell lines, teratocarcinoma 
cells (NT2D1) and the myelomonocytic (THP1) cells, that when undifferentiated 
(non-permissive for HCMV IE gene expression), repression of the MIEP in these 
cells was associated with a closed chromatin conformation.  However, when 
differentiation of these cells was induced with retinoic acid or phorbol esters to 
allow them to become permissive for HCMV IE gene expression acetylated 
histones were associated with the MIEP, consistent with transcriptional activation 
at the MIEP.  Recent studies have shown that cellular transcription factor, Ets-2 
repressor factor, (ERF) physically interacts with HDAC1 to mediate the repression 
of the MIEP in undifferentiated non-permissive cells.  This suggests that the 
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(2002) upon differentiation of cells from a non-permissive to permissive phenotype 
(Murphy et al., 2002) may be due to differential recruitment of chromatin 
remodellers such as HDAC1 by factors such as ERF (Wright et al., 2005).   
 
1.8. HCMV Lytic infection 
 
1.8.1. Attachment and penetration 
 
The first event in HCMV infection is attachment to and penetration of the host cell 
membrane.  During this process, glycoproteins on the viral envelope play an 
important role in adsorption and penetration of the virus into the cell (Cirone et al., 
1994, Yurochko et al., 1997).  The initial association of the virion with the cell 
membrane is followed by binding of viral glycoproteins to specific receptors 
(Navarro et al., 1993).   
 
Three major glycoprotein complexes of the virus have been identified, the gCI, 
gCII, and gCIII.  The gCI complex, which is composed of homodimeric molecules 
of gB, is a highly conserved herpesvirus glycoprotein, linked by disulphide bonds.  
This homodimeric complex can promote virion penetration into cells and promote 
transmission of infection from cell-to-cell (Bold et al., 1996, Compton et al., 1992, 
Navarro et al., 1993). The gCII complex is composed of glycoproteins gM and gN 
(Li et al., 1997), linked by non-covalent and disulphide bonds (Mach et al., 2000).  
The physical interaction between the two glycoproteins is presumed to be 
necessary for the correct post-translational modification and transport of the 
complex through the exocytic pathway (Mach et al., 2000).  Deletion of the 
carboxy-terminal of gN resulted in a replication incompetent virus.  However, when 
compared to wild-type virus it was found that complex formation of mutant gN with 
gM and transport of the complex to the viral assembly compartment seemed to be 
unaltered (Mach et al., 2007).  Mach et al. (2007) suggest that gN may be involved 
in the secondary envelopment of the HCMV virion as disruption of the 
carboxy-terminus of gN resulted in a decrease in secondary envelopment of 
HCMV capsids. 
 
The gCIII complex was initially thought to consist of two glycoproteins with 
average molecular masses of 145 and 86 kDa.  These were thought to be 
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later established that the gH homologue of HSV-1 required a second protein, gL, 
for intracellular transportation, and correct folding of gH.  Thus, the gL homologue 
of HCMV was identified (Spaete et al., 1993).  Spaete et al. (1993) showed gH and 
gL of HCMV complexed by forming disulphide bonds, suggesting the gCIII 
complex consisted of an oligomeric form of gH and gL.  Later work identified a 
third member of this complex, gO (Huber & Compton, 1997, Huber & Compton, 
1998, Li et al., 1997).  The tripartite gH-gL-gO complex assembled in two steps 
with gH and gL associating by disulphide bonding to form the gH-gL complex, 
followed by subsequent association of gO.  This forms a precursor pgCIII complex 
that is processed to the mature gCIII complex in a post-endoplasmic reticulum 
compartment (Huber & Compton, 1999).  In addition a gO deletion mutant virus 
was impaired for viral growth and cell-to-cell spread, suggesting a role for gO in 
the fusion and entry process (Hobom et al., 2000).   
 
Following interaction with gB and heparan sulphate binding, the gB homodimer is 
believed to interact with the epidermal growth factor receptor (EGFR) inducing an 
intracellular signalling cascade (Wang et al., 2003).  Activation of EGFR initiates 
receptor homodimerization/hetero-oligomerization, leading to autophosphorylation 
at specific tyrosine residues, receptor internalization and the induction of 
associated intracellular signalling (Schlessinger, 2000, Ullrich & Schlessinger, 
1990).  Following release of the capsid into the cytoplasm some of the tegument 
components are lost.  Transport of the capsid is thought to occur when viral 
tegument proteins interact with the host machinery involved in cellular transport 
systems (Sodeik, 2000). Studies have demonstrated a close association of the 
HCMV capsid with the microtubule network in fibroblasts infected with HCMV. 
(Towne strain).  Disruption of the microtubule network with the microtubule 
depolymerising drugs nocodazole and colchicine resulted in capsids being unable 
to move to close proximity to the nucleus.  This suggested that HCMV capsids 
associate with the microtubule network to facilitate their own movement to the 
nucleus prior to the onset of IE gene expression and that this association is 
required to start efficient gene expressin (Ogawa-Goto et al., 2003). 
 
1.8.2. IE gene expression 
 
The expression of HCMV genes is temporally regulated.  The first genes to be 
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(Chambers et al., 1999).  At least 1 hr post-infection, four genomic regions, UL36-
38, TRS1-IRS1, MIE and US3 begin producing IE transcripts (Mocarski, 2001).  
The majority of gene expression immediately after viral entry arises from a single 
locus, known as the major immediate early (MIE) locus, comprising the IE1/IE2 
(alternatively spliced UL122 and UL123 genes).  This generates proteins that are 
synthesised by alternative mRNA splicing, the two most important products of 
which are IE1/IE72 and IE2/IE86 (Mocarski, 2001).  Both IE1 and IE2 share 85 
amino-terminal amino acids that correspond to MIE exons 2 and 3 but have 
distinct carboxy-terminal parts encoded by exons 4 and 5 (IE1 and IE2 
respectively) (Marchini et al., 2001).  Regulation of HCMV gene expression by the 
IE proteins is presented in figure 1.4. 
 
1.8.2.1. IE1 
 
IE1 is able to augment transcription from a number of viral and cellular promoters, 
including the HCMV MIEP, various HCMV E promoters and the SV40 early 
promoter (Castillo & Kowalik, 2002, Mocarski, 2001).  Studies using IE1-null 
viruses have shown that at high input multiplicities the viruses are able to replicate 
efficiently.  However, at low MOI the absence of IE1 causes a block in HCMV E 
gene expression (Gawn & Greaves, 2002, Greaves & Mocarski, 1998).  This 
defect of IE1 mutant viruses at low MOI is attributed to a failure/delay in the 
accumulation of E gene products.  Examination of levels of IE2 protein in cells 
infected with these viruses showed it was comparable to levels in wild-type virus 
but the intranuclear localisation pattern was altered (Ahn & Hayward, 2000, 
Greaves & Mocarski, 1998). 
 
The IE1 gene product behaves similarly to ICP0 by associating with and disrupting 
ND10 structures.  IE1 accumulates at ND10 domains, disassembling their 
structure and allowing IE2 to gather juxtaposed to ND10 in a region where HCMV 
can initiate transcription (Ishov et al., 2002).  Subsequently PML, Sp100, SUMO 
and IE1 are all displaced from ND10s into the cytoplasm (Ahn et al., 1998, Ahn & 
Hayward, 1997, Korioth et al., 1996, Mocarski, 2001).  Ahn et al. (1998) proposed 
that a direct interaction of IE1 and the N-terminal RING finger domain of PML 
leads to the displacement of both PML and IE1 from ND10 domains into the 
nucleus. 
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Figure 1.4  Regulation of HCMV gene expression during productive infection
Productive infection with HCMV results in a regulated cascade of viral gene expression designated IE, E and L.  
Expression of the major IE gene products, IE1 and IE2 is a result of differential splicing of the same primary transcript.  
IE1 is compromised of exons 2, 3, and 4 and IE2 of exons 2, 3, and 5. IE1 and IE2 act synergistically to activate viral E 
and L gene expression.  IE2 can negatively auto-regulate its own promoter by binding to the cis-repression signal (CRS).
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IE1 is also post-translationally modified by covalent conjugation of SUMO-1 
(Spengler et al., 2002).  Mutant viruses deficient for SUMOylation of IE1 have 
shown that the SUMO modification of IE1 is necessary for efficient HCMV 
replication (Nevels et al., 2004a).  Mutational analysis revealed the acidic 
C-terminal region of IE1 is dispensable, while the central hydrophobic region is 
required for binding to and deSUMOylation of PML.  Mutant forms of IE1 that failed 
to bind to or deSUMOylate PML were also unable to target to or disrupt ND10s.  
This indicated that the disruption of ND10 domains by IE1 was linked to the 
deSUMOylation of PML (Lee et al., 2004) 
 
An additional activity of IE1 is its ability to bind to cellular chromatin, which is 
dependent upon sequences within the acidic C-terminus (Wilkinson et al., 1998).  
Recently it has been proposed that IE1 can promote viral transcription by 
antagonising histone deacetylation (Nevels et al., 2004b).  Nevels et al. (2004b) 
showed that IE1 and HDAC3 could be co-immunoprecipitated from extracts of 
transfected and virus infected cells, suggesting IE1 may interact with HDAC3 to 
inhibit its activity. 
 
1.8.2.2. IE2 
 
IE2 is able to control the switch between IE, E, and L gene expression during 
productive infection (Mocarski, 2001).  The IE2 gene product regulates 
homologous/heterologous viral and cellular promoters in the absence of IE1, or 
more efficiently in the presence of IE1 (Kim et al., 1999, Mocarski, 2001).  Like 
IE1, IE2 localises to or adjacent to ND10 domains however, it is unable to disrupt 
them.  When acting in conjunction IE1 and IE2 cause efficient viral gene 
expression and DNA replication (Ahn & Hayward, 2000).   
 
IE2 is a repressor of its own MIEP via direct DNA binding to the MIE cis-repression 
signal (CRS) near the 5’ cap site in transient-co-transfection assays (Liu et al., 
1991, Pizzorno & Hayward, 1990).  Recent studies have shown that 
autorepression by IE2 at late times of infection correlates with changes in 
chromatin structure around the MIEP.  IE2 can interact with HDAC1 and histone 
methyltransferases in vitro and in vivo, resulting in an increase in autorepression 
of the MIEP (Reeves et al., 2006). 
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IE2 (like IE1) is affected by SUMO-1; however, IE2 has both covalent conjugation 
and a direct protein-protein interaction with SUMO-1, SUMO-2, SUMO-3 and a 
SUMO-conjugating enzyme Ubc9 (Ahn et al., 2001).  Two lysine residues were 
identified as the major alternative SUMO-1 attachment sites and it was established 
that the SUMOylation of IE2 is required for its transactivation function.  The SUMO 
modification of IE2 is enhanced via an interaction with a protein inhibitor of STAT 
(PIAS1), which can act as an E3 ligase for IE2 (Lee et al., 2003).   
 
Sommer et al. (1994) showed that IE2 interacts with a hypo-phosphorylated form 
of Rb (Sommer et al., 1994).  They suggested this interaction takes place via two 
separate binding domains and IE2 can regulate gene expression through the 
formation of multimeric protein complexes (Hagemeier et al., 1994).  Further 
studies showed that, not only does IE2 bind to Rb, but this complex also acts to 
relieve the IE2 repression of the MIEP (Choi et al., 1995).   
 
1.8.2.3. Role of HCMV E and L genes 
 
The classification of E and L genes is dependent on both their timing of expression 
and their sensitivity to inhibitors of viral DNA synthesis.  Both E and L genes are 
thought to be activated by targeting the TATA box, initiator elements and upstream 
promoter elements located within 100-200 bp of transcription start sites by IE gene 
products (Mocarski, 2001).  The timing of expression of these viral genes is 
modulated by transcriptional and post-transcriptional controls dictating the 
appearance of proteins and sensitivity of viral replication to the physiological 
control of the host cell. This influences events such as the activation of host cell 
protein degradation machinery and the accumulation of E and L gene products 
during infection (Mocarski, 2001).  Most E and L genes have a polycistronic 
structure correlating with the few polyadenylation signals within the viral genome.  
Most of the 3’ co-terminal families of transcripts are generated from a series of 
promoters each controlling a separate gene (Mocarski, 2001).  
 
E genes have a promoter structure, consisting of an upstream region, spanning a 
100-200 bp sequence containing a cis-acting regulatory element for transactivating 
viral and cellular promoters.  Two E transcripts of 1.2 Kb and 2.7 Kb represent 
approximately 20%-40% of total viral transcription during early times of infection 
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DNA replication, packaging and maturation of virus particles (Chambers et al., 
1999, Mocarski, 2001). 
 
Investigations into L gene expression have been limited, thus little is known about 
these genes.  Two types of transcripts known as the leaky late or true late genes 
are produced, the regulation of each being markedly different (Mocarski, 2001).  
The true late genes, for example, encoding pp28, have a very basic promoter 
structure in that they lack upstream cis-regulatory elements, thus true late gene 
expression is dependent on the replication of viral genomic DNA (Depto & 
Stenberg, 1992).  The L genes are essentially expressed after the onset of viral 
DNA replication and their products are responsible for virion assembly and 
morphogenesis (Chambers et al., 1999). 
 
1.8.3. HCMV DNA replication and packaging 
 
HCMV contains a single lytic origin of replication, ori-Lyt, (Hamzeh et al., 1990) 
which is located near the centre of the UL region upstream of the DNA binding 
protein ppUL57 ORF (Masse et al., 1992).  The HCMV ori-Lyt is composed of a 
core that spans 1548 nucleotides, and contains two essential regions (I and II) 
(Anders et al., 1992, Masse et al., 1992).  Both regions are a site of active 
transcription and are complex in nature, consisting of a pyrimidine-rich region, 
several transcription factor binding sites, and direct and inverted repeat sequences 
(Anders et al., 1992, Huang et al., 1996, Masse et al., 1992).  In human fibroblasts 
ori-Lyt dependent DNA replication requires core replication machinery and the 
gene products of IE2, and UL36-38 (Reid et al., 2003, Sarisky & Hayward, 1996).  
However while Sarisky and Hayward (1996) perceived that UL84 was essential for 
ori-Lyt activity, Reid et al. (2003) found UL84 to be dispensable in their transient 
transfection assays.  However, Reid et al. (2003) found UL84 inhibited both 
transactivation of E genes by IE2 and enhanced its activity as a negative 
autoregulator.  This suggested that the balance between levels of IE2 and UL84 
may have a significant effect on viral DNA replication (Reid et al., 2003).  Recent 
studies however, have shown UL84 interacts with IE2 to activate the ori-Lyt 
promoter to initiate DNA replication, however, the precise mechanisms of this 
process remain unknown (Xu et al., 2004).   
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The majority of research regarding capsid assembly has been derived from 
studies of HSV-1 (see section 1.4.5).  In the case of HCMV it is generally accepted 
that capsid assembly occurs in the nucleus of infected cells (Sanchez et al., 
2000a).  The virally encoded DNA polymerase produces large-head-to tail 
concatemers, which are cleaved into genomic-length pieces before being 
packaged into capsids.  Genomes are packaged into capsids through a portal 
coded by UL104 that acts a dock for the terminase enzyme (Dittmer & Bogner, 
2005, Nixon & McVoy, 2002).  The driving force behind this process is the 
ATP-ase activity of the terminase enzyme, which pushes DNA into the capsid 
(Hwang & Bogner, 2002).  Recently several putative functional domains in pUL89, 
such as the pUL89 zinc finger (pUL89-ZF), DNA cutting sites and portal binding 
sites, were identified as being involved in DNA cleavage and packaging (Champier 
et al., 2007). 
 
1.8.4. HCMV capsid transport 
 
The size of HCMV capsids prevents their transport into the cytoplasm through the 
NPC, therefore nuclear egress requires the penetration of nuclear membranes and 
the nuclear lamina.  This occurs through an envelopment/de-envelopment process 
similar to that observed in HSV-1.  Following release into the cytoplasm, the 
HCMV capsid acquires the majority of its tegument proteins (including UL25, UL32 
and UL99 which are excluded from the nuclei during productive infection), which 
aggregate at the cytoplasmic surface of the membrane (Sanchez et al., 2000b).  
Of particular importance is UL32, which encodes the tegument protein pp150 that 
accumulates in a cytoplasmic inclusion adjacent to the nucleus at late times during 
infection.  Use of a UL32 deletion mutant has shown that pp150 is critical for virion 
maturation in the cytoplasmic compartment and for virion egress at the final stages 
of envelopment (AuCoin et al., 2006).  The capsids are enveloped at Golgi 
apparatus-derived cisternae by a wrapping process and released by fusion with 
the plasma membrane (Buser et al., 2007, Homman-Loudiyi et al., 2003).   
However given that several models of capsid assembly have been proposed for 
HSV-1 this might also be the case for HCMV. 
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1.9. The HCMV MIEP 
 
The MIE regulatory region controls transcription of the IE1 and IE2 genes through 
both positive and negative cis-acting elements.  The area upstream of the HCMV 
MIEP is divided into three regions: the modulator, the unique region and the 
enhancer.  Deletion of the modulator region has no detectable effect on viral 
replication (Meier & Stinski, 1997).  The unique region contains multiple protein 
binding sites however, deletion analysis of the unique region showed it has no 
effect on transcription from the MIEP (Lundquist et al., 1999). 
 
The boundaries of the enhancer regions span –65 to –550 bp, with respect to the 
transcription start site at position +1 of the MIEP.  It can be further divided into a 
distal and proximal enhancer and many of the cis-acting elements are found in the 
enhancer region (Isomura & Stinski, 2003).   
 
The enhancer region is extremely complex and contains a strong transcriptional 
enhancer made up of an array of 17, 18, 19 and 21 bp repeat elements (Boshart et 
al., 1985, Ghazal et al., 1987).  Activity of the MIE enhancer is dependent on an 
interaction of various cellular and viral proteins with the cis-acting elements in a 
number of transfection, in vitro or transgenic animal studies (Meier & Stinski, 1996, 
Meier & Stinski, 1997).  The enhancer’s activity can be stimulated by cellular 
transcription factors including Sp1, NF-κB, ATF, ELK1, AP1 and serum response 
factor (SRF) (Ghazal et al., 1992, Ghazal et al., 1987, Ghazal et al., 1988).  These 
transcription factors bind to the different repeat elements located throughout the 
enhancer, and many of them bind to multiple sites (Meier & Stinski, 1997).  The 
cellular CREB/ATF proteins bind to the TTGACGTCAA sequence which forms the 
core of the 19 bp repeat element, five of which are located in the enhancer region.  
The Sp1 and NF-κB transcription factors bind to 21 bp and 18 bp repeat elements 
respectively.  Three copies of the 21 bp elements and four copies of the 18 bp 
elements have been found in the enhancer region (Cherrington & Mocarski, 1989, 
Liu & Stinski, 1992). 
 
Studies have shown that the distal enhancer is necessary for efficient IE gene 
expression and viral replication at low MOIs (Meier & Pruessner, 2000).  Various 
viral proteins including pp71 can also stimulate enhancer activity in the presence 
of one or more ATF sites within the region (Liu & Stinski, 1992) (The actions of 
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In contrast to the positive regulatory effects of the MIE enhancer region, its 
function can also be repressed by a transcription factor YY1.  When YY1 binds to 
a 21 bp repeat element in the HCMV MIEP-regulatory region in un-differentiated 
non-permissive cells, it mediates a repressive effect on HCMV IE gene expression 
and may be a mechanism by which viral latency is maintained (Liu et al., 1994). 
 
Although expression of the MIEP can be modulated by various cellular factors, its 
role in viral infection remains unclear.  Murphy et al. (2002) demonstrated a role 
for HDAC in suppressing the MIEP.  It has already been suggested that HDACs 
play a role in controlling HSV-1 latency, (Arthur et al., 2001) therefore the 
recruitment of chromatin silencing factors to the MIEP may be involved in 
repressing gene expression during HCMV latency.  This HDAC-mediated 
repression of HCMV appears to occur within the MIEP in the region encompassing 
the modulator and 21 bp repeat elements of the enhancer region.  Upon 
differentiation of cells, the histones surrounding the promoter are thought to 
become acetylated thus viral transcription and, in turn, productive HCMV infection 
occurs.  In non-permissive cells the presence of high levels of HDACs causes 
inhibition of HCMV infection due to deacetylation of histones surrounding the 
MIEP, and recruitment of HP1 causes silencing of the promoter (Murphy et al., 
2002). 
 
1.10. HCMV pp71 protein 
 
1.10.1. The UL82 gene 
 
The two most abundant proteins in the HCMV tegument are pp65 (a lower matrix 
protein), encoded by the UL83 gene, and pp71 (an upper matrix protein), encoded 
by the UL82 gene.  Transcript analysis of both genes show that a bicistronic 4 kb 
mRNA, encoding both pp71 and pp65 ORFs, is produced at both early and late 
times of infection (Nowak et al., 1984, Ruger et al., 1987).  Work by Ruger et al. 
(1987) suggested that the 4 kb mRNA is formed through the splicing of a 39 
nucleotide intron.  It codes for pp65, the most abundant tegument protein, but 
contains all the information for pp71.  The protein pp71 is itself encoded for by a 
rare, unspliced 1.9 kb mRNA.  The two mRNAs are 3‘ co-terminal and employ a 
single polyadenylation signal (Ruger et al., 1987). 
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Studies show that two specific mRNAs (1.9 kb and 4 kb), coding for pp71 and 
pp65, can be detected at 5 hr post-infection (Hensel et al., 1996, Ruger et al., 
1987).  Both transcripts exhibit a biphasic pattern of expression during a single 
round of HCMV infection, peaking at 12 hr, and 72 hr post-infection.  The biphasic 
pattern of pp71 expression suggests a bifunctional role for this protein in the 
nucleus: firstly during the IE and E phases as a transactivator of gene expression, 
and secondly in progeny maturation during the late phase of viral replication 
(Hensel et al., 1996).  An overview of the HCMV genome and the two pp71 
transcripts is presented in figure 1.5. 
 
1.10.2. Functional properties of pp71 
 
HCMV pp71 was first realised to be of importance when the HCMV virion was 
found to contain a structural component, homologous to HSV-1 VP16, able to 
transactivate transcription from the MIEP (Spaete & Mocarski, 1985, Stinski & 
Roehr, 1985).  Co-transfection assays showed that pp71 was able to stimulate 
transcription from HCMV, SCMV and MCMV MIEPs and also SV40 promoters (Liu 
& Stinski, 1992).  Promoter responsiveness to pp71 was associated with a number 
of 19 bp repeat elements containing ATF binding sequences in the MIEPs 
investigated.  Mutations at the ATF site within these 19 bp repeat element 
abolished responsiveness of promoters to pp71 in co-transfection assays (Liu & 
Stinski, 1992).   
 
In later work, infection with HSV-1 recombinant viruses expressing pp71 showed 
that pp71 could transactivate the HCMV MIEP in the absence of de novo protein 
synthesis.  It was also demonstrated that recombinant HSV-1 viruses expressing 
pp71 showed that this tegument protein could transactivate a number of promoters 
in tissue culture cells including the already established HCMV MIEP, SCMV MIEP, 
the HSV-1 ICP4 and ICP0 promoters and the adenovirus VAI promoter (Homer et 
al., 1999, Marshall et al., 2002).  Some of these data disagree with that put 
forward by Liu and Stinski (1992), in that pp71 transactivated promoters that did 
not contain consensus ATF motifs including the HSV-1 ICP4 and adenovirus VAI 
promoters (Homer et al., 1999). 
 
The protein pp71 can enhance the infectivity of viral DNA and accelerate the 
infectious cycle (Baldick et al., 1997).  Alone, viral HCMV DNA has low intrinsic TR S
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Figure 1.5 Schematic representation of the HCMV genome
A scheme of the HCMV genome showing the location of the UL82 and UL83 genes encoding the upper matrix 
(pp71) and lower matrix (pp65) proteins. Translation initiation, and translation termination signals are 
indicated.  The 3’ end of the transcription unit is designated by polyA. The direction of transcription is indicated 
by an arrow. Both the 4 kb and 1.9 kb transcripts are shown.
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infectivity, however when co-transfected with a plasmid expressing pp71, a 30 to 
80-fold increase in infectivity was observed due to increased expression levels of 
the IE1 and IE2 proteins.  When plasmids expressing the IE proteins IE1 and IE2 
were co-transfected into cells with HCMV viral DNA the increase in production of 
infectious virions was not as great as observed after transfection of plasmids 
expressing pp71.  Also co-expression of plasmids expressing IE1, IE2 and pp71 
only modestly increased DNA infectivity beyond that seen with pp71 alone (Baldick 
et al., 1997).  This group concluded that pp71 and the IE proteins have different 
roles during early times after infection, and that it is possible that pp71 
transactivates other IE genes which have important functions early in infection. 
 
Further work by Bresnahan and Shenk. (2000) was in agreement with that of 
Baldick et al. (1997) in that pp71 acts to increase the infectivity of viral DNA and 
activates the MIEP to allow expression of IE1 and IE2 proteins.  They also 
demonstrated that pp71 facilitates mRNA accumulation from other IE genes 
including UL37exon1, UL38, UL106-109 and UL115-UL119 by constructing a 
HCMV mutant which lacks a substantial portion of the pp71 coding region.  This 
mutant, named ADsubUL82, is derived from the AD169 strain of HCMV and has 
nucleotides 117648-119185 deleted.   
 
ADsubUL82 displays a multiplicity dependent growth phenotype whereby at a low 
MOI its replication is restricted.  At higher MOIs, replication is restored to nearly 
that of wild-type virus.  A decrease in viral DNA accumulation in cells infected with 
ADsubUL82 was observed compared with DNA levels in wild-type infected cells, 
suggesting that pp71 functions before or during viral DNA synthesis.  DNA array 
analysis was used to investigate mRNA accumulation in cells infected with 
ADsubUL82.  A deficiency was observed at early times of infection (8 hr), thus 
confirming that the defect associated with ADsubUL82 occurs early in the 
replication cycle (Bresnahan & Shenk, 2000).  Gene array and northern blot 
analyses were also used to confirm previous work showing that virion-associated 
pp71 facilitates the activation of IE genes.  Expression of a number of IE genes 
(IE1, IE2 UL37 and UL38) were significantly decreased in cells infected with 
ADsubUL82 compared to wild-type HCMV (Bresnahan & Shenk, 2000).  
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1.10.3. Interaction of pp71 with cellular proteins 
 
1.10.3.1. Rb Tumour suppressor proteins and pp71 
 
Various studies have shown that HCMV is able to alter cell cycle regulation, 
possibly as means to suit its own needs by causing arrest at the G1/S phase of the 
cell cycle (Dittmer & Mocarski, 1997, Kalejta & Shenk, 2003b).  Infection of 
quiescent cells with HCMV forces re-entry into the cell cycle, a process that is 
modulated by pp71 (Kalejta et al., 2003a).  Kalejta et al. (2003a) illustrated that 
pp71 stimulated cell cycle progression through the G1 phase into S phase by 
binding to and degrading hypophosphorylated forms of the Retinoblastoma (Rb) 
family of tumour suppressor proteins p107, p130 and p105 (Kalejta et al., 2003a).  
The oncoproteins of the DNA tumour viruses adenovirus E1A, SV40 T antigen and 
papillomavirus E7 show a degree of similarity with pp71, as they are also able to 
interact with Rb family members to stimulate cell cycle progression.  These 
proteins share a similar motif (LXCXE, or LXCXD in the case of pp71) that 
mediates binding in the pocket domains of the Rb family members.  As in the case 
of E1A a single point mutation in the conserved C residue of the LXCXD motif of 
pp71 resulted in its inability to degrade Rb proteins.  Other than this motif, 
however, the general mechanisms and effects of cell cycle stimulation differ 
significantly between pp71 and the DNA tumour virus oncoproteins despite the 
sequence and functional homologies (Kalejta et al., 2003a). 
 
The ubiquitin-proteasome pathway is the main intracellular machinery involved in 
eliminating unfolded proteins and destroying regulatory proteins involved in cellular 
processes (Glickman & Ciechanover, 2002).  Substrates are usually targeted to 
the 26S proteasome by polyubiquitination on internal lysine residues.  The 
polyubiquitin chains mediate the binding of targeted proteins to the proteasome 
and assist in their unfolding but are removed from the substrate before 
proteasomal degradation takes place (Glickman & Ciechanover, 2002).  Therefore 
the actual substrate for proteasomal degradation is a partially denatured, 
non-ubiquitinated protein, indicating that if a protein is delivered to the proteasome 
in a denatured or partially unfolded state, ubiquitination may not be essential for its 
degradation (Kalejta & Shenk, 2003c). Work by Kalejta and Shenk (2003c) 
provided a mechanism whereby pp71 degrades the Rb proteins.  It was shown 
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ubiquitin-dependent pathway, whilst in its presence, p130 was degraded 
independently of ubiquitin.  Also, in the presence of a proteasome inhibitor, pp71 
mediated degradation of p130 was prevented.  These experiments established 
that the pp71-mediated degradation of the hypophosphorylated Rb family proteins 
is via a proteasome-dependent, ubiquitin-independent pathway that then 
stimulates quiescent cells to re-enter the cell cycle and progress to the S phase 
(Kalejta & Shenk, 2003c). 
 
Having established that pp71 can stimulate progression of the cell cycle by 
inducing the proteasome-dependent, ubiquitin-independent degradation of the Rb 
family of proteins (Kalejta et al., 2003a, Kalejta & Shenk, 2003c), this group went 
on to show that pp71 accelerates progression through the G1 phase of the cell 
cycle via a mechanism that is independent of its ability to target Rb proteins 
(Kalejta & Shenk, 2003b).  Studies by Kalejta (2003b) demonstrated that the major 
component of G1 acceleration caused by pp71 is not due to Rb degradation.  A 
pp71 mutant that failed to degrade Rb family members retained the ability to 
accelerate movement through the G1 phase.  This suggested that the acceleration 
could be due to the ability of pp71 to degrade another unidentified cell cycle 
regulatory protein, its ability to regulate transcription or due to a currently unknown 
function of pp71 (Kalejta & Shenk, 2003b). 
 
1.10.3.2. hDaxx, PML and pp71 
 
ND10s are spherical structures of approximately 0.3-1.0 μm in diameter.  They are 
present in virtually all cell types and each cell nucleus usually contains between 5 
and 20 of these punctate sub-structures.  They consist of a central core 
surrounded by an electron dense capsule and are defined by the presence of PML 
(Dyck et al., 1994).  ND10 domains are thought to behave as nuclear depots for 
the homeostatic maintenance and release of proteins and are altered in size and 
number in response to the cell cycle e.g. during mitosis (Everett et al., 1999b) and 
S-phase (Dellaire et al., 2006).   
 
The human PML locus is 35 Kbp in length and consists of nine exons.  PML gene 
transcripts undergo alternative splicing to produce multiple mRNAs that encode for 
13 different PML isoforms (Fagioli et al., 1992, Ruggero et al., 2000).  PML is 
known to be the major protein of ND10 domains and is essential for recruiting Tanya Chaudry 2008    Chapter 1  54
other cellular proteins associated with ND10 such as hDaxx, Sp100 and SUMO-1 
(Everett et al., 2006).  Other proteins associated with ND10s are p53 (Fogal et al., 
2000), BRCA1, (French et al., 2006), USP7 (Everett et al., 1997) and ATRX (Ishov 
et al., 2004).  ND10s have been associated with a number of processes including 
transcriptional regulation, genome stability response to viral infection, apoptosis 
and are also considered as nuclear depots (Bernardi & Pandolfi, 2003, Negorev & 
Maul, 2001).  
 
It is known that PML is covalently modified by SUMO-1, and it is this SUMOylation 
that is vital for targeting polypeptides to specific cellular compartments, and is 
required by PML for the formation of ND10 domains (Ishov et al., 1999).  A recent 
model for ND10 formation proposed the RING finger of PML to be essential for 
both self-SUMOylation and ND10 formation.  Furthermore, its SUMO binding motif 
independently can interact with nearby SUMOylated PML molecules and allow the 
formation of a PML network.  Together with other SUMOylated proteins e.g. 
hDaxx, these networks may eventually form higher order structures, i.e. ND10 
domains (Shen et al., 2006).  In the case of hDaxx, a SUMO-interacting motif 
(SIM) has been identified which is thought to be crucial for recruiting hDaxx to 
ND10 domains.  It is thought that the SIM acts in trans to repress several 
SUMO-modified transcription factors (Lin et al., 2006). 
 
The hDaxx protein was first identified as a protein able to bind to the death domain 
of FAS in the cytoplasm and to mediate signal transduction pathways, which lead 
to apoptosis (Chang et al., 1999, Yang et al., 1997).  hDaxx is also known to 
interact with at least eighteen other cellular proteins leading to functional 
consequences ranging from activation of transcription to apoptosis (Salomoni & 
Khelifi, 2006). 
 
The cellular protein hDaxx is presumed to be involved in the repression of 
transcription due to its interaction with HDAC molecules.  This interaction causes 
chromatin to be condensed into a state that is unfavourable for transcription (Li et 
al., 2000b). More recently, immunoprecipitation and co-fractionation studies have 
shown that both HDAC and hDaxx are associated with histones and interact with 
Dek, a chromatin associated protein (Hollenbach et al., 2002).  Moreover, 
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able to repress transcription of incoming HCMV genomes through the recruitment 
of HDACs for chromatin remodelling at the viral MIEP (Woodhall et al., 2006). 
 
Using confocal microscopy the HCMV tegument protein pp71 has been 
demonstrated to localise directly at the nucleus in a punctate pattern in transient 
transfection assays.  This led to the tentative idea that pp71 co-localises at specific 
locations within the nucleus involved in transcription (Hensel et al., 1996).  Work 
by Hofmann et al. (2002) determined that the central glutamine rich region of 
hDaxx spanning amino acids 409-501 was a strong binding region for pp71.  As it 
was not possible to narrow down a putative hDaxx binding site within pp71 by 
deletion analysis internal domains were identified using sequence analysis.  Two 
putative hDaxx interaction domains (DIDs) were mapped to amino acids 206-213 
(DID I) and 324-331 (DID II) of pp71, which exhibited sequence similarity to the 
DID within centromere protein C (CENP-C).  Transfection experiments using a 
vector expressing pp71 fused to a green fluorescent protein (GFP), showed pp71 
co-localising with the ND10 proteins PML and Sp100 in nuclear speckles, 
correlating with that observed by Hensel et al. (1996).  Upon deletion of these 
binding domains the pp71-hDaxx interaction was blocked, preventing pp71 
localisation to ND10s and resulting in the inability of pp71 to transactivate the 
MIEP in transient transfection assays.  This suggested that pp71 was recruited to 
ND10 domains via binding to hDaxx, a process essential for the efficient onset of 
IE gene expression (Hofmann et al., 2002).  This observation was confirmed by 
Ishov et al. (2002) who showed that, during HCMV infection, pp71 accumulates at 
ND10s prior to the production of IE proteins.  It is the interaction of pp71 and 
hDaxx, mediated by the interaction of the C-terminus of hDaxx with SUMO 
modified PML, which trafficks pp71 to ND10s (Ishov et al., 2002).  This was 
confirmed by the observation that pp71 failed to accumulate at ND10s in hDaxx 
deficient cells and PML deficient cells.  In the PML deficient cells pp71 was 
distributed throughout the nucleus in a diffuse pattern.   
 
In 2005, Cantrell and Bresnahan showed that the pp71-hDaxx interaction 
regulated efficient HCMV replication.  Viral mutants deleted for pp71 or DIDs 
within pp71 were seriously attenuated for replication at low MOI, but this was 
overcome at higher MOI.  Both mutant viruses showed a significant decrease in 
the abundance of IE1 and IE2 and also a delay in their expression compared to 
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requirement for efficient gene expression and viral replication.  It was also noted 
that the pp71-hDaxx interaction was involved in enhancing the infectivity of viral 
DNA, as co-transfection of plasmids expressing pp71-hDaxx binding mutants and 
viral DNA failed to enhance plaque production (Cantrell & Bresnahan, 2005). 
 
More recent studies have proposed that that the pp71-hDaxx interaction may act 
to relieve repression of the genome and stimulate IE gene expression (Cantrell & 
Bresnahan, 2006, Preston & Nicholl, 2006, Saffert & Kalejta, 2006).  Work by 
Saffert and Kalejta. (2006) initially proposed that the mechanism by which pp71 
activates the MIEP is by inducing the degradation of hDaxx to permit viral gene 
expression.  Their work showed that pp71 alone is necessary for hDaxx 
degradation in HCMV-infected cells and that HCMV IE gene expression can be 
rescued in the presence of hDaxx by inhibiting HDACs.  A model was proposed in 
which the viral MIEP is silenced by hDaxx through the recruitment of HDAC, a 
process that is reversed when pp71 degrades hDaxx.  Work by Preston and 
Nicholl. (2006) also showed a role for hDaxx in HCMV IE gene expression.  In 
hDaxx depleted cells there was no effect upon wild-type HCMV IE gene 
expression or MIEP activity in the presence of pp71, suggesting that the 
pp71-hDaxx interaction does not have a positive effect on IE transcription.   
However, in the absence of pp71, an increase in the activity of the MIEP was 
observed in hDaxx depleted cells following infection with ADsubUL82 indicating an 
involvement of hDaxx in the repression of the MIEP activity.  This work was in 
agreement with that of Cantrell and Bresnahan (2006).  Using HCMV permissive 
cell lines (U373) that were depleted for hDaxx expression (using shRNA) it was 
shown that wild-type virus replication was increased.  Furthermore, the pp71 
deletion mutant-associated defects in viral replication and IE gene expression 
were abolished in these knock down cells.  In cell lines over-expressing hDaxx, 
wild-type virus replication and IE gene expression were inhibited in a 
multiplicity-dependent manner.  These findings suggest that hDaxx acts as a 
repressor during HCMV infection and that pp71 is responsible for relieving this 
repression (Cantrell & Bresnahan, 2006). 
 
It has been suggested that the mechanism by which pp71 facilitates the 
degradation of hDaxx is via a proteasome-dependent, ubiquitin-independent 
pathway (Hwang & Kalejta, 2007).  Using a mouse ts20 cell line (containing a 
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recombinant adenovirus expressing pp71, Hwang and Kaljeta (2007) showed that 
at both the permissive temperature (35
oC) and non-permissive temperature (39
oC) 
the steady state level of endogenous hDaxx protein was decreased.  This 
indicated that the pp71-meadiated degradation of hDaxx occurs through a 
ubiquitin-independent mechanism.  Mouse ts20 cells were infected with either 
wild-type HCMV or ADsubUL82 to establish if this mechanism was true for HCMV 
tegument-delivered protein.  It was observed that wild-type HCMV induced the 
degradation of endogenous hDaxx, while the ADsubUL82 virus did not (Hwang & 
Kalejta, 2007).  The proteasomal aspect of this degradation process was 
established when HCMV-infected ts20 cells treated with the proteasome inhibitor 
lactacystin, showed stabilisation of hDaxx (Hwang & Kalejta, 2007).  Therefore 
pp71 is presumed to promote the degradation of hDaxx in a 
proteasome-dependent, ubiquitin-independent manner, in a way similar to pp71 
degradation of the Rb family (see section 1.10.3.1). 
 
It is possible that hDaxx acts as a control of HCMV latency by exerting a 
repressive effect upon the MIEP to induce a repressed chromatin structure, and 
prevent expression of the IE genes, unless neutralised by pp71.  This repressed 
chromatin state (whereby there is an association of HP1 and a lack of acetylated 
histones at the MIEP) is similar to that observed at the MIEP in naturally latently 
infected and incompletely differentiated CD34
+ cells (Saffert & Kalejta, 2007).   
Saffert and Kalejta. (2007) proposed that hDaxx is essential in establishing 
quiescent HCMV infections, as loss of hDaxx causes initiation of the lytic cycle.  
They showed that in undifferentiated cells, viral IE gene expression needs to be 
silenced to establish latency and prevent abortive infection.  Thus this silencing of 
the genome serves to establish lifelong latent infection (Saffert & Kalejta, 2007).  
However, this has recently been disputed by Groves et al. (2007) who showed that 
down-regulation of hDaxx using siRNA in undifferentiated NT2D1 cells did not 
cause changes in the chromatin structure around the viral MIEP.  Productive 
infection and IE gene expression were only observed in differentiated cells 
(Groves & Sinclair, 2007). 
 
1.10.4. The interaction of pp71 with other tegument proteins 
 
The UL35 open reading frame has been identified as an early-late gene, which is 
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phoshorylated protein products ppUL35 and ppUL35A (Liu & Biegalke, 2002).   
PpUL35A localises to the nucleus, and it has been reported that it inhibits 
activation of the MIEP by pp71 (Liu & Biegalke, 2002).  The interaction between 
pp71 and both forms of ppUL35 was identified by yeast two-hybrid screening, with 
a specific interaction of pp71 and ppUL35 confirmed by co-immunoprecipitation of 
both proteins from transfected and infected cells (Schierling et al., 2004).   
Co-localisation of these tegument proteins in human fibroblast cells was 
demonstrated by immunofluorescence.  Alone, ppUL35 appeared as diffuse 
nuclear staining, however in the presence of pp71, discrete punctate foci were 
observed.  The proteins co-localised with ND10 domains, leading to the 
suggestion that pp71 recruits both hDaxx and ppUL35 for efficient initiation of the 
viral replication cycle. Transient luciferase experiments showed strong co-
operative activation of the HCMV MIEP by pp71 and ppUL35, whereas each 
protein alone showed a weak stimulation only (Schierling et al., 2004). 
 
1.10.5. pp71 and the immune system 
 
As discussed in section 1.8 HCMV infects a large proportion of individuals across 
the world.  As HCMV infection can cause serious disease, development of a 
vaccine is vital.  In order to develop a HCMV subunit vaccine, proteins which 
induce protective immune responses in humans were identified by studying the T 
cell proliferative response to five HCMV proteins: IE1, IE2, pp71, gpUL18 and gB 
(He et al., 1995).  In the majority of individuals tested, gB was one of the most 
commonly recognised proteins of the five tested, followed by IE2.  Both IE1 and 
gpUL18 were less frequently recognised.  In the case of pp71, 10 out of 23 
seropositive patients responded, indicating that pp71 may play a role in the 
immune response to HCMV in some individuals. Therefore in order to develop a 
feasible vaccine a combination of proteins would have to be used as different 
seropositive individuals responded to different proteins (He et al., 1995). 
 
The tegument protein pp71 was found to be able to stimulate the activation of the 
US11 promoter (Chau et al., 1999).  The HCMV US11 gene is already known to 
be non-essential for replication in tissue culture and plays an essential role in 
HCMV pathogenesis (Chau et al., 1999).  The product of US11, a glycoprotein 
found in the ER, causes the destruction of the MHC class I proteins, resulting in 
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Chau et al. (1999) revealed two sequence elements (a CREB and an ATF site) 
within the promoter of US11 which are important for activation by IE proteins, the 
ATF site being especially critical for US11 promoter activation.  The tegument 
protein pp71 is already known to bind to ATF sites within the MIEP of HCMV (Liu 
& Stinski, 1992), but as discussed previously pp71 is also able to transactivate 
promoters that do not contain this motif (Homer et al., 1999).  It was observed by 
Chau et al. (1999) that in combination with viral IE proteins, pp71 could 
up-regulate the US11 promoter in transient assays and this up-regulation required 
both CREB and ATF sites to be intact.  US11 promoter mutants inactivated for 
both of these sites were used to show that mutating CREB alone reduced mRNA 
levels to 25% of that observed with the wild-type promoter.  Inactivation of ATF 
alone reduced US11 mRNA levels to 6% of that of the wild-type promoter.  When 
both CREB and ATF elements were mutated, US11 gene expression was almost 
undetectable; indicating that both sites co-operate to regulate the US11 promoter 
in HCMV infected cells (Chau et al., 1999).  
 
More recently a novel function for pp71 has been suggest in relation to the MHC 
class I antigen presentation pathway.  Work by Trgovcich et al. (2006) showed 
pp71 to be capable of interfering with cell surface expression of MHC class I 
complexes.  Ectopic expression of pp71 in human glioblastoma cells caused a 
dose-dependent decrease in the accumulation of cell surface MHC class I 
complexes.  It was established that pp71 delayed transport of MHC class I 
complexes from the ER to cis Golgi apparatus, but did not interfere with 
accumulation of either MHC class I heavy chain transcript or protein.  In cells 
silenced for pp71 and infected with a recombinant adenovirus mutated for the 
unique short region MHC class I evasion genes, an increase in the accumulation 
of cell surface MHC class I complexes was observed.  It was proposed that pp71 
can, at late times of infection, interfere with the transport and cell surface 
expression of MHC class I complexes (Trgovcich et al., 2006). 
 
1.10.6. HSV-1 recombinant viruses impaired for IE gene expression 
 
The study of pp71 at the MRC Virology Unit has previously relied on the use of 
HSV-1 recombinant viruses rather than plasmids to express the protein and as 
reporters to measure its activity (Preston & Nicholl, 2005).  The basic HSV-1 
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transcriptional activity of VP16 and the IE proteins ICP0 and ICP4.  A 12 bp 
insertion mutation in the HSV-1 UL48 gene rendered VP16 incapable of 
transactivating IE gene expression (Ace et al., 1988).  The mutated VP16 was 
incorporated into HSV-1 to produce a mutant in1814, and all subsequent 
recombinant HSV-1 vectors were derived from this virus (Ace et al., 1989).  Harris 
and Preston. (1991) found that the virus in1814 exhibited a multiplicity dependent 
phenotype.  At high MOIs lytic replication levels were equivalent to those of wild 
type HSV-1, however, at low MOI in1814 replicated poorly.  This defect could be 
complemented by the addition of VP16 prior to infection or ICP0 post-infection, 
demonstrating that the in1814 replication block was due to low levels of IE 
proteins.  It was also observed that in cells infected with in1814, the viral genomes 
was retained in a non-linear form and that these quiescent genomes were 
unresponsive to VP16 but remained responsive to ICP0.  It was concluded that the 
in1814 genome established quiescent infections in vitro that resembled latent wild 
type HSV-1 genomes in vivo in some respects (Harris & Preston, 1991). 
 
The virus in1814 was modified by homologous recombination to replace the ICP0 
promoter with the LTR of Moloney murine leukaemia virus to yeid in1820 
(Jamieson et al., 1995, Preston & Nicholl, 1997).  The LTR is inactive under IE 
conditions therefore in1820 lacks functional VP16 and ICP0.   Upon infection it can 
establish quiescent infection, which is reactivated by the addition of ICP0.  In1820 
was then further modified to produce the virus in1820K through homologous 
recombination of viral DNA with a plasmid containing a temperature sensitive 
mutation in ICP4. This mutant (in1820K) failed to produce virus at temperatures 
greater than 31
oC (Preston et al., 1997).  It was also determined that transgenes, 
such as the E.coli lacZ gene and the neomycin phosphotransferase gene could be 
inserted into the in1820K genome under the control of a variety of promoters 
including the HCMV MIEP, and that short-term expression of the transgene was 
observed (Preston et al., 1997, Preston & Nicholl, 1997).  Expression of the 
transgenes, driven by the HCMV MIEP in particular, was repressed considerably 
at 24 hr post-infection, indicating that repression of gene expression observed in 
in1814 derivatives is not confined specifically to the HSV-1 IE genes (Preston & 
Nicholl, 1997). 
 
In 1998 Preston et al. inserted a mutation into the ICP0 coding sequence by 
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mutation in in1820.  This resulted in the virus in1312 (Preston et al., 1998), the 
parental genome used to create the various recombinant viruses used in the study 
of pp71.  Derivatives of this virus may have the E.coli lacZ gene inserted into 
either the TK locus or the UL43 locus of this genome or they may be employed as 
expression vectors. 
 
Recombinant viruses such as in1312 are particularly useful as they can be 
retained in a quiescent state following infection of cultured cells.  Due to the 
mutations rendering the critical HSV-1 transcription factors inactive, the absence 
of IE gene expression ensures that the infected cells survive infection, but do not 
support lytic infection (Preston & Nicholl, 2005).  The input viral genomes are 
responsive to transcription factors immediately after infection, however, a few 
hours post-infection they become repressed i.e. quiescent.  In this quiescent state 
the viral genomes are transcriptionally inactive and retained in a non-linear 
configuration (Preston & Nicholl, 2005).  This quiescent state established by the 
HSV-1 recombinant viruses is believed to resemble the latent state attained by 
wild type HSV-1 in some repects (Preston, 2000).  The quiescent genome is 
believed to be stably repressed, but gene expression can be provoked by the 
addition of ICP0 (Hobbs et al., 2001, Preston et al., 1997, Samaniego et al., 1998) 
as ICP0 can disrupt the chromatin structure into which the quiescent genome is 
packaged. 
 
1.10.7. pp71 directs long-term gene expression 
 
The HSV-1 recombinant virus in1312 was used to construct the recombinant virus 
in1324 which was in1312 with the coding sequence of pp71 inserted into the TK 
locus of the in1312 genome.  Homer et al. (1999) showed that infecting human 
fibroblasts with in1324 stimulated short-term gene expression from the HCMV 
MIEP promoter.  A novel property of pp71 was observed whereby it was able to 
stimulate gene expression from the HCMV MIEP, cloned into the in1324 genome, 
over extended periods in cell culture (Preston & Nicholl, 2005).  Using the HSV-1 
recombinant in1360 (derived from inserting HCMV IE-lacZ into the UL43 locus of 
in1324) to infect human foetal foreskin fibroblast cells (HFFF2), a biphasic pattern 
of β-gal expression was observed.  At early times of infection, β-gal positive cells 
were observed which were indicative of short-term gene expression.  β-gal positive 
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post-infection, possibly because the HCMV MIEP was not fully activated at early 
times of gene expression.  In cells that did not respond to short-term gene 
expression the virus, in1360, initially became quiescent but was slowly turned on 
by pp71.  Low level expression of pp71 unblocked the remainder of the genome, 
increasing expression of pp71 itself along with HSV-1 IE proteins (Preston & 
Nicholl, 2005).  These observations suggest that there may be two populations of 
cells present; one immediately subject to active virus infection and the second 
where the virus becomes quiescent.  This second population of cells does not 
support short-term gene expression but as the MIEP is slowly turned on by low 
levels of pp71, the remainder of the genome is unblocked and the IE proteins, and 
pp71, are expressed. 
 
1.11. A comparison of pp71 with the HSV-1 proteins VP16 and ICP0 
 
Much work has been carried out in order to determine if pp71 has any functional 
analogy with the proteins found in the tegument of HSV-1.  To date pp71 has been 
compared in function to the protein VP16 and the IE protein ICP0. 
 
1.11.1. pp71 and VP16 
 
The HSV-1 tegument protein VP16 activates IE transcription by forming a complex 
with the cellular proteins Oct-1 and HCF at the TAATGARAT sequence.  The 
HCMV tegument protein pp71 activates expression from the MIEP in transfection 
asays by targeting ATF or AP-1 recognition sites in the 19 bp repeated units of the 
promoter (Liu & Stinski, 1992).  It is the most likely candidate for a functional 
counterpart of VP16.   
 
Using a HSV-1 recombinant in1324 that expresses pp71 Homer et al. (1999) 
showed that pp71 is the virion component of HCMV that effects activation of a 
variety of promoters.  Removal of the pp71 ORF from in1324 abolished this 
activity, demonstrating that pp71 is able to act alone.  Unlike VP16, pp71 
dependent promoter activation is not sequence specific (Homer et al., 1999).   
Furthermore despite their similar roles, the broader specificity exhibited by pp71 
may imply that HCMV differs from HSV-1 in its requirements for a virion 
transactivator.  During HSV-1 infection VP16 is essential for the early increase in 
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genome.  It also ensures that sufficient levels of ICP0 accumulate to prevent the 
HSV-1 genome from becoming quiescent.  Homer et al. (1999) suggest that pp71 
is important for the efficient expression of IE loci other than those controlled by the 
MIEP, themselves lacking potent promoters.  In addition, it may function to 
maintain the accessibility of the genome to other transcription factors.   
 
1.11.2. pp71 and ICP0 
 
The HCMV tegument protein pp71 exhibits broad promoter specificity and can 
activate a variety of promoters, including the HCMV MIEP, SCMV MIEP, the 
HSV-1 ICP0 and HSV-1 ICP4 promoters (Homer et al., 1999, Marshall et al., 
2002).  ICP0 is also considered to be a promiscuous transactivator, in as much as 
it activates transcription from HSV-1 and heterologous promoter elements 
independently of a single cis-acting element (Everett et al., 1991).  Marshall et al. 
(2002) showed that the expression of pp71 partially complements the replication of 
an HSV-1 ICP0 null mutant indicating that there exists a degree of functional 
interchangeability between these proteins.  
 
Both ICP0- and pp71-null viruses have been produced in order to better examine 
the biological activities of the proteins.  It has been demonstrated that at low MOIs, 
in human fibroblasts, infection with HSV-1 ICP0-null viruses can result in 
quiescence of the genome (Stow & Stow, 1989).  Absence of ICP0 also leads to 
stalled infection with an incomplete set of expressed IE genes, stalling at the IE 
stage of infection or stalling with the expression of some E proteins but no DNA 
replication (Everett et al., 2004a).  Human fibroblasts infected with a MOI of 10 of 
both ICP0-null and wild-type viruses show little difference in levels of productive 
infection. However, human fibroblasts infected with the same viruses at a lower 
MOI of 1 shows little progress into productive infection in cells infected with the 
ICP0-null virus (Everett et al., 2004a).   
 
The HCMV mutant virus deficient for pp71, ADsubUL82, also displays a multiplicity 
dependent phenotype in human fibroblasts.  The growth of this mutant, like that of 
the ICP0-null virus, is restricted at low MOIs.  However this defect, like that of the 
ICP0-null virus, is overcome at higher MOIs whereby ADsubUL82 replicates to 
wild-type levels.  Again the absence of pp71 means that infection is stalled, as 
ADsubUL82 is unable to effectively activate IE genes (Bresnahan & Shenk, 2000),  Tanya Chaudry 2008    Chapter 1  64
As discussed in section 1.5.1, ICP0 is known to facilitate viral replication and 
reactivation from latency.  When HSV-1 gene expression is repressed in human 
fibroblasts in the absence of viral IE gene expression, ICP0 is required to 
reactivate gene expression from quiescence (Harris et al., 1989, Zhu et al., 1990).  
It has been reported that ICP0 may counteract repression by stimulating the 
degradation of various cellular proteins via a ubiquitin-proteasome pathway 
(Everett et al., 1998a, Everett et al., 1997).  HCMV pp71 has also been reported to 
reactivate viral expression from quiescent genomes (Preston & Nicholl, 2005), 
however the kinetics of reactivation were considerably slower than that of ICP0.  
Moreover, pp71 was observed to be less effective than ICP0 in reactivating 
quiescent genomes (Preston & Nicholl, 2005). 
 
ICP0 and pp71 both localise to ND10 domains following infection.  However, how 
they get there and what they do at these sites differs.  The initiation of gene 
expression due to localisation of ICP0 and degradation of PML at ND10 domains 
is well documented (Boutell et al., 2003, Everett & Maul, 1994, Everett et al., 
1998b, Everett et al., 2006).  Everett and Murray (2005) showed, using live cell 
microscopy that it is not ICP0 that localises to ND10 components, but it is ND10 
domains that are recruited to viral genomes at the periphery of nuclei.  Here ICP0 
targets the disruption of ND10 domains and the degradation of PML. 
 
Marshall et al. (2002) and Hensel et al. (1996) showed that pp71 localises to ND10 
domains but, unlike ICP0, does not induce their disruption.  Also, IE gene 
expression is not initiated by the degradation of PML.  Instead, pp71 participates in 
the degradation of hDaxx in order to relieve IE gene repression (Cantrell & 
Bresnahan, 2006, Preston & Nicholl, 2006, Saffert & Kalejta, 2006). 
 
ICP0 and pp71 differ in sequence and structure.  Analysis of the HCMV pp71 
sequence using ‘Scanprosite’ showed that no homologous sequence motifs such 
as the ICP0 consensus RING finger motif were present in HCMV pp71; however, 
both proteins contain a bipartite nuclear localisation signal (NLS).  The crystal 
structure of pp71 has not been solved and searches of structural databases using 
the amino acid sequence have shown that there are no structural homologues to 
pp71, apart from the functional cytomegalovirus homologues of pp71 described 
previously, which show up to 60% amino acid sequence homology (Jane 
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1.12. Simian Cytomegalovirus Biology 
 
1.12.1. SCMV genome 
 
The simian cytomegalovirus (SCMV) is also known as CMV strain Colburn.  It is 
composed of a linear, double stranded DNA molecule of 220 kbp (Gibson, 1981).  
Like the other herpesviruses, it is replicated and packaged into an icosohedral 
capsid in the nucleus of infected cells, and is surrounded by an envelope. 
 
Various sequence elements and proteins encoded by SCMV have been described.  
These include IE94 (Jeang et al., 1982), an upstream regulatory region which 
directs the expression of IE94 (Jeang et al., 1987), an assembly protein and the 
oriLyt (Anders & Punturieri, 1991, Jeang et al., 1987, Robson & Gibson, 1989).  A 
nuclear DNA binding protein, structural proteins of the mature virus particle, three 
intracellular capsid forms (Gibson, 1981) and a basic phosphoprotein (BPP) 
(Baxter & Gibson, 2001) have also been identified 
 
1.12.2. SCMV lytic infection 
 
1.12.2.1. Attachment and penetration 
 
The little which is known about the lytic cycle of SCMV has been derived by 
extrapolation from the study of HCMV.  Glycoproteins gB and gH are conserved in 
all herpesviruses and are known to be involved in viral attachment and penetration 
of the virion into the host cell (Bold et al., 1996).  It is assumed that these 
glycoproteins play the same role in SCMV attachment and penetration.  Following 
entry into the cell the genome is probably transported to the nucleus by a 
microtubule network system, in a similar manner to HCMV (Ogawa-Goto et al., 
2003). 
 
1.12.2.2. IE gene expression 
 
The HCMV tegument protein pp71 transactivates the MIEP to stimulate production 
of IE proteins, which in turn transactivate the E and L genes to stimulate lytic 
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protein named S82, which is functionally homologus to HCMV pp71 as it 
stimulates IE gene expression (Nicholson, 2004).  S82 also co-localises with 
hDaxx and PML at ND10 domains, possibly exerting its effect on the SCMV MIEP 
in a similar manner to HCMV pp71. 
 
As mentioned previously, the IE1 gene of SCMV, IE94, and its associated 
upstream promoter-regulatory region have been characterised (Jeang et al., 
1987). Studies have shown that this promoter-regulatory region consists of two 
distinct domains.  Two NF1 binding sites have been identified within this region, 
the functional significance of which is not yet known (Jeang et al., 1987). 
 
1.12.2.3. E and L gene expression 
 
Little information is available regarding expression of the SCMV E and L genes.  It 
is assumed that E and L gene expression occurs in a similar manner to that of 
HCMV. 
 
1.12.3. Capsid assembly and DNA packaging 
 
In herpesvirus virion assembly, various kinds of capsids have been identified, 
these include A capsids, C capsids, and B capsids.  Using cryoelectron 
microscopy and image reconstruction, B-capsids recovered from SCMV-infected 
cells have been investigated (Trus et al., 1999).  It was observed that these 
capsids contain an inner shell composed mainly of the assembly protein (Ap) in its 
mature, proteolytically processed form.  An interaction between capsid and 
tegument was observed, as the B capsid revealed two sites of tegument 
attachment (Trus et al., 1999). 
 
Capsid assembly of all herpesviruses is a closely conserved process whereby a 
procapsid is assembled requiring the involvement of several proteins.  In HCMV 
these are the MCP, mc-BP, and pAP homologues all of which have been identified 
in SCMV (Gibson, 1981).  The pAP protein is modulated by proteolytic cleavage, 
which is essential for capsid maturation and production of infectious virus. It is also 
modulated by phosphorylation.  Plafker et al. (Plafker et al., 1999) established that 
the SCMV pAP could be phosphorylated on two adjacent serine residues on a 
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sites, Thr231 and Ser235, the phosphorylation of which resulted in conformational 
changes in the pAP.  Inhibition of phosphorylation at these sites was found to alter 
the interaction of pAP with itself and with the MCP.  This indicates that 
phosphorylation of this protein has a functional significance in the capsid assembly 
of herpesviruses (Casaday et al., 2004). 
 
1.12.4. Virion maturation and egress 
 
As with HCMV, tegumentation of SCMV capsids occurs in the cytoplasm of 
infected cells (Trus et al., 1999).  It is likely that the egress of these SCMV virions 
proceeds via a similar pathway to that of HCMV. 
 
1.13. Rhesus Cytomegalovirus biology 
 
1.13.1. RhCMV genome 
 
The complete genome sequence of rhesus cytomegalovirus (RhCMV) has been 
determined using the shotgun approach (Hansen et al., 2003).  Sequence analysis 
showed a significant degree of homology with the HCMV genome. 
 
As with other herpesviruses the RhCMV has a long, double-stranded unique 
sequence within its genome.  It was found to be 221,459 bp in length, 7895 bp 
shorter than the HCMV genome, with a G+C content of 49% evenly distributed 
throughout the genome.  No large internal or terminal repeats were found in the 
RhCMV genome.  Of the 230 ORFs, 138 ORFs dispersed throughout the genome 
were found to encode proteins homologous to HCMV proteins.  RhCMV was also 
found to encode almost all classified HCMV gene families, including RL11, UL25, 
UL82, US1, US2/6, US12 and US22 (Hansen et al., 2003). 
 
RhCMV encodes enzymes homologous to those of HCMV that are required for 
nucleotide metabolism, replication and repair.  This includes uracil-DNA 
glycosylase, ribonucleotide reductase, and dUTPase all of which have very high 
homologies to their HCMV counterparts (Hansen et al., 2003). 
 
HCMV UL82 family members consist of the upper and lower matrix proteins pp71 
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Rh111/Rh112 (pp65).  The RhCMV pp71 protein has 39% identity with HCMV 
pp71, while the two pp65 copies of RhCMV have 32% (Rh111) and 35% (Rh112) 
identity with the HCMV protein (Hansen et al., 2003).  In HCMV, pp65 illicits 
protective immune responses in humans and represents an important vaccination 
target (Yue et al., 2006).  The RhCMV homologue (Rh112) was characterised by 
Yue et al. (2006) and analysed for its ability to induce host immune responses.  
Rh112 is expressed at L times of infection and localises to the nucleus following 
expression. It elicits both humoral and cellular immune responses.   
 
1.13.2. RhCMV lytic infection 
 
1.13.2.1. Attachment and penetration 
 
The gB of RhCMV was identified and characterised by Kravitz et al. (1997) and 
Kropff and Mach (Kropff & Mach, 1997).  This RhCMV gene had extensive 
homology to gB of HCMV (75% similarity and 60% identity), with many structural, 
modifying and processing signals being maintained (Kravitz et al., 1997).  The 
RhCMV gB protein was also found to be proteolytically processed similarly to 
HCMV gB.  Therefore, gB is an important component of the viral envelope and is 
involved in virus attachment, penetration and viral spread.  RhCMV cross-reacted 
and cross-neutralised with various HCMV gB-specific monoclonal antibodies, 
which revealed homologous immunogenic epitopes between the two molecules 
(Kravitz et al., 1997).  RhCMV infection in rhesus macaques could provide a model 
in which to study HCMV pathogenesis and immune surveillance of 
cytomegaloviruses. 
 
Sequencing of the RhCMV genome identified 21 further glycoproteins, as well as 
gB, encoding homologues to gH, gL, gM, gN and gO of HCMV (Hansen et al., 
2003). 
 
1.13.2.2. RhCMV IE gene expression 
 
The IE region of RhCMV was cloned and sequenced by Barry et al. (1996) and 
was found to span 9.2 kb.  Within this region, ORFs corresponding to the IE1 and 
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found to share 29% identity with HCMV IE1, while the predicted IE2 protein shared 
48% identity with HCMV IE2. 
 
1.13.2.3. RhCMV E and L gene expression 
 
Little information is available regarding expression of the RhCMV E and L genes.  
It is assumed that E and L gene expression occurs in a similar manner to HCMV. 
 
1.13.2.4. Capsid assembly and DNA packaging 
 
Capsid assembly proteins are conserved amongst the betaherpesviruses.   
RhCMV encodes homologues to the MCP, a mc-BP of HCMV.  Also present in 
RhCMV is a UL80 homologue thought to be involved in assembly and packaging 
(Hansen et al., 2003).   
 
1.13.3. RhCMV prevalence and disease 
 
RhCMV was first identified as an incidental infection of rhesus macaques and is 
now known to be ubiquitous in captive rhesus macaques (Kalter & Heberling, 
1990).  The majority of RhCMV infections, like HCMV infections, are subclinical.  
Healthy individuals shed virus in their urine, saliva, semen, cervical secretions and 
breast milk. 
 
As with humans, rhesus macaques are susceptible to infection with simian 
immunodeficiency virus (SIV).  Various studies using SIV-infected rhesus 
macaques have shown that disseminated cytomegalovirus disease is fairly similar 
to that observed in HIV-infected humans (Baskin, 1987).  Symptoms include 
orchitis, encephalitis and respiratory tract disease. 
 
1.14. BCMV biology 
 
Baboons are known to harbour viruses which are closely related to EBV, HHV6 
and VZV (Blewett et al., 2001).  An alphaherpesvirus called herpesvirus papio 2 
(HPV2), bearing significant similarity to human HSV was discovered in a colony of 
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from three sub-species of baboon, all of which were found to be closely related to 
both HCMV and RhCMV (Blewett et al., 2001). 
 
The baboon CMV-like viruses had similar characteristics to other CMVs, including 
slow growth in fibroblast cell cultures, and production of virions with similar size 
and morphology to HCMV (Blewett et al., 2001).  Phylogenetic analysis and 
predicted protein sequences of the gB gene confirmed baboon cytomegalovirus 
(BCMV) to be a member of the cytomegalovirus group, closely related to both 
HCMV and RhCMV.  More detailed analysis via ELISA and western blotting 
showed that BCMV shared greater homology with RhCMV than HCMV (Blewett et 
al., 2001).  gB genes have been isolated from various strains of BCMV, which 
were isolated from three sub-species of cynocephalus baboons (olive, yellow and 
chacma) (Ross et al., 2005).  However, similarities between the gB coding 
sequences were too similar to differentiate by PCR assay.  This similarity may be 
due to a range overlap between two central African baboon subspecies allowing 
transfer of BCMV strains between populations (Ross et al., 2005). 
 
Baboons are perceived to be a possible species for xenogeneic organ donors as 
they are relatively easy to breed in captivity and their organ size is appropriate for 
humans (Blewett et al., 2000).  However baboon to human transplants have been 
restricted due to possible cross-species transfer of baboon viruses to 
xenotransplant patients.  BCMV was isolated from the peripheral blood of the 
recipient of a baboon liver transplant four weeks post-transplantation (Michaels et 
al., 2001).  Furthermore, it has been observed that BCMV was reactivated 
(detected as an increase in BCMV DNA copy numbers by PCR) in baboon 
recipients.  The pattern of reactivation observed was similar to that of HCMV in 
human transplant patients (Mueller & Fishman, 2004). 
 
1.15. ChCMV biology 
 
Chimpanzee cytomegalovirus (ChCMV) is the closest known relative to HCMV.  It 
is thought that the two viruses evolved with their hosts, with a divergence date of 
approximately 5-6 million years ago.  Sequencing of ChCMV revealed a 241,087 
bp genome, with UL, US, RL, and RS components, and a G+C content of 67.7%.  
The greatest degree of sequence similarity was observed in the central part of the 
UL region with similarity decreasing towards the genome termini.  ChCMV was 
found to lack counterparts of HCMV UL1 (a member of the RL11 glycoprotein Tanya Chaudry 2008    Chapter 1  71
family), UL111A (which encodes an interleukin-10 homologue in HCMV), and UL3.  
ChCMV was also found to contain a number of genes absent in HCMV AD169 and 
Toledo strains, including: UL146A (encodes a α-chemokine in HCMV), UL155, 
UL156, and UL157 (Davison et al., 2003a). 
 
The Toledo strain of HCMV produces the functional viral chemokine vCXCL-1 
(UL46), which has been implicated in HCMV virulence.  A similar gene, 
vCXCL-1chcmv, was identified in ChCMV.  It was found that vCXCL-1chcmv had 
similar activation potentials, chemotactic and signalling properties to its HCMV 
counterpart and could provide a model for assessing the role of vCXCL-1 in CMV 
pathogenesis (Miller-Kittrell et al., 2007).   
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1.16. Project aims 
 
Previous work comparing HCMV and SCMV pp71 proteins, by cloning and 
sequencing, had shown that these two homologues can locate to ND10 domains 
and play an active role in transactivating gene expression.  However, only HCMV 
pp71 was able to direct long-term gene expression (Nicholson, 2004).   
Homologues of pp71 obtained from other CMV viruses including RhCMV, BCMV 
and ChCMV had been sequenced but not yet studied.  Close examination of the 
predicted amino acid sequences showed a significant degree of homology 
between the UL82 proteins, especially in the middle region where a large degree 
of similarity is seen.  Therefore the pp71 homologues were expected to behave in 
a similar manner to HCMV pp71.   
 
This study aimed to: 
 
1.  Investigate the activation of gene expression by comparing the non-human 
homologues to HCMV pp71 using transfection assays and HSV-1 vectors.  
To determine how the pp71 homologues behave in short-term and long-term 
gene expression assays.  
 
2.  Map the region of HCMV pp71 involved in long-term gene expression. 
 
 
3.  Further characterise the non-human homologues by comparing the 
intracellular localisation of these proteins with that of HCMV pp71. 
 
 
 
 
 
 
 
 
 
 
    
Chapter 2 
 
Materials and Methods 
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2. Materials  
 
2.1. Chemicals 
 
All chemicals were of analytical grade, and unless otherwise stated, purchased 
from VWR Ltd, Sigma Aldrich Company Ltd. UK, or Invitrogen. 
 
2.1.1. Eukaryotic cells and tissue culture 
 
Culture media 
 
D5+5  
Dulbecco’s modified Eagle’s medium containing 1 mM sodium pyruvate and 2 mM 
L-glutamine, supplemented with 5% newborn calf serum (NBCS), 5% foetal calf 
serum (FCS), 100 U/ml penicillin, 100 μg/ml streptomycin and 1% non-essential 
amino acids (NEAA). 
 
DF2  
Dulbecco’s modified Eagle’s medium containing 1 mM sodium pyruvate and 2 mM 
L-glutamine, supplemented with 2% FCS, 100 U/ml penicillin, 100 μg/ml 
streptomycin and 1% NEAA. 
 
ETC10  
BHK-21 medium supplemented with 10% NBCS, 100 U/ml penicillin, 100 μg/ml 
streptomycin, 7% tryptose phospate broth and 2 mM L-glutamine. 
 
RPMI  
RPMI 1640 medium containing 25 mM HEPES buffer, supplemented with 10% 
FCS, 1% NEAA, 100 U/ml penicillin, 100 μg/ml streptomycin and 2 mM 
L-glutamine. 
 
 Tissue culture solutions 
 
PBSA: 170 mM NaCl, 3.4 mM KCl, 1.8 mM KH2PO4, pH 7.5. 
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Trypsin: 0.25% trypsin in Tris saline pH 7.7 (140 mM NaCl, 0.7 mM Na2HPO4, 5.6 
mM D-glucose, 24.8 mM Tris). 
 
Versene: 0.6 mM EDTA with 0.002% phenol red in PBSA. 
 
Tryptose Phosphate Broth: 29.5 g/L tryptose phosphate (Becton Dickinson). 
 
Eukaryotic cells 
Name Description  Source  Growth 
Medium 
HFFF2  Human foetal foreskin 
fibroblasts 
Provided by C.M. Preston  D5+5 
U2OS   Human  osteosarcoma 
cells 
Provided by C.M. Preston  D5+5 
 
BHK  Baby hamster kidney 
fibroblasts 
Provided by J.Mitchell  ETC10 
U373  Human glioblastoma  Provided by C.M. Preston  D5+5 
 
Table 2.1. Showing cells used and their sources 
 
2.1.2. Primary Antibodies 
Antibody Target  IF/WB
* Source 
Anti-hDaxx 
(mouse 
monoclonal) 
 
Endogenous 
hDaxx 
 
 
IF 
 
Courtesy of 
G.Maul 
Anti-PML A-20 
(goat polyclonal) 
Endogenous PML IF  Santa Cruz 
Anti-GFP 
(rabbit polyclonal) 
 
EYFP-tag 
 
WB 
 
AbCam 
Anti-myc 
(mouse 
monoclonal) 
 
myc-tag 
 
WB 
 
Santa Cruz 
Anti-Actin 
(mouse 
monoclonal) 
 
Actin 
 
WB 
 
Sigma Aldrich UK 
Anti-hDaxx 
(rabbit polyclonal) 
Endogenous 
hDaxx 
WB  Sigma Aldrich UK 
 
Table 2.2. Primary antibodies used, their targets and their source 
*Abbreviations: IF=immunofluorescence, WB=western blotting 
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2.1.3. Secondary Antibodies 
Antibody IF/WB
* Source 
Anti-mouse IgG-Cy5 
conjugate 
 
IF 
Amersham Biosciences 
UK Ltd 
Alexa 647-chicken anti-
goat 
 
IF 
 
Invitrogen 
Anti-rabbit IgG-HRP 
conjugated 
 
WB 
 
Sigma Aldrich UK 
Anti-mouse IgG-HRP 
conjugated 
 
WB 
 
Sigma Aldrich UK 
 
Table2.3. Secondary antibodies used and their source 
*Abbreviations: IF=immunofluorescence, WB=western blotting 
 
2.1.4. Plasmids  
 
Plasmid Description  Source 
 
pEYFP-C1 
EYFP expression vector containing a multiple cloning 
site (MCS) allowing inserts to be fused to the EYFP 
terminus driven by the HCMV MIEP 
 
CM.Preston 
 
pEYFPpp71 
EYFP fused to the N-terminus of the HCMV pp71 ORF 
driven by the HCMV MIEP 
 
C.M.Preston
 
pEYFPS82 
EYFP fused to the N terminus of the SCMV S82 ORF 
driven by the HCMV MIEP 
 
C.M.Preston
 
pEYFPB82 
EYFP fused to the N terminus of the BCMV B82 ORF 
driven by the HCMV MIEP 
 
C.M.Preston
 
pEYFPCh82 
EYFP fused to the N terminus of the ChCMV Ch82 
ORF driven by the HCMV MIEP 
 
M.J.Nicholl 
 
pEYFPRh82 
EYFP fused to the N terminus of the RhCMV Rh82 
ORF driven by the HCMV MIEP 
 
T. Chaudry 
pmycpp71  c-myc tag fused to N-terminus of HCMV pp71 driven 
by the HCMV MIEP  
C.M.Preston
pmycS82  c-myc tag fused to N-terminus of SCMV S82 driven by 
the HCMV MIEP 
M.J.Nicholl 
pmycB82  c-myc tag fused to N-terminus of BCMV B82 driven by 
the HCMV MIEP 
M.J.Nicholl 
pmycRh82  c-myc tag fused to N-terminus of RhCMV Rh82 driven 
by the HCMV MIEP 
M.J.Nicholl 
pmycCh82  c-myc tag fused to N-terminus of ChCMV Ch82 driven 
by the HCMV MIEP 
C.M.Preston
 
pCP1082 
HCMV MIEP controlling E.coli  lacZ gene in HSV-1 
thymidine kinase locus 
 
C.M.Preston
 
Table 2.4. Plasmids used and their acknowledged sources 
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2.1.5. Viruses 
 
Virus Promoter  Transgene  locus 
in1382  HCMV MIEP (-750 to +7)  E.coli lacZ (TK locus) 
in1374  HCMV MIEP (-750 to +7)  E.coli lacZ (UL43) locus 
 
in1310 
 
HCMV MIEP (-750 to +7) 
HCMV EYFPpp71 (TK locus), E.coli  lacZ 
(UL43 locus) 
 
in0150 
 
HCMV MIEP (-750 to +7) 
SCMV EYFPS82 (TK locus), E.coli lacZ (UL43 
locus) 
 
in0146 
 
HCMV MIEP (-750 to +7) 
ChCMV EYFPCh82 (TK locus), E.coli  lacZ 
(UL43 locus) 
 
in0144 
 
HCMV MIEP (-750 to +7) 
RhCMV EYFPRh82 (TK locus), E.coli  lacZ 
(UL43 locus) 
 
in0145 
 
HCMV MIEP (-750 to +7) 
BCMV EYFPB82 (TK locus), E.coli lacZ (UL43 
locus) 
 
in0149 
 
HCMV MIEP (-750 to +7) 
ChCMV mycCh82 (TK locus), E.coli  lacZ 
(UL43 locus) 
 
in0151 
 
HCMV MIEP (-750 to +7) 
HCMV mycpp71 (TK locus), E.coli lacZ (UL43 
locus) 
 
in0156 
 
HCMV MIEP (-750 to +7) 
EYFPTC6 (TK locus), E.coli lacZ (UL43 locus) 
 
in1318 
 
HCMV MIEP (-750 to +7) 
Secreted alkaline phosphatase (SEAP) (TK 
locus)  
 
Table 2.5. Viruses used in this study 
All mutant HSV-1 recombinant viruses were derived from the HSV-1 virus in1312 
(see introduction section 1.10.6).  All HSV-1 recombinant viruses used in this 
study are impaired for the transcriptional stimulating activity of VP16 and 
additionally, the IE proteins ICP0 and ICP4 are rendered non-functional by 
deletion and temperature sensitive mutations respectively. 
 
2.1.6. Restriction endonucleases 
All restriction endonucleases were purchased from New England Biolabs Ltd (UK) 
or Roche Diagnostics Ltd (UK) and were supplied with the appropriate reaction 
buffers. 
 
2.1.7. Miscellaneous enzymes 
T4 DNA ligase and calf intestinal phosphatase (CIP) were obtained from New 
England Biolabs.  Klenow DNA Polymerase was purchased from Roche 
Diagnostics Ltd.  All enzymes were supplied with the appropriate reaction buffers. 
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2.1.8. Composition of commonly used solutions and buffers 
 
2.1.8.1. Bacterial cell culture 
L-Broth: 10 mg/ml tryptone peptone (Becton Dickinson), 5 mg/ml yeast extract 
(Becton Dickinson), 10 mg/ml NaCl pH 7.5. 
 
L-Broth agar: L-broth plus 15 mg/ml agar (Becton Dickinson). 
 
2.1.8.2. DNA manipulation 
 
2.1.8.2a. Small scale DNA preparation 
Resuspension buffer p1: 50 mM Tris.HCl, 10 mM EDTA, 100 μg/ml RNase A pH 
8.0. 
 
Lysis buffer p2: 200 mM NaOH, 1% SDS. 
 
Neutralisation buffer N3: 3.0 M potassium acetate pH 5.5. 
 
Wash buffer 1 PB: Qiagen proprietary information. 
 
Wash buffer 2 PE: Qiagen proprietary information. 
 
Elution buffer EB: 10 mM Tris.HCl, pH 8.5. 
 
2.1.8.2b. Large Scale DNA preparation 
Resuspension buffer: 50 mM Tris.HCl, pH 8.0, 10 mM EDTA, 100 μg/ml RNase 
A. 
Cell lysis buffer: 200 mM NaOH, 1% SDS. 
 
Neutralisation buffer: 3.0 M potassium acetate pH 5.5. 
 
Filter wash buffer: 1 M potassium acetate pH 5.0. 
 
Equilibration buffer: 750 mM NaCl, 50 mM MOPS, pH 7.0, 15% isopropanol, 
0.15% Triton X-100. Tanya Chaudry 2008    Chapter 2  78
Column wash buffer: 1.0 M NaCl, 50mM MOPS, pH 7.0, 15% v/v isopropanol. 
 
Elution buffer I: 1.25 M NaCl, 50 mM MOPS, pH 7.0, 15% v/v isopropanol. 
 
Elution buffer II: 1.6 M NaCl, 50 mM MOPS, pH 7.0, 15% v/v isopropanol. 
 
TE buffer: 10 mM Tris.HCl pH 8.0, 1 mM EDTA. 
 
2.1.8.3. STET preparations 
STET: 8% sucrose, 5% Triton-X 100, 500 mM EDTA, 500 mM Tris.HCl pH 8.0 
 
2.1.8.4. SDS polyacrylamide gel electrophoresis and western blotting 
Running gel buffer: 52 mM Tris.HCl, 53 mM glycine, 1% SDS, pH 6.8. 
 
Transfer Buffer: 25 mM Tris.HCl, 192 mM glycine, 20% methanol, pH 8.3 
. 
SDS gel loading buffer: 50 mM Tris.HCl, pH 6.8, 100 mM DTT, 2% SDS, 10% 
glycerol, 0.1% bromophenol blue. 
 
PBSA+TWEEN: PBSA+1% TWEEN 20 (Calbiochem). 
 
2.1.8.5. DNA electrophoresis  
TBE (10X): 1.25 M Tris, 27mM EDTA, 0.4 M boric acid.  
 
Ficoll loading buffer: 10% Ficoll, 5XTBE, 0.1% bromophenol blue. 
 
2.1.8.6. β-Galactosidase assays 
β-Gal reaction mix (histochemical): 5 mM K4Fe(CN)6, 5 mM K3Fe(CN)6, 2 mM 
MgCl2, 0.01% NP40, 1 mg/ml 5-Bromo-4-Chloro-3-Indolyl-β-D-galactoside (X-gal) 
(Melford) in PBSA. 
 
Carmalum Stain: 5 g Carmine red, 5 ml glacial acetic acid 120 ml dH2O, 5 g 
aluminium potassium sulphate, 80 ml dH2O, 1 crystal thymol. 
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2.1.8.7. SEAP assay 
SEAP 2x buffer:  2 M diethanolamine, 1 M MgCl2, 1 M homoarginine, 12 mM 
pNitrophenyl phosphate.  
 
2.1.8.8. Immunofluorescence reagents 
Fix buffer: 5% Formaldehyde, 2% sucrose in PBSA 
 
Permeabilisation buffer:0.5% NP40, 2% sucrose, in PBSA 
 
2.1.9. Commercial kits and other reagents 
2.1.9.1. DNA Handling 
QIAEXII Extraction kit   Qiagen 
Endofree plasmid Maxi kit  Qiagen 
1KB DNA ladder   NEB 
Klenow Buffer 10 X   66 mM Tris.HCl, 0.5 M NaCl, 66 mM MgCl2, pH 7.5. 
Rainbow Marker   GE Healthcare 
AF1 mounting fluid   Citiflour  
Aquamount fluid     VWR Ltd 
 
2.1.9.2. Transfection reagents 
Nucleofector
TM Solution    Amaxa Biosystems 
 
2.1.9.3. Transformation reagents  
E.Coli DH5α chemically competent cells   Invitrogen Life Technologies 
 
 
 
 
 
 
 
 
 
 
 Tanya Chaudry 2008    Chapter 2  80
2.2. Methods 
 
2.2.1. DNA manipulation techniques 
 
2.2.1.1. Restriction endonuclease digestion 
 
DNA was digested in a final volume of 10-20 μl, in buffer reaction conditions 
according to manufacturer’s guidelines.  The number of units of enzyme added per 
reaction was dependent on the quantity of DNA present.  Typically 10 units of 
enzyme were used per 5 μg of DNA.  Restriction enzyme digests were incubated, 
unless otherwise stated, at 37
oC for 1-3 hr. 
 
2.2.1.2. Removal of phosphate groups from DNA 5’ ends 
 
1 unit of CIP was added to restriction endonuclease digests to remove phosphate 
groups from 5’ ends of DNA fragments to prevent vector re-ligation. 
 
2.2.1.3. Generation of blunt ended linear DNA fragments 
 
DNA fragments generated by digestion with the appropriate restriction enzyme 
were blunt ended using fill in reactions containing 2 units Klenow DNA 
polymerase, 100 μg/μl BSA, 5 mM DTT, 100 μM dATP, 100 μM dTTP, 100 μM 
dGTP, 100 μM dCTP, 1xKlenow buffer.  Reactions (20 μl) were incubated at 37
oC 
for 1 hr.   
 
2.2.1.4. Separation of DNA fragments by agarose gel electrophoresis 
 
DNA fragments were separated and identified using 50-100 ml gels containing 
1%-1.2% agarose.  The DNA samples were analysed by gel electrophoresis with 
50-100 ml 1xTBE and 1μg/ml ethidium bromide at 50 V.  DNA was visualised by 
UV transillumination and photographed using a camera with Polaroid 667 film. 
 
 
 
 Tanya Chaudry 2008    Chapter 2  81
2.2.1.5. Isolation of DNA fragments from agarose gels 
 
Long wave UV transillumination was used to visualise DNA fragments to be 
isolated and purified.  Appropriate DNA fragments were excised using a sterile 
scalpel.  DNA was extracted using a QIAquick gel extraction kit (QIAGEN).   
Purified fragments were checked on 1% agarose gels.  
 
2.2.1.6. Phenol/Chloroform extractions  
 
DNA eluted using the QIAquick method was phenol/chloroform extracted to give 
more concentrated preparations.  The final volume of DNA solutions was brought 
up to 50 μl by the addition of dH2O. An equal volume of phenol/chloroform (1:1) 
was added and the mixture vortexed prior to centrifugation at 13000 rpm (MSE 
microfuge) for 2 min.  The resulting upper aqueous phase was transferred to a 
fresh microfuge tube and an equal volume of chloroform was added.  The mixture 
was vortexed briefly and centrifuged again at 13000 rpm (MSE microfuge) for 2 
min.  For ethanol precipitations 2.5 volumes of 100% ethanol, 0.3 M sodium 
acetate and 5 mM EDTA was added to the aqueous phase and incubated at   
-20
oC for 2 hr.  For isopropanol precipitations an equal volume of isopropanol was 
added to the aqueous phase with 0.3 M sodium acetate and 5 mM EDTA.  The 
mixture was left to precipitate at room temperature for 1 hr and spun down at 
13000 rpm (MSE microfuge) for 5 min.  The resulting pellet was washed with 0.5 
ml 100% ethanol, and air dried and resuspended in an appropriate volume of 
dH2O.  
 
2.2.1.7. Ligation of compatible DNA fragments 
 
Vector and insert were digested with the appropriate restriction endonuclease and 
purified by phenol/chloroform extraction, as described above.  DNA was analysed 
by gel electrophoresis and purified using a gel extraction kit (QIAGEN).  The 
purified DNA fragments were ligated using a variety of vector-insert ratios 
depending on the size of vector and insert.  Final reaction volumes of 10 μl 
containing 1xT4 DNA ligase buffer and 10 units T4 ligase were used per ligation 
mixture.  Reactions were ligated for 4-12 hr at 16
oC.  Ligated DNA was stored at 
-20
oC.  
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2.2.1.8. Transformation of DNA into competent bacteria 
 
Approximately 1-5 μl ligation mix with 25-50 μl of E-coli DH5α bacterial cells was 
incubated on ice for 20 min.  The transformation mix was heat shocked at 37
oC for 
30 sec and followed by a further 2 min incubation on ice.  500 μl of pre-warmed 
L-broth was added to the transformed cells and the mixture placed in an orbital 
shaker (200 rpm) at 37
oC for 1 hr. 150 μl of the transformed cells was plated onto 
L-broth agar plates containing 50 μg/ml of the appropriate antibiotic to allow 
selection of the transformants.  The plates were incubated overnight at 37
oC to 
allow the growth of single colonies.  
 
 2.2.1.9. Small scale DNA preparation 
 
Starter cultures were generated by inoculating 1 ml L-broth containing the 
appropriate antibiotic with a single bacterial colony.  This was placed in an orbital 
shaker at 200 rpm overnight at 37
oC.  Plasmid DNA was extracted from pellets 
using a QIAGEN Mini-prep kit according to manufacturer’s guidelines, as follows: 
Starter cultures were centrifuged at 3000 rpm in a bench top centrifuge for 30 min 
at 4
oC with the resulting supernatant being discarded.  The bacterial pellet was 
resuspended in 4 ml buffer P1 and the cells lysed by the addition of 4 ml buffer P2, 
and incubated at room temperature for 5 min.  4 ml buffer P3 was added to the 
mixture and the tube inverted 4-6 times and incubated on ice for 15 min.  The 
supernatant was applied to a QIAGEN tip, previously equilibrated with 4 ml buffer 
QBT, and allowed to enter the resin.  The column was washed with buffer QC. 
DNA was eluted using 5 ml buffer QF and precipitated by adding 3.5 ml room 
temperature isopropanol to the eluted DNA and centrifuged at 11000 rpm (Sorvall 
SS-34) for 30 min at 4
oC.  The DNA pellet was washed with 2 ml 70% room 
temperature ethanol and centrifuged at 11000 rpm (Sorvall SS-34) for 10 min at 
4
oC.  The supernatant was decanted and the DNA pellet air dried and 
resuspended in 300 μl of 10 mM Tris.HCl pH 8.5. 
 
2.2.1.10. STET preparations 
 
Bacterial colonies were picked from selective plates and inoculated in 2 ml L-broth 
containing the appropriate selective antibodies and incubated overnight at 37
oC in 
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transferred into a 1.5 ml eppendorf tube and centrifuged for 2 min at 6000 rpm 
(MSE microfuge).  The medium was removed and the bacteria were resuspended 
in 100 μl STET plus 5 μl 10 mg/ml lysozyme, and the mixture was vortexed.  The 
eppendorf tubes were transferred to a boiling water bath for 1 min and then 
centrifuged for 10 min at 13000 rpm (MSE microfuge).  The resulting supernatant 
was transferred to a new eppendorf tube containing 400 μl 0.3 M sodium acetate 
pH 7 and 0.5 ml isopropanol and vortexed.  The mix was centrifuged at 13000 rpm 
(MSE microfuge) for 5 min and the resulting supernatant discarded and the pellet 
air dried and resuspended in 33 μl of dH2O. 
 
2.2.1.11. Large Scale DNA preparation 
 
100  μl of starter culture containing the required DNA plasmid was used to 
inoculate 200 ml of L-broth, containing 50 μg/ml of the appropriate antibiotic, and 
shaken overnight at 200 rpm in an orbital shaker at 37
oC.  Cultures were 
centrifuged at 3000 rpm for 30 min at 4
oC (Sorvall RT60000B) and the resulting 
supernatant discarded.  Plasmid DNA was extracted according to manufacturers 
guidelines using a Qiagen Maxi-prep kit as follows.  The bacterial pellets were 
resuspended in 10 ml buffer P1 and lysed with 10 ml buffer P2.  Lysis was stopped 
by the addition of buffer P3.  The lysate was filtered through a QIA filter cartridge.  
2.5 ml buffer ER was added to filtered lysate mix and incubated on ice for 30 min.  
The filtered lysate was transferred to an equilibrated QIAGEN-tip 500 to allow DNA 
to bind to the resin and the column was washed twice with 30 ml buffer QC.  DNA 
was eluted using buffer QN and precipitated by adding 10.5 ml room temperature 
isopropanol to the DNA and centrifuged at 11000 rpm in a Sorvall SS-34 rotor for 
30 min at 4
oC.  The DNA pellet was washed with 5 ml endotoxin free 70% ethanol 
and centrifuged at 11000 rpm (Sorvall SS-34 rotor) for 10 min at 4
oC.  The 
supernatant was discarded and the DNA pellet air dried and re-dissolved in 350 μl 
buffer TE and transferred to a fresh microfuge tube. 
 
2.2.1.12. Nucleofection of adherent cells 
 
Transfection of adherent cells was carried out using a Nucleofector
TM (Amaxa). 
HFFF2 cell monolayers maintained in 175 cm
2 tissue culture flasks were 
trypsinised and resuspended in RPMI growth medium. Cell density was 
determined (2x10
5 - 2x10
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RTH-250 rotor for 10 min at 20
oC.  The supernatant was discarded and the cell 
pellet resuspended in room temperature Nucleofector
TM Solution R to a final 
concentration of 2x10
5 - 2x10
7 cells/100 μl.  Each 100 μl of cell suspension was 
mixed with 5 μg of the required DNA, transferred to a cuvette and placed in the 
Nucleofector
TM at the appropriate program and transfected.  500 μl pre-warmed 
RPMI medium was added to the transfected cells prior to samples being seeded 
into 24 well plates and incubated at 37
oC overnight. 
 
2.2.1.13. Virus infection of mammalian cells  
 
24 well plates seeded with 1.5x10
5 cells, 13 mm coverslips seeded with 8x10
4 
cells or 35 mm plates seeded with 1x10
6 cells (unless otherwise stated) in 1 ml (24 
well plate) or 2 ml (35 mm plates and 13 mm coverslips) D5+5 medium were 
incubated overnight at 37
oC.  The growth medium was removed, the following day 
and cells were infected with the appropriate virus in a volume of either 100 μl (24 
well plate) or 200 μl (35 mm plates and 13 mm coverslips) and incubated at 37
oC 
with plates being rocked gently every 10 min for 1 hr.  Following incubation either 
1 ml (24 well plate) or 2 ml (35 mm plates and 13 mm coverslips) of fresh medium 
was added to the cell monolayers and the incubation continued at 38.5
oC.  For 
longer incubation periods cell culture medium was changed every 2 days. 
 
2.2.2. Protein manipulation techniques 
 
2.2.2.1. Preparation of cell lysates 
 
Culture medium was removed from cell monolayers grown in 24 well tissue culture 
plates and the monolayers were washed with 1 ml PBSA. 40 μl 1xSDS gel loading 
buffer was added to each cell monolayer. The resulting lysates were scraped into 
1.5 ml microfuge tubes and stored at -20
oC. 
 
2.2.2.2. SDS polyacrylamide gel electrophoresis of proteins 
 
Cell lysates were boiled for 10 min at 100
oC to ensure complete denaturation of 
the proteins to be resolved by electrophoresis.  SDS-PAGE was carried out using 
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water, 2.5 ml resolving gel buffer, 3.33 ml 30% acrylamide, 80 μl 10% ammonium 
per sulphate, 8 μl TEMED were overlaid with ethanol.  Following polymerisation 
the ethanol was rinsed off before overlaying with the stacking gel containing 1 ml 
distilled water, 0.6 ml stacking gel buffer, 0.4 ml acrylamide, 20 μl 10% ammonium 
per sulphate and 3 μl TEMED.  Samples were analysed by gel electrophoresis at 
150 V in running gel buffer till the dye front reached the bottom of the gel.  Prior to 
blotting the gel was removed from electrophoresis apparatus. 
 
2.2.2.3. Western blot analysis of denatured proteins 
 
SDS-PAGE gels were transferred to nitrocellulose membranes by the assembly of 
a blotting sandwich, the components of which were pre-soaked in transfer buffer 
and assembled as follows: The gel was placed on a 9.5 cm x 8.0 cm piece of 
Whatman No.1 filter paper and overlayed with nitrocellulose membrane cut to 8.5 
cm x 7.0 cm and a second piece of Whatman No.1 filter paper, cut as before, 
placed on top and air bubbles expelled.  The assembled sandwich was placed in a 
Bio-Rad mini-transblot apparatus and the proteins electroblotted at 250 mA for 2-4 
hr at 4
oC.  The membrane was blocked in 25 ml PBSA+TWEEN and 5% dried milk 
for 1 hr at room temperature.  The membrane was washed 3 times in 100 ml 
PBSA+TWEEN for 5 min and incubated with primary antibody at the appropriate 
dilution in 20 ml PBSA+TWEEN and 5% dried milk for 4-12 hours at 4
oC.  The 
membrane was washed 3 times in 100 ml PBSA+TWEEN for 5 min. The blot was 
incubated for 1 hr at room temperature in secondary antibodies which were diluted 
to appropriate concentrations in 20 ml PBSA+TWEEN and 2% dried milk.  The 
membrane was washed 3 times in 100 ml PBSA+TWEEN for 5 min and proteins 
were detected using ECL reagents (Amersham).  A 2 ml mixture of ECL western 
blotting reagents was applied to the drained membrane for 1 min after which the 
membrane was placed between 2 sheets of Melinex hazy 23-micron film and 
exposed to Kodak X-omat S film. 
 
2.2.2.4. Histochemical staining for β-glactosidase in tissue culture 
monolayers 
 
Cell culture medium was removed from cell monolayers, grown in 24 well plates.  
Each cell monolayer was fixed with 1 ml 1% glutaraldehyde in a fume cupboard.  
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cell monolayers washed with 2 ml PBSA.  1 ml of β-gal reaction mixture was 
added to the cell monolayers and the plates incubated at 37
oC for 2-4 hr until blue 
cells became visible under a low power light microscope.  The cell monolayers 
were washed with 2 ml dH2O and positive blue cells counted. 
 
2.2.2.5. Carmalum staining 
 
Cell monolayers to be retained for digital imaging were washed with dH2O to 
remove the β-gal reaction mixture.  Prior to monolayers drying out, 1 ml of 
Carmalum stain was added and monolayers were incubated at 4
oC for 4-5 days.  
Following staining the dye was removed and the plates were washed with dH2O, 
dried and stored until required. 
 
2.2.2.6. Digital imaging of β-gal positive cells 
 
Digital images of β-gal positive cells were obtained by mounting a clean coverslip 
of the appropriate size over the stained monolayers using aquamount fluid.   
Images were taken using a Nikon TS100 microscope and a SPOT INSIGHT 
camera and software. 
 
2.2.2.7. Secreted Alkaline Phosphatase (SEAP) assays  
 
Analysis of SEAP was carried out by infecting cell monolayers with a HSV-1 
recombinant virus expressing SEAP at 38.5
oC.  150 μl of growth medium was 
harvested and samples were incubated at 65
oC to destroy endogenous alkaline 
phosphatase and allowed to cool to room temperature.  25 μl of sample was 
transferred to a fresh 1.5 ml microfuge tube and the remaining samples stored at 
-20
oC.  To each sample 25 μl of assay buffer, containing 25 μl 2xSEAP buffer and 
1 μl 4-methylumbelliferyl phosphate (MUP) was added.  Reactions were vortexed 
and incubated in the dark for 1 hr at room temperature. The reaction was stopped 
by placing samples on ice and fluorescence measured when 25 μl of each reaction 
was added to 2 ml dH2O in a cuvette in a HSI DNA fluorometer. 
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2.2.3. Virus propagation techniques 
 
2.2.3.1. Preparation of recombinant HSV-stocks 
 
Recombinant HSV-1 stocks were propagated in BHK-21 cells grown at 37
oC in 
tissue culture roller bottles to approximately 90% confluency.  The cells were 
inoculated with 0.2 ml of seed stock in 100 ml ETC10 medium containing 3 mM 
HMBA.  The cells were incubated at 31
oC until CPE was observed.  The cell 
suspension was transferred to a Sorvall goose necked bottle and centrifuged at 
5,000 rpm in a Sorvall SLA-1500 GSA rotor for 10 min at 4
oC.  The supernatant 
was transferred to a fresh goose necked bottle and centrifuged at 12,000 rpm for 2 
hr in a Sorvall SL-1500 GSA rotor.  The resulting cell pellets were resuspended in 
4.5 ml ETC10 medium and sonicated in a bath sonicator to disaggregate the virus.  
The suspension was dispensed into 1.5 ml microfuge tubes and stored at –70
oC. 
 
2.2.3.2. Titration of recombinant HSV-1 stocks 
 
Recombinant HSV-1 stocks were titrated on U2OS cell monolayers grown in 35 
mm dishes to 90-100% confluency.  Cell monolayers were infected with 200 μl 
serial dilutions of the viruses, with titrations being produced in duplicate.  After a 1 
hr incubation at 37
oC the cells were overlaid with fresh D5+5 medium containing 3 
mM hexamethylbisacetamide (HMBA) and 2% human serum.  The cells were 
incubated at 31
oC till plaques were observed.  Upon observation of plaques 
medium was removed and the monolayers fixed with 1 ml 1% glutaraldehyde for 
45 min.  The fix solution was removed and the cells washed with 2 ml PBSA.  1 ml 
β-gal reaction mixture was added to the monolayers and incubation continued at 
37
oC for 2-3 hours until blue plaques could be observed.  The β-gal reaction mix 
was washed off prior to counting plaques. 
 
2.2.4. Cell culture techniques 
 
2.2.4.1. Serial passage of eukaryotic cells 
 
Eukaryotic cells were maintained in 175 cm
2 tissue culture flasks (NUNC) in 50 ml 
of the appropriate growth medium.  For serial passage the growth medium was 
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subsequently poured off.  10 ml versene containing 2 ml trypsin was washed over 
the cells and all but 5 ml removed.  Gentle agitation was applied to the flask for 5 
min, allowing the cell monolayer to detach.  10 ml of appropriate fresh growth 
medium was added to the cell suspension and seeded into tissue culture flasks 
containing 40 ml fresh growth medium. HFFF2 cells were typically split at a ratio of 
1:4, while both U373 cells and U2OS cells were split at a ratio of 1:3. 
 
2.2.4.2. Seeding of eukaryotic cells into tissue culture dishes 
 
Eukaryotic cell monolayers maintained in 175 cm
2 tissue culture flasks were 
trypsinised and re-suspended in appropriate growth medium as described above.  
Cells were seeded, into 24 well plates or 35 mm plates. 
 
2.2.5. Microscopy techniques 
 
2.2.5.1. Immunofluorescence 
 
Cells were grown on sterile 13 mm diameter coverslips in 24 well tissue culture 
plates to approximately 75% confluency. After incubation with virus or DNA 
plasmid, culture medium was removed and monolayers washed twice with PBSA. 
Monolayers were fixed with 0.5 ml fixing solution, at room temperature, for 10 min.  
After fixation cells were washed 3 times with PBSA+1% FCS and permeabilised 
with 0.5 ml permeabilisation buffer for 5 min at room temperature. Following 
removal of permeabilisation buffer cells were washed 3 times with PBSA+1% FCS.  
20  μl of the appropriate primary antibody dilutions, in PBSA+1% FCS, were 
applied to each coverslip and incubated at room temperature for 1 hr. Coverslips 
were washed 3 times with PBSA+1% FCS and 20 μl of the appropriate secondary 
antibody, diluted in PBSA+1% FCS was applied to the coverslips. After incubation 
in the dark for 30 min at room temperature, coverslips were washed 3 times with 
PBSA+1% FCS, once with dH2O and air-dried.  The coverslips were mounted onto 
glass microscope slides using 5 μl Citifluor, the edges sealed with clear nail 
varnish and stored at 4
oC. 
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2.2.5.2. Confocal microscopy 
 
Immunolabelled cells and those expressing EYFP conjugates were examined 
using a Zeiss LSM 510 confocal microscope attached to a computer with the 
appropriate LSM software.  Images were exported and saved. 
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Short-term and long-term expression analyses of 
the UL82 homologues 
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3. Part I 
 
3 1. Introduction 
 
The HCMV tegument protein pp71 is important for transactivating IE gene 
expression and initiating lytic replication.  This protein has also been shown to 
stimulate transcription from IE promoters in HSV-1 genomes.  Studies showed that 
pp71 stimulates expression of genes under the control of the HCMV MIEP in 
short-term assays (Homer et al., 1999, Liu & Stinski, 1992, Marshall et al., 2000).  
Preston and Nicholl (2005) showed, using various reporter based assays, that 
pp71 could direct long-term gene expression (see Introduction section 1.10.7 for 
details).   
 
In the study described here a HSV-1 mutant, in1382, which contains the lacZ gene 
inserted in the TK locus under the control of the MIEP was employed.  This virus 
was impaired for transcriptional activity due to mutations at VP16, ICP0, a 
temperature sensitive mutation at ICP4 therefore was unable to enter lytic 
replication, due to the absence of IE proteins.  In the presence of pp71 quiescence 
was overcome, as pp71 allowed continued expression from the HCMV IE 
promoter cloned into the genome. In the study presented here a comparison of 
pp71 with UL82 homologues from Simian CMV (S82), Baboon CMV (B82), 
Rhesus CMV (Rh82), and Chimpanzee CMV (Ch82) was carried out to establish if 
pp71 was unique in its ability to stimulate long-term gene expression. 
 
3.1 1. Sequence analysis of the UL82 homologues 
 
Amino acid sequences of pp71 (Chee et al., 1990, Dargan et al., 1997, Davison et 
al., 2003a), and its homologues S82 (Nicholson, 2004), B82 (Accession number 
AF324835), Rh82 (Hansen et al., 2003) and Ch82 (Davison et al., 2003a) were 
analysed using Vector NTI (Vector NTI suite 9.0) in order to determine their 
degrees of homology. The analysis of the primate CMV UL82 amino acid 
sequences in figure 3.1 shows a large number of conserved regions between all 
five homologues, indicating a significant degree of homology.  A more detailed 
sequence analysis of the homologues, carried out by Nicholson (2004), led to the 
construction of a phylogenetic tree showing the relative evolutionary distances of 
the proteins from one another (Nicholson, 2004) (figure 3.2).  The tree shows that                  1                                               50 
      B82    (1) ----MDRP-QEEREPRPSTSRPLSLSATFERLSCQVMRVISTQNT-TLEA 
     Ch82    (1) MSRSPS-PGEGPSAAGGPGGAPGDNGSTFGRMHCQVLRLVTNHDS-SLEP 
     pp71    (1) MSQASSSPGEGPSSEAAAISEAEAASGSFGRLHCQVLRLITNVEGGSLEA 
     Rh82    (1) ----MDRPPEEEEEPRPSTSRALAPAATFERLTCQILRLVCTQHS-PLDV 
      S82    (1) ----MDRPPEEEEEPRPSTSRAAAPAATFDRLTCHVLRMITTQST-TMET 
Consensus    (1)     MDRP EEE EPRPSTSRA A AATFERLTCQVLRLITTQ S SLE  
                 51                                             100 
      B82   (45) DAVKVVNWHTHVQVANPAVICAFQESTCTRDALQLTDISIKGRSSSTLRD 
     Ch82   (49) DRLKILDLRTSVEVSRTSVLCLFQENKSQHDTVDLTDLNVKGHCAVGERD 
     pp71   (51) GRLRLLDLRTNIEVSRPSVLCCFQENKSPHDTVDLTDLNIKGRCVVGEQD 
     Rh82   (46) DAVQTMNWHTSVEVANRAVICAFQEMKSSRDALQLTDLNLKGHCSSTFRD 
      S82   (46) NAVKVIDWHANIQVANPAVICTFQEVKSPRDPLQLTDLNLKGRCSSTLRD 
Consensus   (51) DAVKVLDWHT VEVANPAVIC FQE KS RD LQLTDLNIKGRCSST RD 
                 101                                            150 
      B82   (95) QLRTDVGNYANKRLKSGT--HTKSMLVFALPLLRVPVTGIHLFRG--KAK 
     Ch82   (99) QLKADLINYSQRRMSPGS-STPISVLAFGLPLERVPVSGIHLFQAHPRGD 
     pp71  (101) RLLVDLNNFGPRRLTPGSENNTVSVLAFALPLDRVPVSGLHLFQSQRRGG 
     Rh82   (96) SLRTDACNYANRRLSPGS--QTSAMLVFALPIVRVPVTGIHLFRG--RGN 
      S82   (96) SLRTDVCNFSDTRLRSGS--NTMSVLVFALPLVRVPVTGIHLFRG--RAQ 
Consensus  (101)  LRTDL NYANRRLSPGS  NTISVLVFALPLVRVPVTGIHLFRG  RG  
                 151                                            200 
      B82  (141) NENRPLKANARATIRRCQYMWKVKLNLDKIIWNRRRDPNIEGGQFFTTDF 
     Ch82  (148) EENRL-RTEARVDIRRTAYHWGVRTTVSPR-WRRKVDRSLEAEQIFTTEF 
     pp71  (151) EENRP-RMEARAIIRRTAHHWAVRLTVTPN-WRRRTDSSLEAGQIFVSQF 
     Rh82  (142) SQNRPPRANARTTIRRAQYTWTVKVNVSAITWTRKRDQYVEGGYTFATDF 
      S82  (142) SENRPPRANARVTIRRAQYMWTVKVNLAGINWSRRRDSHTEGGQFFTSDF 
Consensus  (151)  ENRP RANAR TIRR QY W VKLNVS I W RRRD  LEGGQ FTTDF 
                 201                                            250 
      B82  (191) IFSTELIPLTVVDAMDQLACSDGYTHVQKAETVGSENLVRVFLINLSHHP 
     Ch82  (196) IFRAGAIPLRLVDAVELLSCSDRNTYIHKAETDARGQWVNVHLQHETLHP 
     pp71  (199) AFRAGAIPLTLVDALEQLACSDPNTYIHKTETDERGQWIMLFLHHDSPHP 
     Rh82  (192) TFLTGLIPLTLVDAIDQLACSNGDTYVQKVETIGEENLILVSLIHFSLHP 
      S82  (192) TFATDLMPLTVVDAMDQLACSDADTYIQKAETVGEQNLIRVYIIHLSGHP 
Consensus  (201)  F TGLIPLTLVDAMDQLACSDG TYIQKAETVG  NLI VFLIH S HP 
                 251                                            300       B82  (241) PQELFLQLSVYSHRAEVMCRHNPEPFFQRHSDNGFIVKNTKGVTIP-AHH 
     Ch82  (246) PPSVFLHFSLYTHGAEVVLRHNPYPHLTRHGDNGFTLHAPRGFTLSRLHR 
     pp71  (249) PTSVFLHFSVYTHRAEVVARHNPYPHLRRLPDNGFQLLIPKSFTLTRIHP 
     Rh82  (242) PTEVFLQLSVYAHRAEVMWRHNPNPFFERHSENGFLVKCPLHVTIP-AHQ 
      S82  (242) PAEMFLQMSVYSHRAEVICRHNPAPFFERHAENGFLVRNPHTVNIP-AHH 
Consensus  (251) P EVFLQLSVYSHRAEVM RHNP PFF RHSDNGFLVK PK VTIP AH  
                 301                                            350 
      B82  (290) THVAHFNNAFETQNTCSFLFFPVDIPGLSIECGPLQNRMKITIKMQNLTK 
     Ch82  (296) EYIVQVQNAFETNNTHDVIFFPADIPGVSMEAGPLPDRVRITIRLTWTGE 
     pp71  (299) EYIVQIQNAFETNQTHDTIFFPENIPGVSIEAGPLPDRVRITLRVTLTGD 
     Rh82  (291) TYVVQFNNALETQDTCYAVFFPLELPGISMDAGPLPNRMKITINVQNLTA 
      S82  (291) THVAHFNNAIETQGTCHLLFFPIDIPGLSIEAGPLTSRMKITLKIQNLTQ 
Consensus  (301) TYVVQFNNAFETQNTC  IFFPIDIPGLSIEAGPLP RMKITIKVQNLT  
                 351                                            400 
      B82  (340) TEISVSFMQTIGLIHFFPRGTLYTMPNKTLTSACSQIRLRAGLCPRESIA 
     Ch82  (346) NSVRIEHMQILGTIHLFKRGVLNLLPGKTEKIKRPQIQLRAGLFPRRAVM 
     pp71  (349) QAVHLEHRQPLGRIHFFRRGFWTLTPGKPDKIKRPQVQLRAGLFPRSNVM 
     Rh82  (341) NAITLAHMQMLGFIHLFRRGSVGVLPNKTETPRCSQIRLRAGLFPRDSIL 
      S82  (341) TAITVNYMQMLGFIHFFPRGSLATMPNRTQTPRCSQTRLRAGLFPRDVIM 
Consensus  (351) NAITL HMQMLG IHFFRRGSL LLPNKTET KCSQIRLRAGLFPRDSIM 
                 401                                            450 
      B82  (390) RG-ISQFAEQ--------HSSSSE---DEDDELPGTTPPIVTEAIFNPFQ 
     Ch82  (396) RGEVSEFRPQSPGELPLEGEEEEEE---EEERSSTPTPPALSESVFAAFE 
     pp71  (399) RGAVSEFLPQSPGLPPTEEEEEEEEEDDEDDLSSTPTPTPLSEAMFAGFE 
     Rh82  (391) RG-ISEFAQQP-------NNSSSSE--DEEEEGPPITPPIITEAIFDPFQ 
      S82  (391) RGVISQFVEQ--------NSSSSEE--EEEDEPVPLTPPILTEAIFAPFQ 
Consensus  (401) RG ISEF  Q          SSSEE  DEEDE    TPPILTEAIFAPFQ 
                 451                                            500 
      B82  (428) SENESTSDEDDER----------KKRGGRPATPHIS-DQLSPTSMLLTLP 
     Ch82  (443) -ESSEEEESDTEEG--------LSRALALTGRRRPRRGADEGEDLMLVIP 
     pp71  (449) -EASGDEDSDTQAG--------LSPALILTGQRR---RSGNNGALTLVIP 
     Rh82  (431) SEDSSDEDDEPQTTMDRLRREAHKAKREGTAAPVTHRERLPKTAMLLVVP 
      S82  (431) SENDSTSDEDEEEPTTSARLRAEARARREAGQPPVP-ERPPPTVQLLSLP 
Consensus  (451) SE SSDEDED E           SRA   TG P    E    TALLLVIP 
                 501                                            550 
      B82  (467) CWNMYMHLENLMPITASVEDNAVKNTSYLKSEMDGDICTAADIDVAYQTL      Ch82  (484) SWNVFVNIDNLVPLTGSVEQAALKPTSYLRSEMQGDVRTAADFTSNLQPV 
     pp71  (487) SWHVFASLDDLVPLTVSVQHAALRPTSYLRSDMDGDVRTAADISSTLRSV 
     Rh82  (481) SWNMYIHPDLLMPLTARIAEEAVKNTSYLRSELDGDICTACRPQ------ 
      S82  (480) CWNMYIHTDLLLPITARIEDTAVKATSYLRSELEGDICTAADLQSTFQEL 
Consensus  (501) SWNMYIHLD LMPLTASVED AVK TSYLRSEMDGDICTAADI S  Q L 
                 551                   575 
      B82  (517) LAPFPL---------SHRSPSRPRI 
     Ch82  (534) PVPRPSPMSLPSTSGTAASRSRPRI 
     pp71  (537) PAPRPSPISTASTSSTPRSR--PRI 
     Rh82  (525) -----------------NHPSRP-- 
      S82  (530) MAPLPA---------RRSPTARPRI 
Consensus  (551)  AP PS         T  S SRPRI 
 
 
Figure 3.1. Conservation of UL82 amino acids in homologue primate CMV sequences 
Amino acid sequences from primate CMV sequences were aligned using the Vector NTI program (suite 9.0).  Coloured 
boxes show degrees of similarity of the amino acids between the sequences.  The yellow boxes indicate 100% amino acid 
conservation between all sequences.  The blue boxes show 100% amino acid homology between certain sequences, while 
green boxes highlight amino acids, similar to each other in structure and charge.  Areas left unhighlighted show amino acids 
with no similarity to each other.  
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Figure 3.2. Phylogenetic analysis of UL82 homologues 
Phylogenetic tree showing evolutionary relatedness between primate UL82
homologues and HCMV pp71.  HCMV pp71 and Ch82 proteins appear to be
evolutionarily distinct from S82, which shows greater homology to B82 and Rh82.
The tree was constructed by the alignment of sequences using ClustalW using a
multipurpose multiple peptide program, which employs the Blosum62 matrix
(Nicholson, 2004). Tanya Chaudry 2008    Chapter 3  91
the pp71 and Ch82 proteins form a distinct group due to a greater degree of 
homology between their sequences (Davison et al., 2003a), while the S82 protein 
exhibits a greater degree of sequence homology with the B82 protein in a group 
separate from the Rh82 protein (Nicholson, 2004).   
 
Studies with an HSV-1 recombinant expressing YFP-tagged S82 under the control 
of the HCMV MIEP showed S82 to be a transactivator of short-term gene 
expression.  However the S82 protein was unable to direct long-term gene 
expression (Nicholson, 2004). The study described here investigated whether the 
Ch82, B82 and Rh82 homologues behaved like pp71 or S82 in terms of long-term 
gene expression. 
 
3.1.2. EYFP-tagged UL82 homologues as transactivators of gene expression 
 
The role of pp71 as a transactivator of short-term gene expression is well known 
(Homer et al., 1999, Liu & Stinski, 1992, Marshall et al., 2002).  Work by 
Nicholson. (2004) showed that the S82 protein also stimulated short-term gene 
expression from the HCMV MIEP (Nicholson, 2004).  To determine if the 
non-human UL82 homologues (B82, Rh82, and Ch82) also transactivated short-
term gene expression, plasmids pEYFPpp71, pEYFPS82, pEYFPB82, 
pEYFPRh82, pEYFPCh82 and pEYFP-C1 all under the control of the HCMV MIEP 
were transfected into HFFF2 cells using the Nucleofector
TM system (Amaxa).  The 
transfected cells were cultivated in 24 well plates overnight at 37
oC.  To 
investigate the activities of the homologues, transfected cells were infected with 
3x10
5 pfu, 1x10
5 pfu or 3x10
4 pfu of the HSV-1 recombinant virus in1382 and 
maintained at 38.5
oC.  This HSV-1 mutant is inactive for VP16 and the IE proteins 
ICP0 and ICP4, but contains lacZ under control of the HCMV MIEP (Preston et al., 
1998).  This virus is unable to progress past the IE stage of infection so can be 
used to assess the activity of the UL82 homologues by observing expression of 
the reporter gene.  At 24 hr post-infection cell monolayers were stained with X-gal 
and the numbers of β-gal positive cells counted. Figure 3.3 shows the average 
numbers of β-gal positive cells at 24 hr post-infection from three individual 
experiments, the raw data for which are presented in table  3.1.    Cultures 
transfected with each of the plasmids expressing a UL82 homologue gave more 
β-gal positive cells than those transfected with the control vector, pEYFP-C1, 
when subsequently infected with 3x10
5 pfu, or 1x10
5 pfu of in1382.  At the highest  
 
 
Experiment 1 
 
 
Experiment 2  Experiment 3 
 
Plasmid 
Titre 
(pfu) 
24 
hours 
10 
days 
24 
hours 
10 
days 
24 
hours 
10 
days 
 3x10
5 18  0 59 0 45  0 
pEYFP-C1  1x10
5 11  0 14 0 0 0 
 3x10
4 4 0 0  0 0 0 
           
 3x10
5 74  300 262  379 66  121 
pEYFPpp71  1x10
5 3  62 24  78 2  35 
 3x10
4 0 0 1  9 1 14 
           
 3x10
5 102  9 205  0 33  0 
pEYFPS82  1x10
5 12  6 41 0 0 0 
 3x10
4 0 0 1  0 0 0 
           
 3x10
5 79  8 115  0 52  0 
pEYFPB82  1x10
5 9 1 33 0 0 0 
 3x10
4 2 0 2  0 0 0 
           
 3x10
5 46 19 134 0  46 0 
pEYFPRh82  1x10
4 8 2 11 0 1 0 
 3x10
4 3 0 1  0 0 0 
           
 3x10
5 81  4 159  0 54  0 
pEYFPCh82  1x10
5 4 0 21 0 1 0 
 3x10
4 2 0 1  0 0 0 
 
 
Table 3.1. Stimulation of β-gal expression by the EYFP-tagged UL82
homologues at 24 hr and 10 days post-infection 
HFFF2 monolayers were transfected with plasmids expressing EYFP-tagged UL82
homologues, and infected with in1382 at 24 hr post-transfection. After a further 24 hr
or 10 days, monolayers were stained with X-gal and β-gal positive cells were
counted.  
 
0
20
40
60
80
100
120
140
160
pEYFP-C1
pEYFPpp71
pEYFPCh82
pEYFPS82
pEYFPB82
pEYFPRh82
plasmid expressing EYFP-tagged UL82 homologue
 
 
 
N
u
m
b
e
r
 
o
f
 
p
o
s
i
t
i
v
e
 
c
e
l
l
s
3x10^5
1x10^5
3x10^4
Figure 3.3. Stimulation of β−gal expression by EYFP-tagged UL82
homologues at 24 hr post-infection 
HFFF2 monolayers were transfected with plasmids expressing the EYFP-tagged
UL82 homologues, and infected with various amounts of in1382 at 24 hr
post-transfection. After a further 24 hr monolayers were stained with X-gal and
β−gal positive cells were counted.  
 Tanya Chaudry 2008    Chapter 3  92
value of 3x10
5 pfu, in cultures transfected with the non-human UL82 homologues 
numbers of β-gal positive cells were greater than the control pEYFPC1.  However, 
cultures transfected with plasmids expressing the non-human homologues all 
produced fewer β-gal positive cells than those transfected with pEYFPpp71.  A 
similar pattern was observed from the numbers of β-gal positive cells in cultures 
infected with 1x10
5 pfu of virus.  
 
At 10 days post-infection cell monolayers were stained with X-gal and β-gal 
expression was analysed.  Figure 3.4 shows the average numbers of β-gal 
positive cells at 10 days post-infection.  At the highest value of 3x10
5 pfu, the 
number of positive cells in cultures transfected with pEYFPpp71 increased in 
comparison to that at 24 hr.  Cultures transfected with plasmids expressing the 
non-human homologues all showed a decrease in numbers of β-gal positive cells 
at 10 days post-infection compared to that observed at 24 hr.   
 
Due to the large degree of variability in numbers of β-gal positive cells between 
individual transfection experiments, (table 3.1), it was not possible to carry out 
statistical analysis.  Further experiments are needed to determine if the numbers 
are due to the alternative behaviour of these proteins or a result of experimental 
variability.  However, the transfection experiments did indicate that that all the 
EYFP-tagged UL82 homologues were functional in the short-term while only 
pEYFPpp71 appeared to stimulate long-term gene expression.  This was further 
confirmed using western analysis. 
 
Lysates of HFFF2 cells transfected with plasmids pEYFP-C1, pEYFPpp71, 
pEYFPCh82, pEYFPS82, pEYFPB82, or pEYFPRh82 were analysed by gel 
electrophoresis, transferred onto nitrocellulose membranes and probed with an 
anti-GFP antibody to detect EYFP-tagged proteins.  Figure 3.5 shows levels of 
UL82 proteins present at 24 hr post-infection.  Plasmids pEYFPpp71, 
pEYFPCh82, pEYFPS82 and pEYFPB82 all expressed similar levels of protein at 
24 hr post-transfection. However lysates transfected with pEYFPRh82 expressed 
lower levels of protein in comparison to those transfected with the other 
homologues. At 4 days post-transfection extracts from cells transfected with the 
plasmids expressing the non-human UL82 homologues continued to express 
similar levels of protein in comparison to lysates transfected with pEYFPpp71.  At 
10 days post-transfection, protein expression of the non-human UL82 homologues  
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Figure 3.4. Stimulation of β−gal expression by EYFP-tagged UL82
homologues at 24 hr and 10 days post-infection 
HFFF2 monolayers were transfected with plasmids expressing EYFP-tagged
UL82 homologues, and infected with 3x10
5 pfu in1382 at 24 hr post-transfection.
After a further 24 hr or 10 days, monolayers were stained with X-gal and β-gal
positive cells counted.  
  
EYFP pp71 S82 B82 Rh82 Ch82
24 hr post-
transfection
EYFP pp71 S82 B82 Rh82 Ch82
10 days post-
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EYFP pp71 S82 B82 Rh82 Ch82
4 days post-
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EYFP pp71 S82 B82 Rh82 Ch82
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Figure 3.5. Expression of EYFP-tagged UL82 homologues 24 hr, 4 days, and
10 days post-transfection. 
HFFF2 monolayers were transfected with plasmids expressing the EYFP-tagged
UL82 homologues.  Cell lysates were harvested at either 24 hr, 4 days or 10 days
post-transfection and electrophoresed via SDS PAGE.  EYFP-tagged UL82
homologues were detected using an anti-GFP primary antibody, and an anti-rabbit
HRP-conjugated secondary antibody.  Tanya Chaudry 2008    Chapter 3  93
was not detectable.  In cultures transfected with pEYFPpp71 an increase in levels 
of pp71 expression was observed indicating that only pEYFPpp71 was able to 
maintain self transcription.   
 
Therefore transfection assays showed all five non-human UL82 homologues to be 
functional and able to stimulate gene expression from the HCMV MIEP in short-
term assays but only pp71 to be able to simulate long-term gene expression. 
 
3.1.3. Myc-tagged UL82 homologues as transactivators of gene expression 
 
In order to confirm that the EYFP tag did not affect the properties of the UL82 
homologues, each homologue was fused to a myc tag at its N-terminus.  The 
myc-tagged plasmids expressing pp71 and the non-human UL82 homologues 
were used to analyse if myc-tagged pp71, like EYFP-tagged pp71, was unique in 
stimulating LT gene expression. 
 
Plasmids pEYFP-C1 (control), pmyc-pp71, pmyc-S82, pmyc-B82, pmyc-Rh82 or 
pmyc-Ch82 were transfected into HFFF2 cells using the Nucleofector
TM system, 
and monolayers were incubated at 37
oC.  At 24 hr post-transfection cell 
monolayers were infected with 3x10
5 pfu, 1x10
5 pfu, or 3x10
4 pfu of in1382 and 
incubated at 38.5
oC.  Following incubation at either 24 hr or 10 days cell 
monolayers were stained with X-gal and β-gal positive cells were counted.  Figure 
3.6 shows the average numbers of positive cells.  The data presented here show 
that only pmyc-pp71 was able to stimulate short-term gene expression from the 
HCMV MIEP.  The plasmids pmyc-Ch82, pmyc-S82, pmyc-B82 and pmyc-Rh82 
did not direct β-gal expression above the levels of the control (pEYFP-C1).   
 
At 10 days post-infection in cultures transfected with pmyc-pp71 and infected with 
3x10
5 pfu of in1382, the numbers of β-gal positive cells, increased at 10 days 
compared to numbers of β-gal positive cells seen at 24 hr post-infection, thus 
pmycpp71 was able to direct long-term gene expression.  At 10 days 
post-transfection in cultures transfected with the myc-tagged non-human UL82 
homologues no β-gal expression was detected.  However as numbers of positive 
cells in cultures transfected with the myc-tagged non-human UL82 homologues 
did not exceed that of the control it is not possible to say that the non-human 
homologues are unable to direct long-term gene expression, as they did not  
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Figure 3.6. Stimulation of β−gal expression by the myc-UL82
homologues at 24 hr and 10 days post-infection 
HFFF2 monolayers were transfected with plasmids expressing myc-tagged
UL82 homologues, and infected with 3x10
5 pfu of in1382 at 24 hr
post-transfection. After a further 24 hr or 10 days, monolayers were stained
with X-gal and β-gal positive cells were counted. Tanya Chaudry 2008    Chapter 3  94
stimulate short-term gene expression.  Protein expression of the myc-tagged UL82 
homologues was analysed at 24 hr and 10 days post-transfection to confirm the 
data obtained from β-gal analysis. 
 
Cell lysates transfected with pEYFP-C1 (control), pmyc-pp71, pmyc-Ch82, 
pmyc-S82, pmyc-B82 or pmyc-Rh82 were harvested at either 24 hr or 10 days 
post-transfection, electophoresed by SDS PAGE and transferred onto 
nitrocellulose membranes. The myc-tagged proteins were detected using an 
anti-myc antibody (9E10).  Figure 3.7 shows levels of protein present in lysates of 
cells transfected with plasmids expressing all five myc-tagged UL82 homologues.  
In lysates of cells transfected with pmyc-pp71 a greater amount of protein was 
expressed compared to that in lysates of cells transfected with the plasmids 
pmyc-Ch82, pmyc-S82, pmyc-B82 and pmyc-Rh82 indicating that all the myc-
tagged homologues were able to show protein expression in the short-term.  The 
differences in levels of protein expression between the myc-tagged UL82 
homologues observed in figure 3.7 maybe be due to different expression effiencies 
of pp71 compared to the non-human homologues.  All myc-tagged plamids were 
under the control of the HCMV MIEP, thus it is possible that pp71 is able to drive 
expression better from its own promoter than the non-human homologues when 
fused to the myc-tag.  However, this is only one explanation as these differences 
may be due to transfection discrepancies. 
 
At 10 days post-transfection protein was only detected in lysates transfected with 
pmyc-pp71, indicating that pp71 was the only protein able to maintain 
transcription, and thus that pmyc-pp71 is unique in directing long-term gene 
expression. 
 
Intial data from transfection experiments showed that while the EYFP-tagged 
UL82 homologues were all functional in the short-term, only EYFP-tagged pp71 
stimulated long-term gene expression.  Upon fusing the UL82 homologes to a 
myc-tag the data obtained was controversial.  β-gal assays showed only 
myc-tagged pp71 was functional in both short-term and long-term assays.   
Numbers of β-gal positive cells observed in cultures transfected with the 
myc-tagged UL82 non-human homologues were lower than numbers of β-gal 
positive cells observed in cultures transfected with the control plasmid.  However   
pp71 S82 B82 Ch82 Rh82 EYFP 10 days post-
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EYFP pp71 Ch82 S82 B82 Rh82
24 hr post-
transfection
myc-tagged protein
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Figure 3.7.Expression of myc-tagged pp71 homologues 24 hr and 10 days
post-transfection. 
HFFF2 monolayers were transfected with plasmids expressing the myc-tagged
homologues. Cell lysates were harvested either 24 hr or 10 days
post-transfection and subjected to SDS PAGE.  The myc-tagged UL82 proteins
were detected using an anti-myc (9E10) primary antibody, and an anti-mouse
HRP conjugated secondary antibody. Tanya Chaudry 2008    Chapter 3  95
all myc-tagged UL82 homologues showed protein expression in the short-term, 
albeit at lower levels than lysates transfected with myc-tagged pp71. 
 
In order to confirm results obtained from transfection assays, and to establish if the 
myc-tagged UL82 non-human homologues do behave differently from the EYFP-
tagged non-human homologues the UL82 homologues were recombined into the 
HSV-1 genome. 
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3. Part II 
 
3.2. Introduction 
 
HCMV pp71 has been shown to have a number of effects on gene expression 
including the ability to maintain reporter gene expression from in1312-derived 
recombinants for extended periods in cell culture (Preston & Nicholl, 2005).  
 
Plasmid transfection assays have demonstrated that EYFP-pp71, along with its 
homologues EYFPS82, EYFPB82, EYFPRh82, and EYFPCh82, can stimulate 
gene expression controlled by the HCMV MIEP in short-term assays.  However 
only EYFPpp71 was able to mediate gene expression in long-term assays.  To 
eliminate the disadvantages of the Nucleofector
TM system, and to confirm the 
results obtained from the transfection assays, all plasmids of interest were 
recombined into a HSV-1 virus named in1312. 
 
In1312 is a HSV-1 multiple mutant, which is defective for the functions of the three 
major HSV-1 transcription activators (VP16, ICPO and a temperature sensitive 
mutation in ICP4) at 38.5
oC. The mutant is unable to progress past the IE stage of 
infection, and in HFFF2 and U373 cells the in1312 genome becomes repressed 
within 24 hr, resulting in ‘quiescent’ infection. Insertions (under the control of the 
HCMV MIEP) at the non-essential thymidine kinase (TK) or UL43 loci of in1312 
(see materials and methods section 2.1.5 for further details) yields mutants that 
express reporter genes in tissue culture cells. The in1312-based virus in1374, 
which has lacZ inserted in the UL43 locus was used as a vector to express pp71 
and its non-human homologues after insertion at the TK locus.  Using a HSV-1 
recombinant virus system expressing the proteins of interest allowed pp71 and its 
non-human UL82 homologues to be examined in an environment similar to that of 
HCMV wild-type, unlike the transfection based system where only a single protein 
in a plasmid vector could be examined. 
 
3.2.1. Infection with the in1312 recombinants expressing the EYFP-tagged 
UL82 homologues stimulates short-term gene expression 
 
Expression vectors were constructed by inserting each EYFP-tagged UL82 
homologue into the plasmid pCP1802.  This plasmid contains a cassette 
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TK locus.  The TK locus allows construction of HSV-1 vectors by recombination of 
the cassette into HSV-1 DNA.  The in1312 UL82 recombinant viruses were 
constructed by recombining the pCP1802 derived plasmids containing the coding 
regions of each of the EYFP homologues, into the TK locus of a HSV-1 mutant, 
in1374 (in1374 is derived from the mutant in1312, with the lacZ coding region 
controlled by the HCMV MIEP inserted in the UL43 locus).  See Appendix 1 for 
further details). 
 
To establish that the EYFP-tagged UL82 homologues expressed by the in1312 
recombinants were functional and able to stimulate short-term gene expression, 
1.5x10
5 U373 cells were infected with 5x10
5 pfu (MOI 3.3) of in1310 (which 
expresses EYFPpp71), in0150 (EYFPS82), in0146 (EYFPCh82), in0144 
(EYFPRh82), in0145 (EYFPB82), in1374 (negative control), or mock-infected.  An 
overview of the experimental plan is presented in figure 3.8.   
 
Infected cells were incubated at 38.5
oC, at 24 hr post-infection, cell monolayers 
were fixed and stained with X-gal reaction mix and expression of β-gal assessed 
by observation.  The results in figure 3.9 show cells infected with the in1312 
recombinant viruses expressing the EYFP-tagged UL82 homologues.  All five of 
the recombinant viruses showed β-gal expression at levels above those of the 
negative control, in1374, implying that each homologue acts on the HCMV MIEP 
to drive short-term gene expression to a similar extent.  This confirms the results 
from the plasmid transfection assays, which showed that all the UL82 homologues 
were able to drive short-term gene expression. 
 
The protein levels of the UL82 homologues expressed by in1312 recombinants in 
lysates of U373 cells were investigated by SDS PAGE and western blot analysis, 
using a polyclonal anti-GFP antibody.  As shown in figure 3.10, no protein was 
recognised by the anti-GFP antibody in lysates of cells infected with in1374 
however, the results show that levels of protein produced by each of the in1312 
recombinant viruses expressing the non-human UL82 homologues were 
somewhat lower than that produced by in1310.  Nonetheless, the results confirm, 
as found in the transfection assays, that all five UL82 homologues are able to 
stimulate short-term gene expression.   
 U373 cell lines
Infected with in1312 recombinants expressing 
EYFP/myc-tagged UL82 homologues
Co-infection 
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Figure 3.8.
Overview of the experimental plan employed  in short term analysis of 
the EYFP/myc-tagged UL82 homologues.
p.i (post-infection)in0144
in1310
in0150
mock in0146
in0145 in0144
in1310
in0150
mock in0146
in0145
in1374 in1374
  
Figure 3.9. β-gal expression of the in1312 recombinants expressing the
EYFP-tagged UL82 homologues at 24 hr post-infection 
U373 cell monolayers were mock-infected or infected with 5x10
5 pfu (MOI 3.3) of
the  in1312 recombinants expressing the UL82 homologues and incubated at
38.5
oC.  At 24 hr post-infection cell monolayers were stained with X-gal. 
 
The in1310 virus expresses EYFPpp71, in0146 expresses EYFPCh82, in0150 
expresses EYFPS82, in0145 expresses EYFPB82, in0144 expresses EYFPRh82, 
and in1374 was used as a negative control. 
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Figure 3.10. Expression of the EYFP-tagged UL82 homologues  at 24 hr
post-infection 
U373 cell monolayers were cultivated in 24 well plates. Cells were either
mock-infected or infected with 5x10
5 pfu (MOI 3.3) of the in1312 recombinants
expressing the UL82 homologues and incubated 38.5
oC.  In1374 was used as a
negative control.  At 24 hr post-infection cell lysates were harvested and were
subjected to SDS PAGE. EYFP-tagged UL82 proteins were detected using an
anti-GFP primary antibody and an anti-rabbit HRP conjugated secondary
antibody.  Blots were stripped and reprobed with an anti-actin primary antibody
and an anti-mouse HRP-conjugated secondary antibody, to act as a loading
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As levels of β-gal expression were in infection experiments were analysed by 
observation an experiment was developed to quantify levels of the promoter 
activity during the short-term assays.  A dual infection system was used, the 
results of which could be measured quantitatively.  In this experiment U373 cells 
cultured in 24 well plates were infected with in1312 recombinants expressing the 
UL82 homologues and co-infected with in1318.  The HSV-1 recombinant virus 
in1318, which encodes secreted alkaline phosphatase (SEAP) under the control of 
the HCMV MIEP, was used because this protein is secreted into the culture 
medium and synthesis of this protein can therefore be measured by simply 
assaying the growth medium for SEAP at various time points without having to 
create cell lysates or stain cultures for the presence of β-gal. 
 
Figure 3.11 shows the average number of arbitrary units of fluorescence from two 
experiments.  The results from figure 3.11 show that cells mock-infected or 
infected with in1374 virus alone produced relatively low amounts of SEAP.  Cells 
infected with the in1312 recombinants expressing the EYFP-tagged UL82 
homologues showed SEAP synthesis was stimulated.  However levels of SEAP 
synthesis stimulated by in1310 were lower than those observed for viruses 
expressing the non-human UL82 homologues.  The lower levels of SEAP 
synthesis stimulated by in1310 in this study is surprising as in previous 
transfection and infection experiments pp71 appeared to stimulate levels of 
expression greater than or equivalent to the EYFP-tagged UL82 non-human 
homologues.  It is possible that the lower levels of SEAP synthesis in this 
experiment could be attributed to experimental artifacts such as cell viability.   
Further experiments would have to be carried out to obtain a larger range of data 
to establish if this is the case or if in this method of analysis pp71 is less efficient in 
the short-term. 
 
3.2.2. Analysis of long-term gene expression 
 
Studies by Preston and Nicholl (2005) showed that, as HFFF2 cells could be 
maintained at 38.5
oC in medium containing 2% serum for two weeks with no 
serious deterioration in cell viability, viral gene expression of pp71 could be 
investigated at later times post-infection.  Preliminary experiments suggested that 
β-gal could be detected for many days in cell monolayers co-infected with in1324, 
(HCMV pp71 inserted into the TK locus, with mutations to VP16, ICP0 and a  
0
50
100
150
200
250
300
350
400
450
Mock in1310 in0146 in0150 in0145 in0144 in1374
in1312 recombinants expressing EYFP-tagged UL82 
homologues
A
r
b
i
t
r
a
r
y
 
u
n
i
t
s
 
o
f
 
 
f
l
u
o
r
e
s
c
e
n
c
e
Figure 3.11. Activation of expression by infection with in1312
recombinants expressing the EYFP-tagged UL82 homologues in trans 
U373 cell monolayers were infected with 5x10
5 pfu (MOI 3.3) of the in1312
recombinants expressing the UL82 homologues and incubated at 38.5
oC for 2
hr.  Cell monolayers were infected with 5x10
5 pfu in1318 and incubation was
continued at 38.5
oC.  At 24 hr post-infection samples of medium were analysed
for SEAP activity. Tanya Chaudry 2008    Chapter 3  99
temperature sensitive mutation to ICP4) and the reporter virus in1382 (containing 
the  lacZ coding sequences in the TK locus controlled by the HCMV MIEP 
promoter).  Contiuned β-gal expression was not observed with in1382 alone, 
suggesting that pp71 expressed by in1324 exerted an effect at late times post 
infection (Preston & Nicholl, 2005). 
 
Previous transfection based assays in the study presented here showed that 
EYFP-tagged pp71 was the only homologue able to direct long-term gene 
expression.  To confirm that pp71 was unique in its ability to do so, and also to 
confirm results from the transfection assays and work by Preston and Nicholl. 
(2005),  in1312 recombinants expressing the EYFP-tagged UL82 homologues 
were used to investigate the effects of the UL82 homologues at late times post-
infection.   
 
Three sets of HFFF2 monolayers consisting of 1x10
6 cells on 35 mm plates were 
each infected with 3x10
6 pfu (MOI 3) of in1310 (expressing EYFPpp71), in0150 
(EYFPS82), in0146 (EYFPCh82), in0144 (EYFPB82), in0145 (EYFPRh82), in1374 
(negative control) or mock-infected.  Following infection, D5+5 medium was 
replaced with DF2 medium and incubation continued at 38.5
oC for 10 days, with 
medium changes every 2 days.  At 9 days post-infection one set of infected 
HFFF2 cells was super-infected with 3x10
6 pfu of tsK, a HSV-1 mutant that 
produces ICP0, and the cells were incubated for a further 24 hr at 38.5
oC.  A 
second set of infected cells was overlaid with DF2 medium containing 2% human 
serum at 9 days post-infection and downshifted to the permissive temperature of 
31
oC for a further 5 days.  The third set of infected HFFF2 cells remained 
untreated at 38.5
oC for 10 days. An overview of the experimental plan is presented 
in figure 3.12. 
 
At day 10 post-infection cell monolayers super-infected with tsK and those left 
untreated were stained with X-gal.  β-gal expression at 10 days post-infection 
showed that only the recombinant virus expressing pp71 was able to maintain 
gene expression.  β-gal expression was not observed in those monolayers 
infected with viruses that express the non-human UL82 homologues (Figure 
3.13a).  This was further confirmed by the results from the downshift experiment 
(figure 3.13b) where infected monolayers were stained with X-gal 14 days 
post-infection.  Downshift of the cells to a permissive temperature of 31
oC allowed Figure 3.12.
Overview of the experimental plan employed  in long term analysis of 
the EYFP/myc-tagged UL82 homologues.
p.i (post-infection)
HFFF2 cell 
lines
Infected with in1312 recombinants expressing 
EYFP/myc-tagged UL82 homologues
38.5oC 38.5oC 38.5oC 38.5oC
Cultures X-gal 
stained for β-gal 
analysis
Lysates 
harvested for 
western 
analysis
Cultures overlaid 
with fresh medium 
containing 2% 
human serum
Cultures super-
infected with 
virus tsk
Cultures X-gal 
stained for β-gal 
analysis
Cultures X-gal 
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Figure 3.13a β-gal expression directed by the in1312 recombinants
expressing the EYFP-tagged UL82 homologues at 10 days post-infection. 
HFFF2 cell monolayers were infected with 3x10
6 pfu (MOI 3) of the in1312
recombinants expressing the UL82 homologues, and incubated at 38.5
oC.
In1374 was used as a negative control.  At 10 days post-infection cell
monolayers were stained with X-gal. 
 
The in1310 virus expresses EYFPpp71, in0146 expresses EYFPCh82, in0150 
expresses EYFPS82, in0145 expresses EYFPB82, in0144 expresses 
EYFPRh82, and in1374 was used as a negative control. mock in1310 in0146
in0150 in0145 in0144
mock in1310 in0146
in0150 in0145 in0144
in1374 in1374
 
Figure 3.13b. Response of the in1312 recombinants expressing EYFP-tagged
UL82 homologues to temperature downshift 
HFFF2 monolayers were infected with 3x10
6 pfu (MOI 3) of the in1312
recombinants expressing the UL82 homologues and incubated at 38.5
oC .   A t  9
days post-infection cell monolayers were overlayed with medium containing 2%
human serum, and downshifted to 31
oC.  At 14 days post-infection cell monolayers
were stained with X-gal. 
 
The in1310 virus expresses EYFPpp71, in0146 expresses EYFPCh82, in0150 
expresses EYFPS82, in0145 expresses EYFPB82, in0144 expresses EYFPRh82, 
and in1374 was used as a negative control. Tanya Chaudry 2008    Chapter 3  100
expression of ICP4 and consequently replication of the viruses if they remained 
potentially replication competent.  Plaques were observed only in those 
monolayers infected with in1310.  Figure 3.13c shows monolayers super-infected 
with tsK and stained with X-gal at 10 days post-infection.  As VP16 and ICP0 are 
both functional in the super-infecting virus,tsK, the superinfection allows ICP0 to 
reactivate the quiescent genomes by driving expression from the lacZ gene. β-gal 
expression at 10 days post-infection showed that all genomes were present at 
functionally comparable levels.  Therefore at 10 days post-infection there 
remained a significant number of cells retaining the genomes of the viruses 
expressing the non-human UL82 homologues despite the HCMV MIEP lacZ 
cassette remaining inactive. 
 
At 9 days post-infection samples of cells were subcultured into 24 well plates and 
incubated overnight at 38.5
oC.  Lysates were harvested, analysed by gel 
electrophoresis and transferred onto nitrocellulose membrane before western 
blotting, using an anti-GFP antibody.  Figure 3.14 shows that at 10 days 
post-infection EYFPpp71 was the only homologue detectable.  Stripping and re-
probing blots for actin demonstrated that protein loading was equivalent. 
 
3.2.3. Myc-tagged UL82 homologues expressed by in1312 based 
recombinants are functional 24 hr post-infection 
 
Data from transfection experiments using myc-tagged UL82 homologues gave 
inconclusive results as only myc-tagged pp71 appeared to be able to direct β-gal 
expression in both short-term and long-term assays (section 3.1.3).  However, all 
five homologues were able to stimulate protein expression in the short-term while 
only myc-tagged pp71 stimulated protein expression in long-term assays.  To 
eliminate transfection discrepencies and in order to determine if myc-tagged pp71 
and its non-human homologue myc-tagged Ch82 behave as the EYFP-tagged 
homologues HSV-1 recombinants expressing myc-tagged pp71 or myc-tagged 
Ch82 were constructed.  The HSV-1 recombinants expressing myc-tagged pp71 
and myc-tagged Ch82 were constructed by homologous recombination of each 
into in1312, as described for the production of viruses expressing EYFP-tagged 
proteins (section 3.2.1). 
 mock in1310 in0146
in0150 in0145 in0144
mock in1310 in0146
in0150 in0145 in0144
 
in1374 in1374
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.13c. Response of the in1312 recombinants expressing the EYFP-
tagged UL82 homologues to super-infection with tsK. 
HFFF2 monolayers were infected with 3x10
6 pfu (MOI 3) of the in1312
recombinants expressing the UL82 homologues and incubated at 38.5
oC.  In1374
was used as a negative control.  At 9 days post-infection cell monolayers were
super-infected with 3x10
6 pfu of tsK and incubated at 38.5
oC for a further 24 hr.  At
10 days post-infection cell monolayers were stained with X-gal. 
 
The in1310 virus expresses EYFPpp71, in0146 expresses EYFPCh82, in0150 
expresses EYFPS82, in0145 expresses EYFPB82, in0144 expresses EYFPRh82, 
and in1374 was used as a negative control. 
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Figure 3.14. Expression of the EYFP-tagged UL82 homologues at 10 days
post-infection 
HFFF2 cell monolyers cultivated in 35 mm plates were either mock-infected or
infected with 3x10
6 pfu (MOI 3) of the in1312 recombinants expressing the UL82
homologues and incubated at 38.5
oC.  At 10 days post-infection cell lysates were
harvested, and subjected to SDS PAGE. EYFP-tagged protein was detected using
an anti-GFP primary antibody and an anti-rabbit HRP conjugated secondary
antibody.  Blots were stripped and reprobed with an anti-actin primary antibody and
an anti-mouse HRP-conjugated secondary antibody to act as a control for loading.  Tanya Chaudry 2008    Chapter 3  101
To assess whether the myc-pp71 and myc-Ch82 proteins expressed by the in1312 
recombinants were functional each virus was tested in short-term assays (an 
overview of the experimental plan is presented in figure 3.8).  U373 cells seeded 
at 1.5x10
5 cells per 13 mm well were infected with 5x10
5 (MOI 3.3) of in0151 
(expressing myc-pp71), in0149 (myc-Ch82), in1374 (negative control), or were 
mock-infected and incubated at 38.5
oC.  At 24 hr post-infection cell monolayers 
were fixed and stained with X-gal reaction mix and β-gal expression was assessed 
by observation.  Figure 3.15 shows that both in0151 and in0149 produced levels of 
β-gal above those seen in cultures infected with the parent virus in1374.  This 
implies that the myc-tagged homologues expressed by the in1312 recombinants 
were functional in the short-term. 
 
The protein levels in U373 cells infected with the in1312 recombinants expressing 
myc-pp71 or myc-Ch82 homologues were investigated by SDS PAGE and 
western blot analysis, using an anti-myc antibody (9E10).  Figure 3.16 shows that 
extracts of cells infected with in0151 and in0149 contained equivalent amounts of 
myc-tagged protein.  Therefore when fused to the myc tag both pp71 and Ch82 
stimulated gene expression.   
 
To quantify the levels of expression directed by the homologues, confluent U373 
cell monolayers were infected with 5x10
5 pfu of each in1312 recombinant virus 
expressing the UL82 homologues and were co-infected with in1318.  At 24 hr 
post-infection samples of growth medium were harvested and assayed for the 
amount of SEAP present. Figure 3.17 shows that samples harvested from 
monolayers mock-infected or infected with in1374 contained relatively low 
quantities of SEAP.  In cell monolayers infected with in0151 and in0149 similar 
levels of SEAP were observed at levels greater than those infected with the 
negative control. 
 
3.2.4. Only myc-pp71 directs long-term gene expression 
 
In order to establish whether the myc-pp71 or myc-Ch82 proteins were able to 
direct long-term gene expression, three individual sets of HFFF2 cell monolayers 
were seeded in 35 mm plates each containing 1x10
6 cells.  Cells were 
mock-infected, or infected with 3x10
6 pfu of in0151 (myc-pp71), in0149 
(myc-Ch82),  in1374 (negative control).  Following infection, D5+5 medium was  
in0151 in0149 mock
in1374
in0151 in0149 mock
in1374
Figure 3.15. β-gal expression directed by the in1312 recombinants expressing
the myc-tagged UL82 homologues at 24 hr post-infection 
U373 cell monolayers were mock-infected or infected with 5x10
5 pfu (MOI 3.3) of the
in1312 recombinants expressing the UL82 homologues and incubated at 38.5
oC.  At
24 hr post-infection cell monolayers were stained with X-gal. 
 
In0151 (expressing myc-pp71), in0149 (expressing myc-Ch82) in1374 (negative 
control).  
24 hr post-
infection
-ve 
control Ch82 pp71 mock
Actin loading 
control
-ve 
control Ch82 pp71 mock
24 hr post-
infection
-ve 
control Ch82 pp71 mock
Actin loading 
control
-ve 
control Ch82 pp71 mock
Figure 3.16. Expression of the myc-tagged UL82 homologues at 24 hr
post-infection. 
U373 cell monolyers were mock-infected or infected with 5x10
5 pfu (MOI 3.3) of the
in1312 recombinants expressing the myc-tagged UL82 homologues and incubated
at 38.5
oC. At 24 hr post-infection cell lysates were harvested and analysed by SDS
PAGE.  The myc-tagged proteins were detected using an anti-myc (9E10) primary
antibody and an anti-mouse HRP-conjugated secondary antibody.  Blots were
stripped and reprobed with an anti-actin antibody and an anti-mouse HRP-
conjugated secondary antibody, to act as a loading control.  
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Figure 3.17. Activation of expression by infection with in1312 recombinants
expressing the myc-tagged UL82 homologue in trans  
U373 cell monolayers were infected with 5x10
5 pfu (MOI 3.3) of the in1312
recombinants expressing myc-tagged pp71 or Ch82 and incubated at 38.5
oC for 2
hr.  The cell monolayers were super-infected with 5x10
5 pfu of in1318 and
incubation was continued at 38.5
oC.  At 24 hr post-infection samples of medium
were analysed for alkaline phosphatase activity. 
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replaced with DF2 medium and infected monolayers were incubated at 38.5
oC for 
10 days with medium changes every two days.  At 9 days post-infection one set of 
infected HFFF2 cells was super-infected with 3x10
6 pfu of tsK, and incubated for a 
further 24 hr at 38.5
oC.  A second set of infected cells was overlaid with DF2 
medium containing 2% human serum at 9 days post-infection and downshifted to 
the permissive temperature of 31
oC for a further 5 days.  The third set of infected 
cells remained untreated at 38.5
oC for 10 days (an overview of the experimental 
plan is presented in figure 3.12). 
 
At day 10 post-infection cell monolayers super-infected with tsK, and those which 
were left untreated, were stained with X-gal.  Analysis of β-gal expression at 10 
days post-infection showed that only in0151 was able to maintain gene 
expression.  β-gal expression was not observed in those monolayers infected with 
in0149 (Figure 3.18a).  This was further confirmed by staining infected cells which 
were downshifted to the permissive temperature of 31
oC (figure 3.18b), in which 
infected monolayers were stained with X-gal 14 days post-infection.  Plaques were 
observed only in those monolayers infected with in0151.  Figure 3.18c shows 
monolayers super-infected with tsK and stained with X-gal at 10 days post-
infection.  As VP16 and ICP0 are both functional in tsK, the super-infection allows 
ICP0 to reactivate the quiescent genomes by driving expression from the lacZ 
gene. β-gal expression at 10 days post-infection showed that all genomes were 
present at functionally comparable levels.   
 
In order to monitor protein expression of myc-tagged proteins at later times of 
infection, cell lysates infected with in0151, in0149, in1374 or mock-infected were 
harvested and subjected to SDS PAGE. Protein was transferred to a nitrocellulose 
membrane prior to being probed with an anti-myc antibody (9E10).  Figure 3.19 
shows that in0151 was the only recombinant virus to produce protein.  No protein 
was detected in lysates of cells infected with in0149.  Equivalent levels of a protein 
assumed to be endogenous c-myc were also observed. 
 
 
 
 
 
   
in0151 in0149
in1374
mock in0151 in0149
in1374
mock
Figure: 3.18a β-gal expression directed by the in1312 recombinants
expressing the myc-tagged UL82 homologues at 10 days
post-infection. 
HFFF2 cell monolayers were infected with 3x10
6 pfu (MOI 3) of the in1312
recombinants expressing the myc-tagged UL82 homologues and incubated
at 38.5
oC.  In1374 was used as a negative control.  At 10 days post-infection
cell monolayers were stained with X-gal. 
 
In1310 (expressing EYFPpp71), in0149 (expressing EYFPCh82) in1374 
(negative control).   
in0149 mock
in1374
in0151 in0149 mock
in1374
in0151
Figure 3.18b. Response of the in1312 recombinants expressing myc-tagged
UL82 homologues to temperature downshift. 
HFFF2 monolayers were infected with 3x10
6 pfu (MOI 3) of the in1312
recombinants expressing the myc-tagged UL82 homologues and incubated at
38.5
oC.  At 9 days post-infection cell monolayers were overlayed with medium
containing 2% human serum and downshifted to 31
oC.  At 14 days post-infection
cell monolayers were stained with X-gal.  
 
In1310 (expressing EYFPpp71), in0149 (expressing EYFPCh82) in1374 (negative 
control).  
mock
in1374
in0149 in0151 mock
in1374
in0149 in0151
Figure 3.18c.  Response of the in1312 recombinants expressing
myc-tagged UL82 homologues to super-infection with tsK. 
HFFF2 monolayers were infected with 3x10
6 pfu (MOI 3) of the in1312
recombinants expressing the myc-tagged UL82 homologues and incubated at
38.5
oC.  In1374 was used as a negative control.  At 9 days post-infection cell
monolayers were super-infected with 3x10
6 pfu tsK and incubated at 38.5
oC for
a further 24 hr.  At 10 days post-infection cell monolayers were stained with
X-gal.  
 
In1310 (expressing EYFPpp71), in0149 (expressing EYFPCh82) in1374 
(negative control).  
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Figure 3.19. Expression of the myc-tagged UL82 homologues 10 days
post-infection 
HFFF2 cell monolayers cultivated in 35 mm plates were either mock-infected
or infected with 3x10
6 pfu (MOI 3) of the in1312 recombinants expressing the
myc-tagged UL82 homologues and incubated at 38.5
oC.  At 10 days post-
infection cell lysates were harvested and analysed by SDS PAGE.  Lysates of
cells infected with in1312 recombinants expressing myc-tagged UL82 proteins
were detected using an anti-myc (9E10) primary antibody and an anti-mouse
secondary antibody.   Tanya Chaudry 2008    Chapter 3  103
3. Part III 
 
3.3. Introduction 
 
The tegument protein pp71 has been shown to have the unique property of 
stimulating gene expression for a prolonged period of time.  The protein pp71 has 
also been shown to act in  trans  on quiescent genomes to reactivate gene 
expression (Preston & Nicholl, 2005) in a manner similar to that of ICP0.  The 
in1312 recombinant viruses expressing EYFP-tagged Ch82 or pp71 were used to 
determine whether Ch82 exhibited the same property as pp71 in terms of being 
able to reactivate a quiescent virus. 
 
3.3.1. Reactivation Assay 
 
In order to quantitatively assay the activity of both pp71 and Ch82 homologues, 
HFFF2 cells seeded at 1x10
6 cells in 35mm plates were infected with 3x10
6 pfu 
(MOI 3) of in1318 at 38.5
oC.  At 10 days post-infection cells were subcultured into 
24 well plates and super-infected with in1310 (expressing EYFPpp71) or in0146 
(EYFPCh82) and incubated at 38.5
oC.  The levels of SEAP in the growth medium 
were measured each day over a further 10 days.  Figure 3.20 shows that there 
was no detectable SEAP in the growth medium of mock-infected cells.  Cells 
infected with in0146 produced relatively low levels of SEAP which peaked at three 
days post-infection and then declined to levels similar to those observed in 
mock-infected cells.  Cell monolayers super-infected with in1310 showed levels of 
SEAP in the growth medium gradually increasing from days one and two post-
infection to peaking at day six post-infection. This represented a 6 fold increase in 
levels of SEAP stimulated by EYFPpp71 compared to EYFPCh82 at three days 
post-infection.  The level of SEAP found in the growth medium of cells infected 
with in1310 dipped slightly at day seven and remained constant until day 10 when 
the experiment was terminated.  Levels of SEAP remained constant from days 7-
10 due to SEAP continuing to be synthesised.  These results indicate that pp71 is 
able to act in trans to reactivate expression from a quiescent virus whereas Ch82 
does not possess this property.  
 
As each of the super-infecting viruses contained the lacZ gene, cell monolayers 
were stained with X-gal at 24 hr post-super-infection to show that the recombinant  
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Figure 3.20. Reactivation of SEAP expression by in1312 recombinants
expressing EYFPpp71 and EYFPCh82 in trans 
HFFF2 monolayers were infected with 3x10
6 pfu of in1318, and incubated at 38.5
oC.
At 10 days post-infection cell monolayers were trypsinised, replated and super-
infected with in1312 recombinants expressing either pp71 or Ch82 and incubated at
38.5
oC.  Samples of medium harvested at days 1-10 were analysed for alkaline
phosphatase activity. Tanya Chaudry 2008    Chapter 3  104
viruses used, (in1310 and in0146), expressed proteins that were functional in the 
short-term.  Figure 3.21 shows that in mock-infected cell monolayers no β-gal 
positive cells were detected.  In monolayers infected with the in1312 recombinant 
viruses expressing pp71 or Ch82 homologues showed, as expected, significant 
numbers of β-gal positive cells indicating that both homologues are functional at 
24 hr post-super-infection.  However by 10 days post-super-infection β-gal positive 
cells were detected in cell monolayers infected with in1310 but not in those 
infected with in0146 (data not shown).  
 
HFFF2 lysates of cells super-infected with in1310 and in0146 were analysed by 
SDS PAGE and EYFP-tagged proteins were detected using an anti-GFP antibody.  
Figure 3.20 shows that at 24 hr post-super-infection, equivalent levels of pp71 and 
Ch82 protein were expressed.  However at 10 days post-super-infection, no 
protein product was not detected in lysates of cells that were mock-infected or 
infected with the Ch82 homologue.  Figure 3.22 shows only the EYFPpp71 band 
was observed indicating only pp71 is capable of directing its own transcription. 
 
Thus pp71 is not only able to stimulate long-term gene expression from its own 
promoter but is also able to reactivate quiescent genomes whereas Ch82 does not 
possess this property. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
in1310 Mock
in0146
Figure 3.21 Activity of the in1312 recombinants expressing EYFP-tagged
pp71 or Ch82. 
HFFF2 monolayers were infected with 3x10
6 pfu of in1318 and incubated at
38.5
oC.  At 10 days post-infection cell monolayers were trypsinised, replated and
super-infected with the in1312 recombinants expressing either pp71 or Ch82 and
incubated at 38.5
oC.  Cell monolayers were stained with X-gal 24 hr
post-super-infection. 
 
The in1310 virus expresses EYFPpp71, in0146 expresses EYFPCh82,  and 
in1374 was used as a negative control.  
EYFP protein
Actin loading 
control
pp71 Ch82 mock pp71 Ch82 mock
pp71 Ch82 mock pp71 Ch82 mock
24 hr 10 days
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Actin loading 
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pp71 Ch82 mock pp71 Ch82 mock
pp71 Ch82 mock pp71 Ch82 mock
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Figure 3.22. Western analysis of the in1312 recombinants expressing EYFP-
tagged pp71 or Ch82 homologues at 24 hr and 10 days post-super-infection
HFFF2 monolayers were infected with 3x10
6 pfu of in1318 and incubated at
38.5
oC.  At 10 days post-infection the cell monolayers were trypsinised, replated
and super-infected with the in1312 recombinants expressing either pp71 or Ch82
and incubated at 38.5
oC.  At 24 hr or 10 days post super-infection cell lysates
were harvested and samples analysed via SDS PAGE.  The EYFP-tagged in1312
recombinants were detected using an anti-GFP primary antibody and an anti-
rabbit HRP conjugated secondary antibody.  Blots were stripped and reprobed
with an anti-actin primary antibody and an anti-mouse HRP-conjugated secondary
antibody to control for loading. 
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3.4 Discussion 
 
The first part of this study compares the transactivation efficiency of HCMV pp71 
with the non-human UL82 homologues.  To do this, a system was employed, 
where plasmids expressing EYFP- or myc-tagged homologues were transfected 
into HFFF2 cells.   
 
Transfection assays were carried out using the Nucleofector
TM system (Amaxa), 
which employs electroporation to introduce the DNA into HFFF2 cell monolayers.  
This method of transfection is more efficient in this cell type than other transfection 
systems e.g. Lipofectamine (Invitrogen).  Cells transfected with EYFP-tagged 
plasmids were observed to fluoresce green allowing transfection levels to be 
ascertained visually using a UV microscope at 24 hr post-transfection.   
Satisfactory levels of transfection were classed as 60-70% of transfected cells 
fluorescing at 24 hr post-transfection.  Transfected cells were infected with 
replication impaired HSV-1 recombinant reporter viruses expressing β-gal driven 
by the HCMV MIEP. 
 
Data obtained from plasmid transfection assays showed that at the highest values 
of  in1382 used (3x10
5 pfu and 1x10
5 pfu), all of the plasmids expressing 
EYFP-tagged non-human homologues stimulated gene expression from the 
HCMV MIEP at levels above the control (pEYFP-C1).  None however stimulated 
gene expression to the same degree as pp71.  Data from long-term experiments 
showed that only pEYFPpp71 was able to direct gene expression over a period of 
10 days post-infection.  Activity of the non-human UL82 homologues appeared to 
be switched off after short times of infection, as confirmed by both western blotting 
and β-gal analysis.  The raw data for EYFP-tagged plasmid transfections showed 
variations in the numbers of β-gal positive cells in individual experiments, although 
trends in the overall data remained unaltered.  The variations in numbers could be 
attributed to transfection discrepancies.  This was again seen in transfection 
experiments where myc-tagged UL82 homologues were transfected into HFFF2 
cells.  The myc-tagged non-human homologues failed to show numbers of β-gal 
positive cells above levels of the control (pEYFP-C1), only pmyc-pp71 was able to 
direct β-gal expression in short-term experiments.  However protein corresponding 
to all the myc-tagged homologues was detected by western analysis in the short-
term.  Since the myc-tagged non-human UL82 homologues did not direct β−gal Tanya Chaudry 2008    Chapter 3  106
expression in short-term experiments, it was uncertain whether they were able to 
direct long-term gene expression.  The low levels of β-gal positive cells detected in 
this assay may be attributed to a low efficiency of transfection as the Nucleofection 
system does not allow control of how much DNA enters each cell.  Consequently 
the low levels of expression observed in some assays could be a result of under 
loading cells with the plasmid of interest. 
 
To eliminate the disadvantages of the Nucleofector
TM system, and to confirm the 
results obtained from the transfection assays, all plasmids of interest were 
recombined into HSV-1 viruses (impaired for VP16, ICP0 and ICP4 activity to 
attain quiescence) and used to infect either U373 or HFFF2 cells.  Using a 
recombinant virus system expressing the protein of interest allowed the protein to 
be examined in an environment akin to that of HCMV wild type, unlike the 
transfection based system where only the single protein in a plasmid vector could 
be examined.  All short-term infection assays showed that the in1312 recombinant 
viruses expressing the EYFP-tagged non-human UL82 homologues were able to 
stimulate reporter gene expression at levels above that of the negative control.  A 
similar result was obtained from assays using U373 cells infected with myc-tagged 
pp71 and Ch82, suggesting that myc-tagged Ch82 like, myc-tagged pp71 was 
functional in short-term assays eliminating discrepancies in the data observed in 
the transfection assays (section 3.1.1).  Therefore, changing the EYFP-tag to a 
myc-tag did not affect functionality of the homologues in short-term β-gal assays.  
The differences in levels of protein expression observed from myc-tagged 
transfection assays was also eliminated in infection experiments, where similar 
levels of protein were expressed by myc-tagged pp71 and myc-tagged Ch82.  The 
different levels of protein expression observed in transfection experiments (section 
3.1.1) were unlikely to be due to different expression efficiencies as suggested 
previously, and more likely caused by experimental artefacts. 
 
Long-term infection experiments carried out in HFFF2 cells, using the in1312 
recombinant viruses expressing the EYFP-tagged UL82 homologues or 
myc-tagged homologues, showed only pp71 continued to drive gene expression, 
as full viral replication was only observed in down shift experiments where the 
medium of infected cells was replaced with fresh medium containing 2% human 
serum and downshifted to the permissive temperature of 31
oC.   
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Data from both transfection and infection experiments presented here showed that 
pp71 is not only able to stimulate long-term gene expression, confirming work by 
Preston and Nicholl (2005), but is unique in its ability to do so.  Long-term gene 
expression by the non-human UL82 homologues was not detected.  The most 
surprising result observed from this study was that the Ch82 homologue was able 
to stimulate only short-term gene expression.  Given that it shares a significant 
degree of homology with pp71, it was initially hypothesised that it would be likely to 
behave in a similar manner, however this was not observed to be the case.  It was 
found to stimulate short-term gene expression only, therefore behaving like the 
S82 homologue that had previously been shown to stimulate short-term gene 
expression and not long-term (Nicholson, 2004). 
 
Results from SEAP assays showed that upon super-infecting quiescent genomes 
with  in1310 and in0146, only pp71 was able provoke resumption of gene 
expression.  Cells that were super-infected with in0146 (expressing EYFPCh82) 
produced low levels of SEAP, peaking at three day post-super-infection then 
declining to levels similar to those observed in mock-infected cells.  In cell 
monolayers super-infected with in1310, an increase in levels of SEAP were 
observed, peaking at 6 days post-super-infection to become steady for the 
remainder of the experiment.  This data confirmed work by Preston and Nicholl 
(2005) that pp71 is able to act in trans to reactivate quiescent genomes, however, 
the data presented in this study shows that pp71 appears to be unique amongst 
the UL82 homologues in its ability to do so.  It also provides further evidence that 
this protein has similar functions to HSV-1 ICP0 (see final discussion for further 
details). 
 
 
 
 
 
 
 
 
    
Chapter 4 
 
Investigation into the region of pp71 responsible 
for long-term gene expression 
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4. Part I 
 
4.1. Introduction 
 
The transfection and infection experiments described in chapter 3 showed that 
pp71 is unique among the UL82 homologues in its ability to stimulate long-term 
gene expression.  Surprisingly, despite its amino acid homology with pp71, the 
Ch82 homologue was unable to direct gene expression at later times after 
transfection or infection.  Given the significant degree of homology between the 
pp71 and Ch82 proteins, it was possible to construct six hybrid proteins in order to 
map the region of pp71 that mediates this unusual property of long-term gene 
expression. 
 
4.1.1. Construction of plasmids that express EYFP-tagged hybrids 
 
Analysis of the pp71 and Ch82 amino acid sequences (figure 4.1) shows residues 
conserved between the homologues.  A 65% homology between the sequences 
was calculated. The only functional difference observed was the inability of the 
Ch82 homologue to stimulate long-term gene expression.  A closer examination of 
the amino acid sequences showed conserved regions to be spread throughout the 
protein, with the greatest degree of homology occurring in the middle.  Analysis of 
the DNA sequences of both pp71 and Ch82  (figure 4.2) showed a conserved BglII 
site and BssHII site in both sequences (figure 4.3).  Using these conserved sites 
plasmids expressing six individual hybrids were constructed by exchanging the 
C-terminal, N-terminal and the middle regions between the homologues.  Figure 
4.3 shows the nucleotide sequence and amino acid sequences around the BssHII 
and BglII sites in pEYFPpp71 and pEYFPCh82.  These homologous sites were 
utilised to construct plasmids expressing the hybrids without altering the 
immediate coding sequences of pEYFPpp71 and pEYFPCh82.  Figure 4.4 shows 
maps of the plasmids that express the hybrids.  These plasmids were used to 
determine the features of pp71 that mediate long-term gene expression.   
 
Plasmid pEYFPTC1 was constructed by exchanging the C-terminal end of pp71 
with that of the Ch82 protein.  Plasmids pEYFPpp71 and pEYFPCh82 were 
digested with the restriction endonucleases SpeI and BssHII.  Reaction mixtures 
were analysed by gel electrophoresis and the 550 bp fragment containing the C-
terminus of pp71 was ligated to the large fragment of pEYFPCh82 and                  1                                               50 
     Ch82    (1) MSRSPS-PGEGPSAAGGPGGAPGDNGSTFGRMHCQVLRLVTNHDS-SLEP 
     pp71    (1) MSQASSSPGEGPSSEAAAISEAEAASGSFGRLHCQVLRLITNVEGGSLEA 
Consensus    (1) MS A S PGEGPSA AA          SFGRLHCQVLRLITN D  SLE  
                 51                                             100 
     Ch82   (49) DRLKILDLRTSVEVSRTSVLCLFQENKSQHDTVDLTDLNVKGHCAVGERD 
     pp71   (51) GRLRLLDLRTNIEVSRPSVLCCFQENKSPHDTVDLTDLNIKGRCVVGEQD 
Consensus   (51)  RLKILDLRT IEVSR SVLC FQENKS HDTVDLTDLNIKG C VGE D 
                 101                                            150 
     Ch82   (99) QLKADLINYSQRRMSPGS-STPISVLAFGLPLERVPVSGIHLFQAHPRGD 
     pp71  (101) RLLVDLNNFGPRRLTPGSENNTVSVLAFALPLDRVPVSGLHLFQSQRRGG 
Consensus  (101)  L  DL NF  RRLSPGS    ISVLAFALPLDRVPVSGIHLFQA  RG  
                 151                                            200 
     Ch82  (148) EENRLRTEARVDIRRTAYHWGVRTTVSPRWRRKVDRSLEAEQIFTTEFIF 
     pp71  (151) EENRPRMEARAIIRRTAHHWAVRLTVTPNWRRRTDSSLEAGQIFVSQFAF 
Consensus  (151) EENR R EAR  IRRTAHHWAVR TVSP WRRK D SLEA QIF S F F 
                 201                                            250 
     Ch82  (198) RAGAIPLRLVDAVELLSCSDRNTYIHKAETDARGQWVNVHLQHETLHPPP 
     pp71  (201) RAGAIPLTLVDALEQLACSDPNTYIHKTETDERGQWIMLFLHHDSPHPPT 
Consensus  (201) RAGAIPL LVDALE LACSD NTYIHK ETD RGQWI L L HDS HPP  
                 251                                            300 
     Ch82  (248) SVFLHFSLYTHGAEVVLRHNPYPHLTRHGDNGFTLHAPRGFTLSRLHREY 
     pp71  (251) SVFLHFSVYTHRAEVVARHNPYPHLRRLPDNGFQLLIPKSFTLTRIHPEY 
Consensus  (251) SVFLHFSLYTH AEVV RHNPYPHL R  DNGF L  PK FTLSRIH EY 
                 301                                            350 
     Ch82  (298) IVQVQNAFETNNTHDVIFFPADIPGVSMEAGPLPDRVRITIRLTWTGENS 
     pp71  (301) IVQIQNAFETNQTHDTIFFPENIPGVSIEAGPLPDRVRITLRVTLTGDQA 
Consensus  (301) IVQIQNAFETNNTHD IFFP  IPGVSIEAGPLPDRVRITIRLT TGDNA 
                 351                                            400 
     Ch82  (348) VRIEHMQILGTIHLFKRGVLNLLPGKTEKIKRPQIQLRAGLFPRRAVMRG 
     pp71  (351) VHLEHRQPLGRIHFFRRGFWTLTPGKPDKIKRPQVQLRAGLFPRSNVMRG 
Consensus  (351) V IEH Q LG IH FKRG   L PGK DKIKRPQIQLRAGLFPR  VMRG 
                 401                                            450 
     Ch82  (398) EVSEFRPQSPGELPLEGEEEEEE---EEERSSTPTPPALSESVFAAFEES 
     pp71  (401) AVSEFLPQSPGLPPTEEEEEEEEEDDEDDLSSTPTPTPLSEAMFAGFEEA 
Consensus  (401)  VSEF PQSPG  P E EEEEEE   EDD SSTPTP  LSEAMFAAFEEA                  451                                            500 
     Ch82  (445) SEEEESDTEEGLSRALALTGRRRPRRGADEGEDLMLVIPSWNVFVNIDNL 
     pp71  (451) SGDEDSDTQAGLSPALILTGQRR---RSGNNGALTLVIPSWHVFASLDDL 
Consensus  (451) S DEDSDT  GLS AL LTG RR    A     L LVIPSW VF  ID L 
                 501                                            550 
     Ch82  (495) VPLTGSVEQAALKPTSYLRSEMQGDVRTAADFTSNLQPVPVPRPSPMSLP 
     pp71  (498) VPLTVSVQHAALRPTSYLRSDMDGDVRTAADISSTLRSVPAPRPSPISTA 
Consensus  (501) VPLT SV  AALKPTSYLRSDM GDVRTAAD SS L  VP PRPSPIS   
                 551        564 
     Ch82  (545) STSGTAASRSRPRI 
     pp71  (548) STSSTPRSR--PRI 
Consensus  (551) STS T  SR  PRI 
 
 
Figure 4.1 Conservation of amino acid sequences between pp71 and Ch82 homologues. 
 
Amino acid sequences from pp71 and Ch82 were aligned using the Vector NTI program (suite 9.0).  Coloured boxes show 
degrees of similarity of the amino acids between sequences.  The yellow boxes indicate 100% amino acid conservation 
between all sequences.  Green boxes highlight amino acids similar to each other in structure and charge.  Areas left 
unhighlighted show amino acids with no similarity to each other.  
 
 Figure 4.2. Schematic representation of the pEYFPpp71 and pEYFPCh82 plasmids
Maps showing the restriction sites used in constructing the EYFPpp71/EYFPCh82 plasmids.  Conserved BssHII and BglII 
sites are marked in red.  The 5’ XhoI and BglII sites in EYFPCh82 plasmid overlapped (sequence marked in purple), this 
was taken into account when constructing the plasmids expressing the EYFPpp71/EYFPCh82 hybrids.  Diagrams not to 
scale.
EYFP
SpeI BssHII BglII
XmaI
XhoI
SacI BssHII
BssHII
5’ 3’
pEYFPpp71
EYFP
SpeI BssHII BglII
SacI BamHI XhoI
BglII
3’ 5’
pEYFPCh82
AGATCTCGAG
BamHIa
Nucleotide sequence gca ggg cag atc ttt
b
Figure 4.3  Schematic representation of the BglII and BssHII restriction 
sites in homologous regions of the pp71 and Ch82 nucleotide 
sequences.
The homologous restriction sites marked were used in constructing the 
pEYFPpp71/pEYFPCh82 plasmids.
BglII
Amino acid sequence AGQI F
pp71
Ch82 gcc gag cag atc ttc Nucleotide sequence
BglII
Amino acid sequence AE QIF
BssHII
cag ctg cgc gcc ggc
BssHII
QLRAG
Nucleotide sequence
Amino acid sequence
Ch82
cag ctg cgc gcc ggt
QLRAG
Nucleotide sequence
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transformed into competent E.coli.  24 hr later colonies were picked and amplified 
to make small scale DNA preparations.  The plasmid DNA was screened by 
digestion with the restriction endonuclease SacI and BssHII to cut out the C-
terminus fragment.   
 
Plasmids pEYFPTC2 and pEYFPTC3 were created by exchanging the N-terminal 
ends of pEYFPpp71 and pEYFPCh82.  In the case of pEYFPCh82 the XhoI and 
BglII sites overlapped (see figure 4.2).  In order to release the N-terminal region 
the plasmid was digested first with XhoI, to linearise the plasmid.  A second digest 
with  BglII was carried out to isolate the region of interest.  The plasmid 
pEYFPpp71 was digested with XhoI and BglII to separate the N-terminal region 
from the rest of the plasmid.  As there was no overlapping XhoI/BglII site there 
was no need to linearise the plasmid initially.  The fragment representing the 
N-terminus of pEYFPCh82 was ligated to the large pEYFPpp71 fragment while the 
isolated fragment containing the N-terminal of pp71 was ligated to the large 
pEYFPCh82 fragment.  Small scale DNA preparations were screened for the 
correct insertions by digestion with restriction endonucleases SacI and BamHI. 
 
To create plasmid pEYFPTC4, the C-terminal of Ch82 was transferred to pp71 via 
three way cloning.  Plasmid pEYFPCh82 was digested with the restriction 
endonucleases SpeI and BssHII to release the 550 bp C-terminus region, while 
pEYFPpp71 was digested with XmaI and SpeI to release the large pEYFPpp71 
fragment or with XmaI and BssHII to release a 190 bp fragment.  The fragments 
were isolated, purified and the Ch82 550 bp C-terminus ligated to the isolated 
pEYFPpp71 190 bp and large fragments.  Small scale DNA preparations were 
made and plasmid DNA was screened using the restriction endonucleases SpeI 
and BssHII.   
 
The two remaining plasmids pEYFPTC5 and pEYFPTC6 were created by 
exchanging the middle coding regions of each homologue, again using three way 
cloning.  Plasmid pEYFPTC5 was constructed by digesting pEYFPpp71 DNA with 
XhoI and BglII to release a 600 bp fragment, or with XhoI and BssHII to release 
the large fragment.  pEYFPCh82 plasmid DNA was digested with the restriction 
endonucleases  BssHII and BglII to release a 585 bp fragment containing the 
middle coding region of Ch82.  Fragments were isolated, purified and the 585 bp 
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scale DNA preparations were screened using XmaI and XhoI restriction 
endonucleases.   
 
Plasmid pEYFPTC6 was constructed by digesting pEYFPpp71 with BssHII and 
BglII releasing 583 bp and 450 bp fragments.  The pEYFPCh82 plasmid was 
digested with XhoI and BglII to release a 600 bp fragment or digested with XhoI 
and BssHII to isolate the large pEYFPCh82 fragment.  The large Ch82 fragment 
and the 600 bp fragment were ligated to the pp71 583 bp fragment.  Plasmid DNA 
was prepared and screened for by digestion with restriction endonucleases XmaI 
and BssHII to check for correct insertions. 
 
A schematic representation of the six resulting plasmids is presented in figure 4.4.  
The hybrid proteins specified by pEYFPTC1 to 6 are named TC1 to TC6 
respectively.  
 
4.1.2. EYFPpp71/EYFPCh82 hybrids as transactivators of gene expression 
 
The role of pp71 as a transactivator of short-term gene expression has been 
described previously (see chapter 3 for further details).  To investigate functionality 
of the EYFPpp71/EYFPCh82 hybrid proteins constructed, plasmids pEYFPTC1, 
pEYFPTC2, pEYFPTC3, pEYFPTC4, pEYFPTC5, pEYFPTC6 were transfected 
into HFFF2 monolayers using a Nucleofector
TM.  Plasmids pEYFP-C1, 
pEYFPpp71 and pEYFPCh82 were used as controls as EYFPpp71 has previously 
been shown to stimulate long-term gene expression while EYFPCh82 did not.  The 
transfected cells were incubated overnight at 37
oC.  Fluoresence levels of cells 
transfected with the EYFP-tagged plasmids were ascertained visually using a UV 
microscope at 24 hr post-infection.  Satisfactory levels of fluorescence were 
classed as 60-70% of cells fluorescing.  
 
To investigate the activities of the hybrids, the transfected cells were infected with 
3x10
5 pfu, 1x10
5 pfu or 3x10
4 pfu of in1382 (a HSV-1 recombinant impaired for 
transcriptional activity, expressing β-gal driven by the HCMV MIEP) and incubated 
at 38.5
oC for a further 24 hr.  Following infection the cell monolayers were stained 
with X-gal reaction mix and the β-gal positive cells were counted.  Figure 4.5 
shows the average numbers of β-gal positive cells counted from two individual 
experiments, the raw data for which are presented in table 4.1.  The results pEYFPTC1
pp71 C-term Ch82
MIEP EYFP-tag SV40 
terminator
pEYFPTC2
MIEP EYFP-tag SV40 
terminator
pp71 N-term Ch82 
pEYFPTC3
MIEP EYFP-tag SV40 
terminator
pp71 Ch82 N-term
pEYFPTC4
MIEP EYFP-tag SV40 
terminator
pp71 Ch82 C-term
pEYFPTC6
MIEP EYFP-tag SV40 
terminator
Ch82 Ch82 pp71
pEYFPTC5
MIEP EYFP-tag SV40 
terminator
Ch82 pp71 pp71
Figure 4.4 Schematic representation of the pEYFPpp71/pEYFPCh82 hybrids
Plasmid maps of the EYFPpp71/EYFPCh82 hybrids.  Six hybrids were constructed by 
exchanging the C-terminal. N-terminal and middle regions off pp71 with those of Ch82.  
Plasmid maps show the MIEP, EYFP-tag and the SV40 terminator.Experiment 1  Experiment 2  Experiment 3  Experiment 4 
Plasmid Titre  24 
hours
10 
days 
24 
hours
10 
days 
24 
hours 
10 
days 
24 
hours
10 
days 
  3x10
5 24 0  17 2  19 9  17 0 
pEYFP-C1  1x10
5 6 0 13  0 6 0 22  0 
  3x10
4 0 0 0 0 0 0 0 0 
           
  3x10
5 39  93  243 976 118 183 76  608 
pEYFPpp71  1x10
5 3  4  102 336 101 101 24  380 
 3x10
4 0 0 0 18  0 0 0 14 
           
 3x10
5 54 0  146  12 
pEYFPCh82  1x10
5 2 0 102  0 
 3x10
4 0 0 3 0 
       
 3x10
5 37 0  171  8 
pEYFPTC1    
1x10
5
 
15 
 
0 
 
49 
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 3x10
4 0 0 0 0 
       
 3x10
5 27 0  161  5 
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1x10
5
 
7 
 
0 
 
51 
 
2 
 3x10
4 0 0 0 0 
       
 3x10
5 58 0  153  11 
pEYFPTC3    
1x10
5
 
6 
 
0 
 
51 
 
0 
 3x10
4 0 0 0 0 
       
  3x10
5 164 41  174 57 
pEYFPTC4    
1x10
5
 
41 
 
6 
 
51 
 
0 
  3x10
4 0 0 0 0 
       
  3x10
5 47 0  151  0 
pEYFPTC5    
1x10
5
 
0 
 
0 
 
0 
 
0 
  3x10
4 0 0 0 0 
       
  3x10
5 82 108  27 0  102  102  44 69 
pEYFPTC6    
1x10
5
 
4 
 
0 
 
2 
 
0 
 
41 
 
20 
 
2 
 
5 
  3x10
4 0  0 0 0 0 0 0 0 
           
 
Table 4.1. Stimulation of β-gal expression directed by the
pEYFPpp71/pEYFPCh82 hybrids at 24 hr and 10 days post-transfection. 
HFFF2 monolayers were transfected with plasmids expressing the required
EYFP-tagged UL82 homologues or EYFPpp71/EYFPCh82 hybrids and
infected with virus in1382 at 24 hr post-transfection. After a further 24 hr or 10
days, monolayers were stained with X-gal and β-gal positive cells were
counted.  
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Figure 4.5. Expression directed by the EYFPpp71/EYFPCh82 hybrids at 24 hr
post-transfection 
HFFF2 monolayers were transfected with plasmids expressing EYFP-tagged UL82
homologues or EYFPpp71/EYFPCh82 hybrids, and infected with various amounts
of in1382 at 24 hr post-transfection. After a further 24 hr, monolayers were stained
with X-gal and β-gal positive cells were counted. Tanya Chaudry 2008    Chapter 4  111
presented in figure 4.5 show that cultures transfected with each of the plasmids 
expressing a EYFPpp71/EYFPCh82 hybrid gave more β-gal positive cells than 
those transfected with the control vector pEYFP-C1, when subsequently infected 
with 3x10
5 pfu or 1x10
5 pfu of in1382.  Cells transfected with plasmids pEYFPTC1, 
pEYFPTC2, or pEYFPTC3 all showed similar numbers of β-gal positive cells, 
when infected with 3x10
5 pfu or at 1x10
5 pfu of virus, to each other and to cultures 
transfected with pEYFPCh82 but fewer β-gal positive cells than cultures 
transfected with pEYFPpp71. However pEYFPTC5 only directed β-gal expression 
in cells infected with 3x10
5 pfu of in1382, no β-gal positive cells were observed 
when transfected cells were infected with 1x10
5 pfu or 3x10
4 pfu of in1382.  Levels 
of expression directed by this plasmid at 3x10
5 pfu were similar to those directed 
by pEYFPCh82.  Cultures transfected with pEYFPTC4 showed a greater number 
of  β-gal positive cells than those transfected with plasmids pEYFPCh82 or 
pEYFPpp71 when infected with 3x10
5 pfu of in1382.  Figure 4.5 shows that the 
lowest levels of β-gal expression were directed by the plasmid pEYFPTC6.  When 
infecting cells with 3x10
5 pfu or 1x10
5 pfu of in1382 fewer β-gal positive cells were 
observed than after transfection with pEFYPpp71, pEYFPCh82 or the other 
pEYFPpp71/pEYFPCh82 plasmids.  However all of the plasmids expressing the 
EYFPpp71/EYFPCh82 hybrids  were able to direct levels of β-gal expression 
above the control (pEYFP-C1), indicating that the hybrid proteins expressed by the 
plasmids were functional and able to stimulate short-term gene expression in a 
similar manner to that of pp71. 
 
At 10 days post-infection cell monolayers were stained with X-gal reaction mix and 
β-gal positive cells were counted.  Figure 4.6 shows the average numbers of b-gal 
positive cells at 10 days post-infection in transfected cultures infected with 3x10
5 
pfu of in1382.  An increase in the number of β-gal positive cells was observed in 
cultures transfected with pEYFPpp71, compared to that observed at 24 hr post-
infection.  Cultures transfected with pEYFPCh82 showed, as expected, a decrease 
in the numbers of β-gal cells observed at 10 days post-infection. A similar result 
was observed in cultures transfected with plasmids pEYFPTC1, pEYFPTC2, 
pEYFPTC3, pEYFPTC4 or pEYFPTC5, all of which directed low levels, or no, 
β-gal expression at 10 days post-infection.  Cultures transfected with plasmid 
pEYFPTC6, however, showed levels of β-gal expression at 10 days that were  
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Figure 4.6. β-gal expression directed by EYFPpp71/EYFPCh82 hybrids at 24
hr and 10 days post-infection. 
HFFF2 monolayers were transfected with plasmids expressing EYFP-tagged
UL82 homologues or hybrids, and infected with 3x10
5 pfu of in1382 at 24 hr
post-transfection. After a further 24 hr or 10 days, monolayers were stained with
X-gal and β-gal positive cells were counted.  
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similar to those observed at 24 hr post-infection.  Numbers of β-gal positive cells 
were however, lower than those observed in cultures transfected with pEYFPpp71.   
 
This result was reflected in the individual experiments as presented in table 4.1.  
Experiment one showed an increase in the number of β-gal positive cells at day 10 
compared to 24 hr, while experiment two showed no β-gal positive cells at 10 days 
post-infection in cultures transfected with pEYFPTC6.  Further investigation into 
the functionality of plasmid pEYFPTC6 showed that in two out of four experiments, 
the number of β-gal positive cells counted either stayed constant or increased at 
10 days post-infection (table 4.1).  Due to the large degree of variability in 
numbers of b-gal positive cells between individual transfection experiments, it was 
not possible to carry out statistical analysis on the numbers.  Therefore all that 
could be confirmed from these experiments was that all of the hybrids were 
functional in short-term assays.  However, in the context of long-term gene 
expression, plasmids pEYFPTC1, pEYFPTC2, pEYFPTC3, pEYFPTC4, and 
pEYFPTC5 all resembled  the pEYFPCh82 homologue as they were unable to 
direct long-term gene expression.  The only exception was pEYFPTC6, which 
contained the middle coding sequence of pp71.  At 10 days post-infection 
conflicting results were observed which made it impossible to determine whether 
pEYFPTC6 was able to drive long-term gene expression, however it was clear that 
some activity was present. 
 
Lysates of HFFF2 cells transfected with the plasmids pEYFP-C1, pEYFPpp71, 
pEYFPCh82, pEYFPTC1, pEYFPTC2, pEYFPTC3, pEYFPTC4, pEYFPTC5, or 
pEYFPTC6 were analysed by gel electrophoresis and transferred onto 
nitrocellulose membranes.  The EYFP tagged proteins were detected using an 
anti-GFP antibody.  Figure 4.7 shows levels of protein present in lysates of 
transfected cells at 24 hr post-transfection.  Blot i shows that plasmids pEYFPTC1 
and pEYFPTC3 directed similar levels of protein expression compared to that in 
lysates of cells transfected with pEYFPpp71, while plasmid pEYFPTC2 expressed 
levels of protein similar to that observed in lysates of cells transfected with 
pEYFPCh82.  Blot ii shows that in lysates of cells transfected with both 
pEYFPpp71 and pEYFPCh82 low levels of protein were expressed, at equivalent 
levels to that observed in lysates of cells transfected with pEYFPTC5.  In lysates 
of cells transfected with pEYFPTC6 very low levels of protein were detected.    
 
 
 
igure 4.7. Analysis of protein expression directed by the 
EYFPpp71/pEYFPCh82 plasmids at 24 hr and 10-days post-transfection. 
71, 
EYFPCh82 or the pEYFPpp71/pEYFPCh82 hybrids. Cell lysates were harvested 
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HFFF2 monolayers were transfected with plasmids expressing pEYFPpp
p
at either 24 hr or 10 days post-transfection and EYFP-tagged proteins were 
subjected to SDS PAGE.  The EYFP-tagged proteins were detected using an anti-
GFP primary antibody and an anti-rabbit HRP conjugated secondary antibody.   
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However plasmid pEYFPTC4 expressed protein at levels greater than for 
pEYFPpp71. 
 
Blots iii and iv show protein expression of pEYFPpp71 and pEYFPCh82 and 
EYFPpp71/EYFPCh82 hybrids at 10 days post-transfection. Both blots showed 
increased levels of protein expression in lysates of cells transfected with 
pEYFPpp71, while no protein was detected in lysates of cells transfected with 
pEYFPCh82, indicating that protein expression was switched off.  No protein was 
detected in lysates of cells transfected with pEYFPTC1, pEYFPTC2, pEYFPTC4, 
pEYFPTC5 and pEYFPTC6, however in lysates of cells transfected with 
pEYFPTC3 protein expression was similar to that after transfection of pEYFPpp71.  
The western blot in figure 4.7 shows contrasting results to those in figure 4.5 in 
that pEYFPTC3 was able to continue producing protein after 10 days post-
infection but did not direct β-gal expression at 10 days.  Surpsingly, given the 
results of the β-gal assays, no protein was detected in cells transfected with 
pEYFPTC6 at 10 days post-infection. 
 
Data from transfection assays showed that it was possible to construct hybrid 
proteins using particular regions of the pp71 and Ch82 proteins which were 
functional in short-term assays.  However in long-term assays, while it was again 
confirmed that pp71 could stimulate long-term gene expression, conflicting results 
were obtained from the plasmid pEYFPTC6.  It appeared that this hybrid was 
unable to stimulate protein synthesis at late times post-infection, while the 
numbers of β-gal positive cells gave conflicting results as to whether this hybrid 
was able to direct long-term gene expression or not.  To establish the true 
behaviour of this protein, TC6 was recombined into a HSV-1 recombinant virus 
(in1312). 
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4. Part II 
 
4.2. Introduction 
 
Plasmid transfection assays using EYFP-tagged pp71/Ch82 hybrids showed all of 
the hybrids to be functional because they stimulated short-term gene expression.  
However in terms of long-term gene expression, plasmid pEYFPTC6 (mid region 
of pp71 cloned into the Ch82 homologue) produced conflicting results.  Expression 
assays showed that pEYFPTC6 might direct long-term gene expression, while 
western analysis showed protein expression to be at a considerably lower level 
than that of pp71 at 24 hr post-transfection with no detectable protein expressed 
by pEYFPTC6 at 10 days post-transfection.  In order to determine if this hybrid 
was able to direct long-term gene expression and to elimimate the problem of 
variability in numbers incurred from transfection assays, the HSV-1 in1312 
recombinant, in0156, was constructed. This recombinant virus was analogous to 
in1310 but contained the DNA sequence encoding EYFPTC6 in place of the 
EYFPpp71 coding region and β-gal inserted into the non-essential UL43 locus 
under the control of the MIEP. The HSV-1 recombinat virus, in0156, again 
contained mutations at of VP16, ICP0 and a temperature sensitive mutation in 
ICP4 ensuring the virus became quiescent shortly after infection.  The DNA 
sequences encoding EYFPTC6 was recombined into the HSV-1 recombinant 
using a method similar to that described in section 3.2.1. 
 
4.2.1. Infection with the in1312 recombinant in0156 stimulates short-
term gene expression 
 
The in1312 recombinant virus expressing EYFPTC6, in0156, was first analysed for 
short-term gene expression. 1.5x10
5 U373 cells were seeded in a 24 well plate 
and infected, with 5x10
5 pfu (MOI 3.3) of in1310 (expressing EYFPpp71), in0146 
(EYFPCh82), in0156 (EYFPTC6), in1374 (negative control) or mock-infected and 
incubated at 38.5
oC.  At 24 hr post-infection cell monolayers were stained with 
X-gal reaction mix and β-gal positive cells were observed.  Figure 4.8 shows that, 
in U373 monolayers infected with in1310 or in0146, equivalent numbers of β-gal 
expressing cells were detected at levels above those of in1374.  U373 cells 
infected with in0156 showed numbers of β-gal expressing cells that were similar 
to, or slightly higher than, those in in1310 or in0146 infected cultures.  
in1374
in1310 in0146
in0156
mock
in1374
in1310 in0146
in0156
mock
Figure 4.8. β-gal expression directed by in1312 recombinants expressing
EYFP-tagged UL82 homologues or hybrid EYFPTC6 at 24 hr post-infection
U373 cell monolayers were mock-infected or infected with 5x10
5 pfu (MOI 3.3)
of the in1312 recombinants expressing either the UL82 homologues or
EYFPTC6 and incubated at 38.5
oC.  In1374, a virus lacking the ORF of the
UL82 homologues was used as a control.  At 24 hr post-infection cell
monolayers were stained with X-gal. 
 
The in1310 virus expresses EYFPpp71, in0146 expresses EYFPCh82, in0156 
expresses EYFPTC6 and in1374 was used as a negative control. Tanya Chaudry 2008    Chapter 4  115
U373 cells were mock-infected or infected with 5x10
5 pfu of in1310,  in0146, 
in0156 or in1374 and lysates were analysed SDS PAGE and transferred onto a 
nitrocellulose membrane. Protein expression was detected using an anti-GFP 
antibody.  Figure 4.9 shows that lysates from cells infected with in1310 and in0146 
produced equivalent amounts of protein at 24 hr post-infection while lysates from 
cells infected with in0156, contained lower levels of protein compared to those in 
lysates from cells infected with in1310 or in0146.  As expected no EYFP-tagged 
protein was observed in lysates from mock-infected or cells infected with in1374.  
Mock-infected and infected cell lysates were analysed by SDS PAGE again and 
blots were probed with an anti-actin antibody and an anti-mouse secondary 
antibody, to control for loading. 
 
In order to quantify expression levels, U373 cells infected with 5x10
5 pfu of in1310, 
in0146,  and in0156  in1374 or mock-infected were super-infected with in1318 
(expressing SEAP under the control of the MIEP) and incubated at 38.5
oC for 24 
hr.  Following infection, samples of the growth medium were harvested and 
endogenous alkaline phosphatase was eliminated by heating samples to 65
oC 
prior to assaying for the amount of SEAP.  Figure 4.10 shows the average number 
of arbitrary units of fluorescence from two experiments.  The results show that 
samples of growth medium harvested from mock or in1374 infected monolayers 
exhibited low levels of alkaline phosphatase activity.  Cell monolayers infected with 
in1310 and in0156 showed similar levels of alkaline phosphatase activity.   
However, medium harvested from cells infected with in0146 appeared to release 
levels of alkaline phosphatase activityto higher levels than cells infected with 
in1310 and in0156. 
 
4.2.2. Analysis of long-term gene expression 
 
Data from transfection assays (presented in section 4.1.2) showed that of all the 
six EYFPpp71/EYFPCh82 hybrids constructed for this study only one showed any 
indication of stimulating long-term gene expression.  However, variability in the 
numbers of β-gal positive cells was observed between individual experiments.  To 
overcome this and to establish if the hybrid EYFPTC6 had any role in long-term 
gene expression, the HSV-1 recombinant virus in0156 was used to investigate the 
ability of this hybrid protein to direct β-gal expression at late times post infection. 
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Figure 4.9. Expression of the EYFP-tagged UL82 homologues or TC6 at 24 hr post-
onolayers were mock-infected or infected with 5x10  pfu (MOI 3.3) of the
infection. 
U373 cell m
5
in1312 recombinants expressing either the UL82 homologues or TC6 and incubated at
38.5
oC. At 24 hr post infection cell lysates were harvested, and subjected to SDS PAGE.
Proteins were transferred to a nitrocellulose membrane and were probed with an anti-
GFP primary antibody and an anti-rabbit HRP conjugated secondary antibody.  Lysates
were subjected to SDS PAGE again and probed with an anti-actin antibody and an anti-
mouse HRP-conjugated secondary antibody, to act as a loading control. 
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Figure 4.10. Activity of the in1312 recombinants expressing either the UL82
homologues or EYFPTC6 in trans 
U373 monolayers were infected with 5x10
5 pfu (MOI 3.3) of the in1312
recombinants expressing either the UL82 homologues or EYFPTC6 and
incubated at 38.5
oC for 2 hr.  The cell monolayers were super-infected with 5x10
5
pfu of in1318 and incubation was continued at 38.5
oC.  At 24 hr post-infection
samples of medium were analysed for alkaline phosphatase activity. 
 
 
 
 
 
 
 
 
 
 
 
 
 Tanya Chaudry 2008    Chapter 4  116
Three sets of HFFF2 cells were seeded at 1x10
6 cells per 35 mm dish. Confluent 
cell monolayers were either mock-infected or infected with 3x10
6 pfu (MOI 3) of 
in1310 (expressing EYFPpp71), in0146 (EYFPCh82), in0156 (EYFPTC6) or 
in1374 and incubated in DF2 medium at 38.5
oC for 10 days with medium changes 
every two days. At 9 days post-infection one set of HFFF2 cells was super-
infected with 3x10
6 pfu of tsK and incubation was continued for a further 24 hr at 
38.5
oC.  The growth medium on one set of cells was replaced with fresh medium 
supplemented with 2% human serum and the cultures were downshifted to 31
oC 
for a further 5 days.  One set of cells remained untreated at 38.5
oC. At 10 days 
post-infection cell monolayers super-infected with tsK, and those left untreated, 
were fixed and stained with X-gal.  Cells that were downshifted to the permissive 
temperature of 31
oC were stained at 14 days post-infection.   
 
Figure 4.11a shows that untreated cell monolayers that were mock-infected or 
infected with in1374 exhibited no β-gal expression.  Monolayers infected with 
in0146 showed no β-gal expression while those infected with in1310 expressed, 
as expected, significant levels of β-gal.  Monolayers infected with in0156 still 
showed some β-gal expression, as some positive cells were observed at 10 days 
post-infection.  The levels of expression observed however were significantly lower 
than those seen in monolayers infected with in1310.  These results were 
confirmed by the downshift assay where figure 4.11b shows no β-gal expression in 
cell monolayers infected with in1374,  in0146 or mock-infected.  In HFFF2 
monolayers infected with in1310, large plaques could be observed indicating that 
the virus was able to replicate at its permissive temperature.  Cell monolayers 
infected with in0156 also showed a number of plaques, indicating that, by moving 
the cultures to 31
oC the virus retained some replicative properties.  However the 
numbers of plaques observed in this case were significantly fewer and the plaques 
were smaller in size than those seen in cells infected with in1310.  Figure 4.11c 
shows cell monolayers super-infected with tsK at day 9 post-infection. Functional 
ICP0 expressed by the tsK virus allowed quiescent genomes to reactivate.  β-gal 
expression at 10 days post-infection showed that viral genomes were present in all 
of the cell monolayers at functionally comparable levels. 
 
At 9 days post-infection a proportion of untreated cells was subcultured into 24 
well plates and incubated at 38.5
oC for a further 24 hr.  At 10 days post-infection 
lysates were harvested, analysed by gel electrophoresis and subjected to SDS  
mock in1310 in0146
in0156 in1374
mock in1310 in0146
in0156 in1374
Figure 4.11a. β-gal expression directed by the in1312 recombinants
expressing the EYFP-tagged UL82 homologues or TC6 at 10 days post-
infection. 
HFFF2 cell monolayers were infected with 3x10
6 pfu (MOI 3) of the in1312
recombinants expressing either the UL82 homologues or TC6 and incubated
at 38.5
oC.  In1374, a virus lacking the ORF of the UL82 homologues was used
as a control.  At 10 days post-infection cell monolayers were stained with X-
gal. 
 
The in1310 virus expresses EYFPpp71, in0146 expresses EYFPCh82, in0156 
expresses EYFPTC6 and in1374 was used as a negative control. 
  
in1310 in0146
in0156 in1374
mock in1310 in0146
in0156 in1374
mock
Figure 4.11b. Response of the in1312 recombinants expressing the UL82
homologues or TC6 to temperature downshift. 
HFFF2 monolayers were infected with 3x10
6 pfu (MOI 3) of the in1312
recombinants expressing either the UL82 homologues or TC6 and incubated at
38.5
oC. In1374, a virus lacking the ORF of the UL82 homologues was used as a
control. At 9 days post-infection cell monolayers were overlayed with medium
containing 2% human serum and downshifted to 31
oC. At 14 days post-infection
cell monolayers were stained with X-gal.  
 
The in1310 virus expresses EYFPpp71, in0146 expresses EYFPCh82, in0156 
expresses EYFPTC6 and in1374 was used as a negative control. 
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Figure 4.11c. Response of the in1312 recombinants expressing the UL82
homologues or TC6 to super-infection with tsK. 
HFFF2 monolayers were infected with 3x10
6 pfu (MOI 3) of the in1312
recombinants expressing either the UL82 homologues or TC6 and incubated at
38.5
oC.  in1374, a virus lacking the ORF of the UL82 homologues was used as a
control.  At 9 days post-infection cell monolayers were super-infected with tsK and
incubated at 38.5
oC for a further 24 hr. At 10 days post-infection cell monolayers
were stained with X-gal.  
 
The in1310 virus expresses EYFPpp71, in0146 expresses EYFPCh82, in0156 
expresses EYFPTC6 and in1374 was used as a negative control. Tanya Chaudry 2008    Chapter 4  117
PAGE.  Protein expression was detected using an anti-GFP antibody.  Figure 4.12 
shows at 10 days post-infection, as shown previously in figure 4.7, pp71 protein 
could be detected whereas in lysates of cells infected with in0146, no protein was 
detected.  Furthermore no protein was detected in lysates of cells infected with 
in0156 suggesting reduced production of the protein at late times of infection.   
 
Data from the infection assays presented here show again that pp71 is able to 
stimulate long-term gene expression.  Interestingly however, cells infected with 
in0156 still exhibited some β-gal activity at 10 days post-infection.  Levels of β-gal 
expression observed appeared to be lower than observed in cells infected with 
in1310.  Therefore EYFPTC6 seems to retain some of the properties involved in 
long-term gene expression of pp71. 
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Figure 4.12. Expression of the EYFP-tagged UL82 homologues or TC6 at
10 days post-infection. 
HFFF2 cell monolayers were either mock-infected or infected with 3x10
6 pfu
(MOI 3) of the in1312 recombinants expressing the UL82 homologues or TC6
and incubated at 38.5
oC. At 10 days post-infection cell lysates were harvested,
subjected to SDS PAGE and proteins transferred onto a nitrocellulose
membrane.  EYFP-tagged proteins expressed by the in1312 recombinants were
detected using an anti-GFP primary antibody and an anti-rabbit HRP conjugated
secondary antibody. Blots were stripped and reprobed with an anti-actin primary
antibody and an anti-mouse HRP-conjugated secondary antibody to act as a
control for loading.  Proteins were detected using ECL prior to exposure to
autoradiographic film. Tanya Chaudry 2008    Chapter 4  118
4.3. DIscussion 
 
Having established that pp71 is unique in its ability to stimulate long-term gene 
expression, the second part of this study aimed to investigate the region of pp71 
involved in this.  Due to the significant degree of homology between the pp71 and 
Ch82 homologues, hybrid proteins were constructed in order to closely examine 
the effects on gene expression of their C-termini, N-termini and mid-regions. 
 
Initial experiments using plasmid based transfection assays showed all six hybrids 
were functional in short-term assays, as numbers of β-gal positive cells were 
observed at levels above the control.  These results were also reflected in the 
western analysis whereby all six hybrids stimulated protein expression.  In the 
long-term expression studies pEYFPpp71 continued to direct β-gal expression at 
10 days post-infection.  No activity was observed in cells transfected with 
pEYFPCh82 or the majority of pEYFPpp71/pEYFPCh82 hybrids, the only 
exception being cells transfected with pEYFPTC6.  There was no difference in the 
average numbers of β-gal positive cells at 10 days post-transfection compared to 
24 hr post-transfection although there were variabilites in numbers within individual 
experiments.  With regards to western analysis no protein was detectable at 10 
days post-transfection.  From this it was concluded that some activity may have 
been retained, however the degree of activity was lower than that observed with 
pEYFPpp71. 
 
Variability in numbers of β-gal positive cells was also observed with the remaining 
hybrids and was attributed to transfection discrepencies.  However, the variability 
in numbers between experiments meant that statistical analysis could not be 
performed. 
 
To eliminate the problem of variable numbers of β-gal positive cells observed in 
the transfection assays, a HSV-1 recombinant virus (in0156) was constructed 
containing the DNA cassette encoding EYFPTC6.  All three assays employed in 
the short-term studies showed that in0156 was able to stimulate levels of reporter 
gene expression above the negative control, confirming results from the 
transfection assays that this hybrid, like the pp71 protein, was functional in the 
short-term.   
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Results from long-term assays in HFFF2 cells showed that at 10 days 
post-infection, cell monolayers infected with in0156, contained β-gal positive 
plaques when the infected cells were downshifted to the permissive temperature of 
31
oC.  However, numbers of β-gal positive plaques observed were fewer and 
smaller in size than those observed in cell monolayers infected with in1310 (no 
β-gal expression was observed in cells infected with in0146).  This suggests that 
the hybrid TC6 protein retains a degree of functionality that can be attributed to the 
middle region of pp71.  Results from this part of the study showed that it is 
possible to exchange regions of the DNA coding sequences of the pp71 and Ch82 
homologues, while retaining functionality. 
 
In infection assays EYFPTC6 appeared to direct a lower degree of gene 
expression compared to pp71 at 10 days post-infection.  This could be attributed 
to the region of pp71 that was inserted into the Ch82 homologue.  The middle 
region of pp71 appears to be the most highly ordered region of the protein (figure 
4.13), with less order observed at the C- and N-termini.  Incidentally, the other 
non-human UL82 homologues show a very similar pattern to pp71 in the RONN 
structural analysis program (figure 4.13).  Some of the most important features of 
pp71 are found in the central third of this protein including the DIDs (Hofmann et 
al., 2002) and the LASCD (Kalejta & Shenk, 2003c) motif.  It is possible that some 
part of this region of pp71 may contribute to the continued expression seen in 
cultures infected with in0156 at 10 days post-infection.  The 
EYFPpp71/EYFPCh82 hybrid proteins were constructed so as not to destroy the 
immediate coding sequence of the proteins, however, it is possible that while the 
coding sequences were not altered, the folding of the protein was affected.  Small 
changes to the more ordered mid-section of pp71 could alter its structure and may 
affect its ability to direct long-term gene expression. Hofmann et al. (2002) 
suggested that internal deletion of the putative DIDs may cause an alteration in the 
3D protein structure of pp71, causing a loss of interaction between pp71 and 
hDaxx.  Davison and Stow (2005) also suggested that alterations to this region of 
the protein could result in gross structural changes to the protein.  Therefore it is 
possible that the minor alterations to pp71 protein in the construction of the 
EYFPpp71/EYFPCh82 hybrid proteins may have affected the ability of this protein 
to drive long-term gene expression.  To gain a better understanding of how the 
folding and structure of pp71 affects its ability to drive long tem gene expression, 
the structures of both pp71 and Ch82 would have to be solved.   Ch82
S82
Regions of disorder: 1-33, 55-60, 105-118, 139-162, 176-176, 214-217, 271-281, 
398-473, 507-518, 526-558
Regions of disorder: 1-26, 84-102, 136-154, 174-186, 287-292, 360-378, 393-476, 525-545
pp71
Regions of disorder: 1-25, 115-121, 139-163, 218-220, 333-338, 376-388, 404-470, 
515-559Rh82
B82
Regions of disorder: 1-24, 83-107, 138-146, 390-457, 522-532
Region of disorder: 1-22, 84-90, 95-104, 106-107, 134-156, 394-473, 523-530
Figure 4.13 Showing the regions of disorder in the UL82 proteins.  
The graphs show that the greatest degree of order within these proteins is 
conserved within their middle regions, while the most significant disorder is 
observed at the C- and N- termini.  All analysis was carried out using RONN 
software. 
Yang et al. 2005    
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5. Part I 
 
5.1. Introduction 
 
A large number of proteins, including PML, hDaxx, SUMO, and Sp100 are 
associated with ND10 structures.  The protein hDaxx has been reported to be 
involved in various cellular processes including embryo development, apoptosis 
and transcription regulation (Salomoni & Khelifi, 2006).  It has also been shown to 
co-localise with pp71 in the nucleus of transfected cells (Hofmann et al., 2002), 
and studies have shown that pp71 co-localises with PML at ND10 domains via an 
interaction with hDaxx (Hofmann et al., 2002, Ishov et al., 2002). 
 
In the study described here the four non-human UL82 homologues (Ch82, S82, 
B82, and Rh82) were further characterised by comparing them to their human 
counterpart pp71, by examining the nuclear distribution patterns of the 
homologues and their abilities to co-localise with either hDaxx or PML. 
 
Initial experiments to examine the nuclear distribution patterns of the UL82 
homologues were carried out at 7 hr and 24 hr post-infection.  Data obtained at 
these times of infection showed that the non-human homologues (Ch82, B82 and 
Rh82) behaved more like the S82 homologue than pp71.  In the majority of cells 
infected with in1310, at 7 hr post-infection EYFP-tagged pp71 localised to discrete 
punctate foci whereas at 24 hr a number of infected cells showed pp71 
accumulating as large aggregates in the nucleus (data not shown).  At 7 hr 
post-infection in cells infected with in0150, EYFP-tagged S82 predominantly 
exhibited a diffuse pattern of fluorescence, while in some infected cells S82 was 
observed in punctate foci superimposed on a diffuse background.  In HFFF2 cells 
infected with the in1312 recombinants expressing EYFP-tagged Ch82, B82 or 
Rh82, in the majority of cells all three non-human homologues exhibited a 
punctate/diffuse pattern of fluorescence.  Few infected cells showed these 
homologues localising to discrete punctate foci at 7 hr post-infection.  Again at 24 
hr post-infection in some infected cells the non-human homologue proteins 
accumulated in large masses (data not shown).  Therefore in order to establish 
whether the non-human homologues localised to discrete punctate foci, like pp71, 
before forming the patterns of fluorescence observed at 7 hr and 24 hr post-
infection, experiments were carried at the earlier time points of 3 hr and 5 hr as 
well as 7 hr post-infection. Tanya Chaudry 2008    Chapter 5  121
5.1.1. Distribution patterns of EYFPUL82 homologues at 3 hr post-infection 
 
To obtain comparisons between the nuclear distribution patterns of pp71 and the 
non-human homologues, 8x10
4 HFFF2 cells, cultivated on 13 mm coverslips in 
D5+5 medium, were infected with 5x10
5 pfu of in1310 (expressing EYFPpp71), 
in0146 (EYFPCh82), in0150 (EYFPS82), in0145 (EYFPB82), or in0144 
(EYFPRh82).  At 3 hr post-infection cells were fixed and mounted onto microscope 
slides.  Nuclear distribution patterns of each of the homologues were identified and 
tabulated (table 5.1).  Figure 5.1 shows the various patterns of fluorescence 
observed.  Figure 5.1a shows a typical pattern of discrete punctate foci, usually 
associated with pp71.  Infected cells displaying foci that became larger were 
termed punctate/diffuse (figure 5.1b).  The diffuse pattern of fluorescence was 
characterised by signal throughout the nucleus as presented in figure 5.1c. 
 
Table 5.2 shows that in 95% of the cells infected with in0146 the Ch82 homologue 
localised to discrete punctate foci, while in the remaining 5% Ch82 exhibited a 
punctate/diffuse pattern of fluorescence.  Cells infected with in0145 and in0144 
showed a slightly different distribution to that in cells infected with in1310 and 
in0146.  Upon infection with in0145 and in0144, the B82 and Rh82 proteins 
localised primarily to discrete punctate foci (figure 5.2).  However table 5.2 shows 
that despite the dominant nuclear pattern of discrete punctate foci, a greater 
percentage of cells showed these proteins in a punctate/diffuse pattern of 
fluorescence.  Cells infected with in0150 showed a different distribution pattern.  
The majority of infected cells (84%) examined contained S82 in a diffuse pattern of 
fluorescence, while in some cells punctate/diffuse patterns of fluorescence were 
observed. 
 
At 3 hr post-infection the UL82 homologues exhibited varied distribution patterns 
ranging from the well-documented discrete punctate foci to increasingly diffuse 
patterns of fluorescence. 
 
5.1.2. Distribution patterns of the EYFPUL82 homologues 5 hr post-infection 
 
HFFF2 cell monolayers (8x10
4 cells) infected with 5x10
5 pfu of the in1312 
recombinant viruses expressing EYFP-tagged UL82 homologues were fixed at 5 
hr post-infection.  Nuclear distribution patterns exhibited by each homologue were Patterns of 
Distribution 
3 hr 
post-infection 
5 hr 
post-infection 
7 hr 
post-infection 
Number of 
punctate foci 
 
95 
 
939 
 
730 
 
in1310 
(pp71)  Number of 
punctate/diffuse 
patterns of 
fluorescence 
 
 
5 
 
 
42 
 
 
167 
    
Number of 
punctate foci 
 
124 
 
45 
 
24 
 
in0146 
(Ch82)  Number of 
punctate/diffuse 
patterns of 
fluorescence 
 
 
7 
 
 
39 
 
 
95 
    
Number of 
punctate foci 
 
0 
 
0 
 
0 
Number of 
punctate/diffuse 
patterns of 
fluorescence 
 
 
27 
 
 
13 
 
 
37 
 
in0150 
(S82) 
Number of diffuse 
patterns of 
fluorescence 
 
 
149 
 
 
84 
 
 
78 
    
Number of 
punctate foci 
 
31 
 
42 
 
3 
 
in0145 
(B82)  Number of 
punctate/diffuse 
patterns of 
fluorescence 
 
 
58 
 
 
35 
 
 
54 
    
Number of 
punctate foci 
 
163 
 
44 
 
8 
 
in0144 
(Rh82)  Number of 
punctate/diffuse 
patterns of 
fluorescence 
 
 
46 
 
 
17 
 
 
67 
 
 
Table 5.1. Nuclear distribution patterns of the EYFPUL82 homologues at 3 hr, 5 hr and 7
hr post-infection. 
HFFF2 cells were infected with 5x10
5 pfu of the in1312 recombinant viruses expressing the
EYFP-tagged UL82 homologues.  Cell monolayers were fixed at 3 hr, 5 hr and 7 hr post-infection
and the various patterns of fluorescence were examined and categorised as presented in figure
5.1.  Cells expressing the different patterns of fluorescence were counted, in a range of fields,
and the results tabulated. Patterns of 
Distribution 
3 hr 
post-infection 
5 hr 
post-infection 
7 hr 
post-infection 
Percentage of 
punctate foci 
 
95 
 
95 
 
81 
 
in1310 
(pp71)  Percentage of 
punctate/diffuse 
patterns of 
fluorescence 
 
 
5 
 
 
5 
 
 
19 
    
Percentage of 
punctate foci 
 
95 
 
54 
 
20 
 
in0146 
(Ch82)  Number of 
punctate/diffuse 
patterns of 
fluorescence 
 
 
5 
 
 
46 
 
 
80 
    
Percentage of 
punctate foci 
 
0 
 
0 
 
0 
Percentage of 
punctate/diffuse 
patterns of 
fluorescence 
 
 
16 
 
 
13 
 
 
12 
 
 
 
in0150 
(S82) 
Percentage of 
diffuse patterns of 
fluorescence 
 
 
84 
 
 
87 
 
 
88 
    
Percentage of 
punctate foci 
 
65 
 
55 
 
5 
 
in0145 
(B82)  Percentage of 
punctate/diffuse 
patterns of 
fluorescence 
 
 
35 
 
 
45 
 
 
95 
    
Percentage of 
punctate foci 
 
78 
 
72 
 
11 
 
in0144 
(Rh82)  Percentage of 
punctate/diffuse 
patterns of 
fluorescence 
 
 
22 
 
 
28 
 
 
89 
 
Table 5.2. Nuclear distribution patterns of the EYFPUL82 homologues at 3 hr, 5 hr 
and 7 hr post-infection. 
HFFF2 cells were infected with 5x10
5 pfu of the in1312 recombinant viruses expressing 
the EYFP-tagged UL82 homologues.  Cell monolayers were fixed at 3 hr, 5 hr and 7 hr 
post-infection and patterns of fluorescence were examined using a confocal microscope. 
 
 Punctate foci Punctate/diffuse 
pattern of 
fluorescence
Diffuse pattern of 
fluorescence
Figure 5.1 Patterns of fluorescence exhibited by the EYFPUL82 
homologues
HFFF2 monolayers infected were infected with 5x105 pfu of the in1312 
recombinants expressing the EYFP-tagged UL82 homologues, and 
incubated at 38.5oC. Cell monolayers were fixed and permeabilised and 
images were captured on a confocal microscope.  Images were selected 
specifically to illustrate the different patterns of fluorescence observed 
throughout this study .
ac
abc c
10µm 10µm 5µmEYFPpp71
EYFPCh82
EYFPS82
EYFPB82
EYFPRh82
Figure. 5.2 Nuclear distribution of the EYFPUL82 homologues at 3 hr, 5 hr and 7 hr 
post-infection.
HFFF2 monolayers infected were mock-infected or infected with 5x105 pfu of the in1312 
recombinants expressing the EYFP-tagged UL82 homologues, and incubated at 38.5oC.  
At 3 hr, 5 hr, or 7 hr post-infection cell monolayers were fixed and permeabilised. Images 
were captured on a confocal microscope and the magnification of each image was 
optimised to fit the area of the cell(s) in the field.
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counted and tabulated (table 5.1 and 5.2).  At 5 hr post-infection cell monolayers 
infected with in1310 showed no change from the distribution pattern observed at 3 
hr post-infection (figure 5.2).  Again pp71 localised to discrete punctate foci in the 
nucleus (95%) however, in some infected cells pp71 exhibited a punctate/diffuse 
pattern of fluorescence (5%) (table 5.2). 
 
HFFF2 cells infected with in0146 showed a change in distribution patterns at 5 hr  
In HFFF2 cells infected with in0146 a change in distribution patterns at 5 hr was 
observed compared to that at 3 hr post-infection (figure 5.2).  At 5 hr 
post-infection, 54% of infected cells showed the Ch82 protein localising to discrete 
punctate foci, while an increasing proportion of infected cells (46%) showed Ch82 
exhibiting a more punctate/diffuse pattern of fluorescence (tables 5.1 and 5.2).   
Therefore, at 5 hr post-infection, despite the nuclear localisation pattern of the 
Ch82 homologue continuing to show similarities to that of pp71, a change in the 
degree of similarity was observed.  Cell monolayers infected with in0145 and 
in0144 showed little change in patterns of distribution at 5 hr compared to 3 hr.  
The majority of infected cells showed both B82 and Rh82 proteins localising as 
discrete punctate foci, however the number of cells exhibiting punctate/diffuse 
patterns of fluorescence increased (tables 5.1 and 5.2).  When HFFF2 cells were 
infected with in0150, no significant change in nuclear distribution patterns was 
observed when compared to 3 hr post-infection.  Tables 5.1 and 5.2 show that in 
cells infected with in0150, S82 exhibited a more diffuse pattern of fluorescence, 
and again no punctate foci were observed (figure 5.2).  The nuclear distribution 
pattern of S82 continued to differ from that of pp71. 
 
5.1.3. Distribution patterns of the EYFPUL82 homologues at 7 hr 
post-infection 
 
HFFF2 cells (8x10
4 cells) infected with 5x10
5 pfu of the in1312 recombinants 
expressing the EYFP-tagged UL82 homologues were fixed and mounted onto 
microscope slides.  Nuclear distribution patterns were counted and tabulated 
(table 5.1 and 5.2). Cell monolayers infected with in1310 showed a change in the 
nuclear distribution pattern.  Tables 5.1 and 5.2 show that in the majority of cells 
infected with in1310, pp71 continued to localise to discrete puncate foci in the 
nucleus as observed at 3 hr and 5 hr post-infection.  However a greater number of Tanya Chaudry 2008    Chapter 5  123
infected cells showed pp71 exhibiting a more punctate/diffuse pattern of 
fluorescence (figure 5.2). 
 
In HFFF2 cells infected with in0146 a change in the distribution pattern at 7 hr 
post-infection compared to that at 3 hr and 5 hr post-infection was observed.  The 
majority of infected cells showed Ch82 exhibiting a more punctate/diffuse pattern 
of fluorescence (80%), while fewer infected cells (20%) retained the discrete 
punctate foci exhibited at 3 hr and 5 hr post-infection (table 5.2).  This was also 
found to be the case in those cell monolayers infected with in0145 and in0144.  A 
greater number of infected cells showed both B82 and Rh82 proteins exhibiting a 
more punctate/diffuse pattern of fluorescence at 7 hr post-infection compared to 
that observed at 3 hr and 5 hr post-infection, as presented in tables 5.1 and 5.2, 
and in figure 5.2.  Cell monolayers infected with in0150 showed little change in 
distribution patterns.  The majority of infected cells (88%) showed S82 exhibiting a 
more diffuse pattern of fluorescence observed at earlier time points (tables 5.1 and 
5.2).  However, in a few infected cells S82 exhibited a punctate/diffuse pattern of 
fluorescence, as seen in figure 5.2.  At later times of infection the Ch82, B82 and 
Rh82 homologues began to show a divergence from the discrete punctate foci 
exhibited by pp71.   
 
This part of the study indicated that the majority of the non-human homologues 
(B82, Rh82 and Ch82) all displayed similar attributes to pp71 at 3 and 5 hr 
post-infection by localising to punctate foci.  Unlike pp71, the S82 homologue 
exhibited a punctate/diffuse pattern of fluorescence at 3 hr post-infection which 
became increasingly diffuse throughout the time period examined.  No discrete 
punctate foci were observed in any cells infected with in0150 at any time 
post-infection.  However, while pp71 predominantly localised to discrete punctate 
foci at 7 hr post-infection the B82, Rh82 and Ch82 homologues began to diverge 
away from the pattern exhibited by pp71 to localise to the punctate/diffuse pattern 
of fluorescence associated with the S82 homologue. These distinct changes in 
patterns of fluorescence exhibited by the non-human UL82 homologues were 
hypothesised to affect their ability to co-localise with the cellular proteins hDaxx 
and PML. 
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5. Part II 
 
5.2. Introduction 
 
Various studies have shown that pp71 co-localises with PML (Marshall et al., 
2002) and also with the cellular protein hDaxx (Hofmann et al., 2002, Ishov et al., 
2002).  To investigate whether the non-human UL82 homologues also localised 
with these cellular proteins, initial experiments were carried out at 7 hr and 24 hr 
post-infection.  It was observed that the Ch82, B82 and Rh82 homologues co-
localised with hDaxx and PML at these times.  However in those cells where S82 
exhibitied a diffuse pattern of fluorescence, hDaxx was seen to be dispersed from 
the larger more intense foci associated with this distribution pattern (data not 
shown).  Experiments were carried out at the earlier times of 3 hr and 5 hr post-
infection to establish whether the Ch82, B82 and Rh82 homologues co-localised 
with hDaxx and PML when their distribution patterns were more like those 
associated with pp71.  Experiments at these time points also served to establish if 
the S82 homologue caused hDaxx to be dispersed at earlier times after infection 
or if this property was associated with later times of infection. 
 
5.2.1. The EYFPUL82 homologues co-localise with the cellular proteins 
hDaxx and PML at 3 hr 5 hr and 7hr post-infection. 
 
HFFF2 cells, seeded at 8x10
4 cells, were infected with the in1312 recombinant 
viruses expressing the EYFP-tagged UL82 homologues.  At 3 hr post-infection cell 
monolayers were fixed and stained with an anti-PML A-20 antibody or an 
anti-hDaxx antibody and their appropriate secondary antibodies. 
 
Cell monolayers infected with in1310 showed co-localisation of pp71 with hDaxx at 
the punctate foci observed at the three time points under investigation (figure 
5.3a).  Further staining showed that pp71 also co-localised with PML in these 
punctate foci (figure 5.3b).  These results were in agreement with the reports by 
other groups that pp71 co-localises with hDaxx and PML at ND10 domains 
(Hofmann et al., 2002, Ishov et al., 2002).  As time progressed, pp71 displayed a 
punctate/diffuse pattern of fluorescence in an increasing number of infected cells 
while maintaining discrete punctate foci in the majority of infected cells. 
 hDaxx Merge EYFPpp71
hDaxx Merge
hDaxx
7hr
EYFPpp71 Merge
3hr
5hr
EYFPpp71
Figure 5.3a. EYFPpp71 co-localises with hDaxx at 3 hr, 5 hr and 7 hr 
post-infection.
HFFF2 monolayers were  infected with 5x105 pfu of in1310 (expressing 
EYFPpp71), and incubated at 38.5oC.  At 3 hr, 5 hr and 7 hr post-infection 
cell monolayers were fixed and permeabilised.  Cells were stained with anti-
hDaxx primary antibody and subsequently with secondary antibody (anti-
mouse Cy5-conjugated).  Images were generated on a confocal microscope 
and the magnification of each image was optimised to fit the area of the 
cell(s) in the field of view.PML Merge
3 hr
PML Merge
5 hr
EYFPpp71
7 hr
PML Merge
Figure 5.3b. EYFPpp71 co-localises with PML at 3 hr, 5 hr and 7 hr post-
infection.
HFFF2 monolayers were infected with 5x105 pfu of in1310 expressing 
EYFPpp71), and incubated at 38.5oC.  At 3 hr, 5 hr and 7 hr post-infection 
cell monolayers were fixed and permeabilised.  Cells were stained with 
primary antibody anti-PML  A-20 for 1 hr followed by incubation with 
secondary antibody (Alexa 647-chicken anti-goat) for 1 hr.  Images were 
captured on a confocal microscope and the magnification of each image was 
optimised to fit the area of the cell in the field of view.
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Cell monolayers infected with in0146 exhibited a distribution pattern analogous to 
that of pp71 at 3 hr post-infection.  The Ch82 homologue localised to discrete 
punctate foci, which in turn co-localised with both hDaxx and PML.  The pattern if 
fuorescence became more punctate/diffuse at 5 hr post-infection and by 7hr post-
infection, the majority of infected cells displayed this pattern.  Co-localisation with 
hDaxx and PML persisted at both these times of infection (figure 5.4a and 5.4b). 
 
Unlike pp71, the S82 homologue expressed from virus in0150 exhibited a 
punctate/diffuse or diffuse pattern of fluorescence at 3 hr post-infection (figure 
5.2).  However despite these distinct distribution patterns, foci co-localised with 
both hDaxx (figure 5.5a) and PML (figure 5.5b). Through 5 hr post-infection until 
7hr post-infection an increasingly diffuse pattern of fluorescence was observed in 
most infected cell nuclei.  While some co-localisation with PML was retained, 
hDaxx appeared to be dispersed throughout the nucleus (figure 5.5a and figure 
5.5b).   
 
In cells infected with in0145 (figure 5.6a and 5.6b) and in0144 (figure 5.7a an 5.7b) 
both homologues displayed the typical punctate foci associated with pp71, and 
again co-localised with hDaxx and PML at 3 hr post-infection.  The pattern of 
fuorescence exhibited by both these homologues became more punctate/diffuse at 
5 hr post-infection and by 7hr post-infection, the majority of infected cells displayed 
this pattern.  Co-localisation with hDaxx and PML persisted at both these times of 
infection (figure 5.4a and 5.4b). 
 
Data at all three times post-infection post-infection showed that the Ch82, B82 and 
Rh82 homologues appeared to be most like pp71 in terms of nuclear distribution 
patterns and in their ability to co-localise with hDaxx and PML at ND10 domains.  
The S82 homologue, though unlike pp71 in terms of nuclear distribution patterns, 
still behaved in a similar way to pp71 by co-localising with PML.  However, as the 
patterns of fluorescence became increasingly diffuse, hDaxx was observed to be 
dispersed from the nucleus, suggesting that the changes in patterns of 
fluorescence may affect the ability of the homologues to co-localise with hDaxx.  
Further experiments with the B82, Rh82 and Ch82 homologues at later times 
would need to be carried out to establish if they also exhibit diffuse patterns of 
fluorescence and, like S82, disperse hDaxx. 
 hDaxx Merge
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7hr
hDaxx Merge
Figure 5.4a. EYFPCh82 co-localises with hDaxx at 3 hr, 5 hr and 7 hr 
post-infection.
HFFF2 monolayers were  infected with 5x105 pfu of in0146 (expressing 
EYFPCh82), and incubated at 38.5oC.  At 3 hr, 5 hr and 7 hr post-infection 
cell monolayers were fixed and permeablised.  Cells were stained with anti-
hDaxx primary antibody and subsequently with secondary antibody (anti-
mouse Cy5-conjugated).  Images were generated on a confocal microscope 
and the magnification of each image was optimised to fit the area of the 
cell(s) in the field of view.
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Figure 5.4b. EYFPCh82 co-localises with PML at 3 hr, 5 hr and 7 hr post-
infection.
HFFF2 monolayers were infected with 5x105 pfu of in0146 (expressing 
EYFPCh82), and incubated at 38.5oC.  At 3 hr, 5 hr and 7 hr post-infection 
cell monolayers were fixed and permeabilised.  Cells were stained with 
primary antibody anti-PML  A-20 for 1 hr followed by incubation with 
secondary antibody (Alexa 647-chicken anti-goat) for 1 hr.  Images were 
captured on a confocal microscope and the magnification of each image was 
optimised to fit the area of the cell in the field of view.
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Figure 5.5a. EYFPS82 and hDaxx at  3 hr, 5 hr and 7 hr post-infection.
HFFF2 monolayers were  infected with 5x105 pfu of in0150 (expressing 
EYFPS82), and incubated at 38.5oC.  At 3 hr, 5 hr and 7 hr post-infection 
cell monolayers were fixed and permeabilised.  Cells were stained with anti-
Daxx primary antibody and subsequently with secondary antibody (anti-
mouse Cy5-conjugated).  Images were generated on a confocal microscope 
and the magnification of each image was optimised to fit the area of the 
cell(s) in the field of view.  (7 hr image courtesy of Dr. Chris Preston).
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Figure 5.5b. EYFPS82 co-localises with PML at 3 hr, 5 hr and 7 hr post-
infection.
HFFF2 monolayers were infected with 5x105 pfu of in0150 (expressing 
EYFPS82), and incubated at 38.5oC.  At 3 hr, 5 hr and 7 hr post-infection cell 
monolayers were fixed and permeabilised.  Cells were stained with primary 
antibody anti-PML  A-20 for 1 hr followed by incubation with secondary 
antibody (Alexa 647-chicken anti-goat) for 1 hr.  Images were captured on a 
confocal microscope and the magnification of each image was optimised to fit 
the area of the cell in the field of view.
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Figure 5.6a. EYFPB82 co-localises with hDaxx at 3 hr, 5 hr and 7 hr 
post-infection.
HFFF2 monolayers were  infected with 5x105 pfu of in0145 (expressing 
EYFPB82), and incubated at 38.5oC.  At 3 hr, 5 hr and 7 hr post-infection 
cell monolayers were fixed and permeabilised.  Cells were stained with anti-
hDaxx primary antibody and subsequently with secondary antibody (anti-
mouse Cy5-conjugated).  Images were generated on a confocal microscope 
and the magnification of each image was optimised to fit the area of the 
cell(s) in the field of view.
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Figure 5.6b. EYFPB82 co-localises with PML at 3 hr, 5 hr and 7 hr post-
infection.
HFFF2 monolayers were infected with 5x105 pfu of in0145 (expressing 
EYFPB82), and incubated at 38.5oC.  At 3 hr, 5 hr and 7 hr post-infection cell 
monolayers were fixed and permeabilised.  Cells were stained with primary 
antibody anti-PML  A-20 for 1 hr followed by incubation with secondary 
antibody (Alexa 647-chicken anti-goat) for 1 hr.  Images were captured on a 
confocal microscope and the magnification of each image was optimised to fit 
the area of the cell in the field of view.
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Figure 5.7a. EYFPRh82 co-localises with hDaxx at 3 hr, 5 hr and 7 hr 
post-infection.
HFFF2 monolayers were  infected with 5x105 pfu of in0144 (expressing 
EYFPRh82), and incubated at 38.5oC.  At 3 hr, 5 hr and 7 hr post-infection 
cell monolayers were fixed and permeabilised.  Cells were stained with anti-
hDaxx primary antibody and subsequently with secondary antibody (anti-
mouse Cy5-conjugated).  Images were generated on a confocal microscope 
and the magnification of each image was optimised to fit the area of the 
cell(s) in the field of view.
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Figure 5.7b. EYFPRh82 co-localises with PML at 3 hr, 5 hr and 7 hr post-
infection.
HFFF2 monolayers were infected with 5x105 pfu of in0144 (expressing 
EFYPRh82), and incubated at 38.5oC.  At 3 hr, 5 hr and 7 hr post-infection 
cell monolayers were fixed and permeabilised.  Cells were stained with 
primary antibody anti-PML  A-20 for 1 hr followed by incubation with 
secondary antibody (Alexa 647-chicken anti-goat) for 1 hr.  Images were 
captured on a confocal microscope and the magnification of each image was 
optimised to fit the area of the cell in the field of view.
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5. Part III 
 
5.3. Introduction 
 
In chapter 4 the hybrid protein EYFPTC6 (mid region of pp71 cloned into Ch82) 
was constructed and later recombined into a HSV-1 in1312 recombinant virus 
named  in0156.  This hybrid was shown to retain some activity at 10 days 
post-infection however levels of activity appeared to be lower than that observed 
with pp71.  The properties of this protein were further examined by observing its 
nuclear distribution patterns and co-localisation with the cellular proteins hDaxx 
and PML to establish if this hybrid behaved more like pp71 or Ch82. 
 
5.3.1 Hybrid TC6 co-localises with the cellular proteins hDaxx and PML at 3 
hr post-infection. 
 
HFFF2 cells (8x10
4) were infected with 5x10
5 pfu of in1310 (expressing 
EYFPpp71), in0146 (EYFPCh82) or in0156 (EYFPTC6).  At 3 hr post-infection cell 
monolayers were fixed and stained with primary antibodies anti-PML A-20 or anti-
hDaxx and their appropriate secondary antibodies. 
 
Figure 5.1 shows that in cell monolayers infected with in1310, pp71 localised to 
discrete punctate foci.  When cell monolayers were stained with an anti-hDaxx 
antibody (figure 5.3a), pp71 localised with hDaxx in these discrete punctate foci.  
When stained with an anti-PML antibody, co-localisation of pp71 with PML was 
also observed (figure 5.3b).  Cell monolayers infected with in0146 showed the 
Ch82 protein also localised to discrete punctate foci (figure 5.2).  And, as 
expected, co-localisation with both hDaxx and PML was observed.  These results 
were in agreement with those described previously (figure 5.4a and 5.4b).  In cell 
monolayers infected with in0156, the same distribution pattern as both pp71 and 
Ch82 homologues was observed at 3 hr post-infection (figure 5.8a, panel a.)  The 
hybrid protein TC6 also localised to discrete punctate foci in the nucleus.  Figure 
5.8a shows the discrete punctate foci of hybrid TC6 co-localising with hDaxx.   
Co-localisation was also observed in infected cells stained with anti-PML A20 
antibody (figure 5.8b). 
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Figure 5.8a. EYFPTC6 co-localises with hDaxx at 3 hr, 5 hr and 7 hr 
post-infection.
HFFF2 monolayers were  infected with 5x105 pfu of in0156 (expressing 
EYFPTC6), and incubated at 38.5oC.  At 3 hr, 5 hr and 7 hr post-infection cell 
monolayers were fixed and permeabilised.  Cells were stained with anti-
hDaxx primary antibody and subsequently with secondary antibody (anti-
mouse Cy5-conjugated).  Images were generated on a confocal microscope 
and the magnification of each image was optimised to fit the area of the 
cell(s) in the field of view.
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Figure 5.8b. EYFPTC6 co-localises with PML at 3 hr, 5 hr and 7 hr post-
infection.
HFFF2 monolayers were infected with 5x105 pfu of in0156 (expressing 
EYFPTC6), and incubated at 38.5oC.  At 3 hr, 5 hr and 7 hr post-infection cell 
monolayers were fixed and permeabilised.  Cells were stained with  primary 
antibody anti-PML  A-20 for 1hr followed by incubation with secondary 
antibody (Alexa 647-chicken anti-goat) for 1 hr.  Images were captured on a 
confocal microscope and the magnification of each image was optimised to fit 
the area of the cell in the field of view.
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5.3.2. Hybrid TC6 co-localises with the cellular proteins hDaxx and PML at 5 
hr post-infection. 
 
HFFF2 cells (8x10
4) were infected with 5x10
5 pfu of in1310 (expressing 
EYFPpp71), in0146 (EYFPCh82), or in0156 (EYFPTC6).  At 5 hr post-infection 
cell monolayers were fixed and stained with either anti-hDaxx or anti-PML 
antibodies and their appropriate secondary antibodies. 
 
Cell monolayers infected with in1310 showed the same nuclear distribution 
patterns as observed at 3 hr post-infection whereby pp71 localised to discrete 
punctate foci in the nucleus (figure 5.2).  When stained with antibodies raised 
against both hDaxx and PML, pp71 was found to co-localise with both cellular 
proteins (figure 5.3a and 5.3b).  In cell monolayers infected with in0146 a change 
in the nuclear distribution pattern of cells was observed.  An increasing number of 
cells infected with in0146 showed Ch82 exhibited a punctate/diffuse pattern of 
fluorescence (figure 5.2).  However, as expected, both hDaxx and PML were seen 
to co-localise with these foci as presented in figures 5.4a and 5.4b.  Surprisingly, 
cells infected with in0156 showed no change in nuclear distribution patterns at 5 hr 
compared to that at 3 hr.  In all cells observed, hybrid TC6 localised to discrete 
punctate foci associated with pp71 (figure 5.8a, panel b).  When cell monolayers 
were stained with antibodies raised against hDaxx and PML the punctate foci of 
TC6 were found to co-localise with both cellular proteins (figure 5.8a and 5.8b).   
 
5.3.3. Hybrid TC6 co-localises with the cellular proteins hDaxx and PML at 7 
hr post-infection. 
 
HFFF2 cells (8x10
4) were infected with 5x10
5 pfu of in1310 (expressing 
EYFPpp71), in0146 (EYFPCh82) or in0156 (EYFPTC6).  At 7 hr post-infection cell 
monolayers were fixed and stained with anti-hDaxx and anti-PML antibodies and 
their appropriate secondary antibodies.  In the majority of cells infected with 
in1310, pp71 localised to discrete punctate foci, however some infected cells 
showed pp71 exhibiting a punctate/diffuse pattern of fluorescence (figure 5.2).   
When infected monolayers were stained with anti-hDaxx and anti-PML antibodies, 
all foci were seen to co-localise with both cellular proteins (figure 5.3a and 5.3b).  
As shown previously, as late as 7 hr post-infection pp71 co-localised with hDaxx 
and PML at ND10 domains.  In cell monolayers infected with in0146, in the 
majority of cells Ch82 exhibited a punctate/diffuse pattern of fluorescence (figure Tanya Chaudry 2008    Chapter 5  128
5.2), but continued to localise with both hDaxx and PML (figure 5.4a and 5.4b).  
Surprisingly, in cell monolayers infected with in0156, the nuclear distribution 
pattern continued to resemble that of pp71 (figure 5.8a, panel c), with hybrid TC6 
localised to discrete punctate foci.  When cell monolayers were stained with 
antibodies raised against hDaxx or PML, these punctate foci co-localised with both 
hDaxx and PML (figure 5.8a and 5.8b).  Therefore, at 7 hr post-infection, hybrid 
TC6 behaved in a manner similar to that of pp71 in terms of both nuclear 
distribution and co-localisation with hDaxx and ND10 domains. 
 
In previous experiments the difference in nuclear distribution patterns of pp71 and 
Ch82 were based on counting fluorescence patterns in cell nuclei.  In the case of 
hybrid TC6, due to low levels of infection with in0156 very few infected cells were 
observed at each time post-infection.  At each time point hybrid TC6 localised to 
discrete punctate foci, mimicking the pattern of pp71.  However it remains a 
possibility that the nuclear distribution pattern of hybrid F may become more like 
that of Ch82 at 5 hr and 7 hr post-infection.  In order to investigate this further 
higher levels of infection with in0156 would need to be obtained in order to 
observe a greater number of infected cells. 
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5. Part IV 
 
5.4. Introduction 
 
In various cell types the cellular protein hDaxx has been shown to bind to the 
transcription factors Ets-1 and Pax-3, thus exerting a repressive effect on the 
respective target genes (Hofmann et al., 2002, Li et al., 2000b).  The repressive 
effect of hDaxx on IE gene expression is thought to occur via the action of a HDAC 
(Li et al., 2000a).  Work by Saffert and Kalejta (2006) has shown that pp71 may 
act to mediate the proteasomal degradation of hDaxx in order to relieve its 
repressive effect and activate viral IE gene expression in infected cells.  Preston 
and Nicholl (2006) also reported that the interaction of pp71 with hDaxx is 
important in relieving repression of IE gene expression and permitting the efficient 
initiation of productive replication. 
 
As pp71 was recently reported to be sufficient to promote the degradation of 
hDaxx in the absence of every other HCMV protein (Saffert & Kalejta, 2006), (see 
section 1.10.3.2 for further details), work was carried out to establish if the 
non-human homologues also promote the degradation of hDaxx. 
 
5.4.1. Infection with the in1312 recombinants expressing EYFP-tagged 
homologues does not result in the degradation of hDaxx. 
 
In order to determine whether the EYFP-tagged UL82 homologues were able to 
promote the degradation of hDaxx, 1.5x10
5 U373 cells were infected with 5x10
5 
pfu of the in1312 recombinant viruses expressing the EYFP-tagged UL82 
homologues or HCMV AD169 (positive control).  Following incubation at 38.5
oC 
lysates were harvested at 7 hr and 24 hr post-infection for analysis by SDS PAGE, 
or cell monolayers were stained with X-gal in order to determine levels of infection. 
 
Figure 5.9 shows a western blot of cell lysates harvested at 7 hr post-infection.  
The protein hDaxx was detected using an anti-hDaxx primary antibody and an 
HRP-conjugated anti-rabbit secondary antibody.  Similar levels of hDaxx were 
observed in all lysates, including those from cells mock-infected or infected with 
the negative control (in1374).  Figure 5.10 shows cell monolayers infected with the 
in1312 recombinant viruses expressing EYFP-tagged UL82 homologues stained 
with X-gal at 7 hr post-infection.  All five viruses expressing EYFP-tagged UL82  
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Figure 5.9. Western blot analysis of lysates of cells infected with in1312
recombinants expressing UL82 homologues at 7 hr post infection. 
U373 cell monolayers were infected with 5x105 pfu (MOI 3.3) of the in1312
recombinants expressing the UL82 homologues or HCMV AD169 (control) and
incubated 38.5
oC.  At 7 hr post-infection cell lysates were harvested and
analysed by SDS PAGE.  hDaxx was probed for using an anti-Daxx primary
antibody and an anti-rabbit HRP conjugated secondary antibody.  Blots were
stripped and reprobed with an anti-actin primary antibody and an anti-mouse
HRP conjugated secondary antibody, to control for loading. 
 in1310 mock in0146
in0150 in0145 in0144
in1310 mock in0146
in0150 in0145 in0144
in1374 in1374
 
Figure 5.10. β-gal expression directed by the in1312 recombinants expressing
the EYFP-tagged UL82 homologues at 7 hr post-infection 
U373 cell monolayers were mock-infected or infected with 5x10
5 pfu (MOI 3.3) of the 
in1312 recombinants expressing the EYFP-tagged UL82 homologues and incubated at 
38.5
oC.  At 7 hr post-infection cell monolayers were stained with X-gal and images 
were obtained. 
 
The in1310 virus expresses EYFPpp71, in0146 expresses EYFPCh82, in0150 
expresses EYFPS82, in0145 expresses EYFPB82, in0144 expresses EYFPRh82, and 
in1374 was used as a negative control. Tanya Chaudry 2008    Chapter 5  130
homologues showed β-gal positive cells at levels above the negative control, 
implying that each homologue acts on the HCMV MIEP, to drive short-term gene 
expression to a similar extent.   
 
Lysates of cell monolayers, infected with the in1312 recombinant viruses 
expressing EYFP-tagged UL82 homologues and harvested at 24 hr post-infection, 
were analysed by SDS PAGE.  Figure 5.11 shows a western blot containing all 
lysates probed with an anti-hDaxx primary antibody, and a HRP-conjugated 
anti-rabbit secondary antibody.  At 24 hr post-infection no significant changes in 
the levels of hDaxx expression were observed in cell lysates compared to 7 hr 
post-infection.  As expected, there was no change in the levels of hDaxx 
expression in lysates of cells infected with in1374 (negative control) or 
mock-infected.  X-gal staining showed that monolayers were infected to similar 
levels as presented in figure 5.12, ensuring lysates harvested at 24 hr 
post-infection were also infected at equivalent levels.  Therefore no major change 
in levels of hDaxx was observed in lysates of cells infected with in1312 
recombinants expressing EYFP-tagged UL82 homologues or HCMV, and in these 
experiments none of the UL82 homologues detectably promoted the degradation 
of hDaxx. 
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Figure 5.11. Western blot analysis of lysates of cells infected with in1312
recombinants expressing UL82 homologues 24 hr post-infection. 
U373 cell monolayers were infected with 5x105 pfu (MOI 3.3) of the in1312
recombinants expressing the UL82 homologues or HCMV AD169 (control) and
incubated 38.5
oC.  At 24 hr post-infection cell lysates were harvested and
analysed by SDS PAGE.  The protein hDaxx was probed for using an anti-Daxx
primary antibody and an anti-rabbit HRP conjugated secondary antibody.
Lysates were subjected to SDS PAGE again and probed with an anti-actin
antibody and an anti-mouse HRP-conjugated secondary antibody, to act as a
loading control.  
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EYFP-tagged UL82 homologues at 24 hr post-infection 
U373 cell monolayers were mock-infected or infected with 5
5
EYFP-tagged UL82 homologues at 24 hr post-infection 
U373 cell monolayers were mock-infected or infected with 5
5
the in1312 recombinants expressing the EYFP-tagged UL82 homologues and 
incubated at 38.5
oC.  At 24 hr post-infection cell monolayers were stained with 
gal and images were obtained. 
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expresses EYFPS82, in0145 expresses EYFPB82, in0144 expresses EYFPRh8
and in1374 was used as a negative control. 
 
expresses EYFPS82, in0145 expresses EYFPB82, in0144 expresses EYFPRh8
and in1374 was used as a negative control. 
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5.5. Discussion 
 
The study presented here has confirmed that pp71 is able to stimulate both short-
term and long-term gene expression from the HCMV MIEP.  Earlier work by 
Marshall et al. (2002) suggested that pp71 is a non-sequence-specific activator of 
gene expression, and could thus be compared to the HSV-1 IE protein ICP0. It is 
well known that ICP0 is a RING-finger ubiquitin E3 ligase protein that is able to 
induce the proteasome-dependent degradation of PML (Boutell & Everett, 2003, 
Everett et al., 1999a, Everett & Maul, 1994).  The ICP0 induced degradation of 
PML at ND10 domains is a vital stage in the expression of HSV-1 early and late 
genes. 
 
The HCMV protein pp71 is known to accumulate at ND10 domains, prior to the 
production of IE proteins, by co-localisation with hDaxx (Hofmann et al., 2002, 
Ishov et al., 2002).  It is the interaction of pp71 with hDaxx, mediated by the 
interaction of the C-terminus of hDaxx with SUMO modified PML which trafficks 
pp71 to ND10 domains (Hofmann et al., 2002, Ishov et al., 2002).  The data 
presented in the final part of this study aimed to characterise the UL82 
homologues in terms of their nuclear distribution patterns and their interactions 
with the cellular proteins hDaxx and PML.   
 
In tissue culture, cells infected with the viruses in1310, in0146, in0150, in0145, 
and  in0144 exhibited significant differences in terms of nuclear distribution 
patterns.  The pp71 protein localised predominantly to discrete punctate foci up to 
7 hr post-infection.  The work presented in this study agrees with previous work 
that pp71 does indeed localise to discrete punctate foci.   
 
At 3hr post-infection Ch82, B82, and Rh82 all appeared to localise to discrete 
punctate foci.  However at 5 hr post-infection, a greater number of infected cells 
showed these proteins in a punctate/diffuse pattern of fluorescence and by 7 hr 
post-infection in the majority of cells infected with in0146, in0145 and in0144 the 
Ch82, B82 and Rh82 proteins exhibited a punctate/diffuse pattern of fluorescence.  
The S82 protein was markedly different from the outset, as it exhibited a 
punctate/diffuse diffuse pattern of fluorescence at 3 hr post-infection. At both 5 hr 
and 7 hr post-infection, the majority of infected cells exhibited a diffuse pattern of 
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non-human homologues diverge from those of pp71 to become increasingly like 
S82.   
 
The distribution pattern exhibited by the EYFP-tagged hybrid protein TC6 was also 
investigated when cells were infected with in0156.  At 3 hr, 5 hr and 7 hr 
post-infection, hybrid TC6 was observed to localise to discrete punctate foci similar 
to foci to which pp71 localises.  However due to the low levels of initial infection, 
very few infected cells were observed and the possibility remains that the nuclear 
distribution pattern exhibited by hybrid TC6 could become more like the Ch82 
homologue at later times of infection.  Further experimental work is needed to 
confirm that data. 
 
HFFF2 cell monolayers infected with the in1312 recombinant viruses expressing 
the EYFP-tagged UL82 homologues or hybrid TC6 were stained for endogenous 
PML and hDaxx at 3 hr, 5 hr and 7 hr post-infection.  The HCMV protein pp71 was 
observed to co-localise with hDaxx and PML at all times post-infection, in 
agreement with other studies (Hofmann et al., 2002, Ishov et al., 2002).   
Interestingly, the Ch82, B82 and Rh82 homologues were observed to co-localise 
with ND10 domains and interact with hDaxx at all time points investigated.  It was 
observed that the various nuclear distribution patterns did little to alter the 
localisation of the homologues with these cellular proteins.   
 
However in the case of S82 at 5 hr and 7 hr post-infection, few foci were observed 
to co-localise with hDaxx.  In cells infected with in0150 cells, where a diffuse 
pattern of fluoresence was observed, hDaxx appeared to be dispersed.  Data 
presented here show that at 7 hr post-infection S82 appears to disperse hDaxx 
from within the nucleus.  It is possible that the S82 protein may have a lower 
binding affinity for hDaxx at 7 hr post-infection compared to the other UL82 
homologues.  As this study shows no evidence of protein-protein interactions 
between S82 and hDaxx further experimental work would have to be carried out to 
establish if this is indeed the case.  Also further studies would need to be carried 
out at later times post-infection to establish if the B82, Rh82 and Ch82 
homologues also exhibit diffuse patterns of fluoresence and they also disperse 
hDaxx.  Hybrid TC6 was also observed to interact with hDaxx and was able 
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hybrid protein possibly retains some of the attibutes of pp71 and Ch82 which allow 
them to co-localise with hDaxx and PML. 
 
This study has not only confirmed the co-localisation of pp71 and S82 with PML 
and hDaxx at ND10 domains (Hofmann et al., 2002, Ishov et al., 2002, Nicholson, 
2004), it has also demonstrated that the remaining non-human homologues are 
also able to co-localise with these cellular proteins at ND10 domains. 
 
It has been suggested that hDaxx acts as a transcriptional repressor by interacting 
with HDAC molecules, Dek and various transcription factors such as Pax1 or 
ETS1 (Hollenbach et al., 2002, Li et al., 2000a).  Histone deacetylase activity 
occurs at sites of transcription where hDaxx facilitates the deacetylation of histone 
tails.  The histone tails then bind to DNA, blocking access to the transcriptional 
machinery and causing repression of transcription.  Dek has been reported to 
associate with chromatin, altering its condensed state and resulting in the 
repression of gene expression, as transcription factors are unable to access the 
DNA (Hollenbach et al., 2002, Kappes et al., 2001, Woodhall et al., 2006).  Recent 
studies have proposed that pp71 acts to degrade hDaxx and relieve histone 
deacetylation.  The histones associated with the MIEP during infection can then be 
acetylated (Cantrell & Bresnahan, 2006, Preston & Nicholl, 2006, Saffert & Kalejta, 
2006).  The mechanism whereby pp71 degrades hDaxx is believed to be by a 
proteasome-dependent ubiquitin independent pathway (Hwang & Kalejta, 2007).   
 
Earlier in this study it was established that the non-human UL82 homologues act 
on the MIEP to drive short-term gene expression.  As all the non-human 
homologues were observed to co-localise with hDaxx and PML, at ND10 domains, 
like pp71, it was hypothesised that the non-human homologues may also degrade 
hDaxx to relieve repression at the MIEP promoter during infection.   
 
Cells infected with the in1312 recombinant viruses expressing the EYFP-tagged 
UL82 homologues were probed for hDaxx at 7 hr and 24 hr post-infection by 
western analysis.  Infected cell monolayers were also stained with X-gal to ensure 
similar levels of infection were obtained.  Data from this study showed that at both 
7 hr and 24 hr post-infection, no significant changes in levels of hDaxx were 
observed in lysates infected with in0146, in0150, in0144, in0145.  Surprisingly, 
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in1310 (expressing EYFPpp71) or in lysates infected with HCMV at either 7 hr or 
24 hr post-infection.  The data presented in this study showed that neither pp71 
nor the non-human homologues appear to be directly involved in promoting the 
degradation of hDaxx. 
 
Since there is considerable evidence to support the hypothesis that pp71 
stimulates the proteasomal degradation of hDaxx (Cantrell & Bresnahan, 2006, 
Preston & Nicholl, 2006, Saffert & Kalejta, 2006, Saffert & Kalejta, 2007), it  is 
possible that the lack of proteasomal degradation of hDaxx by pp71 in this study 
could be due to experimental differences.  The proteasomal degradation of hDaxx 
by pp71 appears to be cell-type specific, and dependent on specific experimental 
conditions.  Work by Saffert and Kalejta (2006) showed that pp71-induced hDaxx 
degradation in human foreskin fibroblast cells (HFFs) inoculated with virus at 4
oC 
for a 1 hr incubation period, followed by a 5 min shift to 37
oC where the virus 
inoculum was removed and the medium replaced.  In studies described here, 
U373 cells were utilised and all infections were carried out at only 38.5
oC.  These 
differences may account for the lack of detectable proteasomal degradation, 
especially in the case of HCMV.  Further work is required to establish if these 
differences in experimental conditions affect the pp71-induced degradation of 
hDaxx and if the homologues, like pp71, also induce proteasomal degradation of 
hDaxx.  Work by Tavali et al. (2008) has recently shown that hDaxx is degraded 
by pp71 as early as 3 hr post-infection, but levels of hDaxx become stabilised by 
12 hour post-infection to complement hDaxx levels observed in mock-infected 
cells.   
 
All experiments carried out in this study employed HSV-1 recombinant viruses, 
thus it still remains unknown how the non-human UL82 homologues behave in 
vivo.  Confocal microscopy studies have shown that S82 appears to disperse 
hDaxx at 7 hr post-infection; it is possible that at later times the other non-human 
homologues may not degrade hDaxx but instead disperse it to allow the onset of 
transcription.  Therefore the non-human homologues may act by a different 
mechanism to eradicate hDaxx in order to relieve repression.  It is also possible 
that in vivo the non-human UL82 homologues may employ a different repression 
mechanism or that they may need to degrade other cellular proteins in order to 
relieve repression at the MIEP to activate transcription.  
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6.Final Discussion 
 
6.1. Introduction 
 
HCMV pp71 has been established as a transactivator of gene expression, capable 
of acting on heterologous promoters (Homer et al., 1999, Liu & Stinski, 1992).  It 
fulfils several functions as a tegument protein of HCMV and is conserved in 
chimpanzee (Ch82), simian (S82), baboon (B82), and rhesus (Rh82) CMV 
isolates.  The aims of this study have been to characterise some of the attributes 
of B82, Ch82, Rh82 and S82 with regard to HCMV pp71.  The focus of the work 
described here has been (a) to determine how the pp71 non-human UL82 
homologues behave in terms of activation of short-term and long-term gene 
expression, (b) to map the region of pp71 involved in long-term gene expression 
and (c) to further characterise the non-human UL82 homologues by studying the 
intracellular localisation of these proteins. 
 
6.1.1. UL82 homologues; short-term and long-term expression analyses 
 
The first part of this study aimed to investigate the ability of the non-human UL82 
homologues to direct short-term and long-term gene expression.  Previous work 
by Nicholson (2004) and Preston and Nichol (2005) showed that pp71 was able to 
direct both short-term and long-term gene expression, while its non-human 
counter-part, S82, was only able to direct short-term gene expression. 
 
To investigate if B82, Rh82 and Ch82 behaved like pp71 or S82, transfection 
assays were employed.  Data from these experiments showed that pp71 appeared 
to be unique in its ability to stimulate long-term gene expression.  Results from 
transfection experiments were confirmed by infection assays.  The UL82 
homologues were recombined into the HSV-1 genome, which was impaired for the 
transcriptional activity of VP16 and ICP0 and had a temperature sensitive mutation 
in ICP4.  Each recombinant virus expressing the UL82 homologues had β-gal 
inserted into the non-essential UL43 locus under the control of the HCMV MIEP.  
The results from the infection assays confirmed those obtained previously from 
transfection assays whereby all the UL82 homologues were functional in the short-
term.  Only HCMV pp71 was observed to direct long-term gene expression. 
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6.1.2. The UL82 homologues and long-term gene expression 
 
Preston and Nicholl (2005) suggested that when cells are infected with the HSV-1 
recombinant viruses expressing EYFP-tagged pp71 (in1310), the quiescent state 
of the genome is incomplete.  Low levels of gene expression, including pp71, 
continue thereby allowing pp71 to act on the MIEP which results in the eventual 
unblocking of the genome, leading to long-term gene expression.  The non-human 
UL82 homologues (S82, B82, Rh82 and Ch82) were all found to be unable to 
stimulate long-term gene expression, and only short-term activation was observed.  
This may suggest that the quiescent state of the HSV-1 recombinant viruses 
expressing the non-human UL82 homologues is more complete than that of 
in1310.  β-gal positive cells were observed at 24 hr post-infection, representing the 
population of infected cells that respond to short-term gene expression.  At 10 
days post-infection no β-gal positive plaques were observed in cells subjected to a 
temperature downshift i.e. at a temperature permissive for replication.  The 
expression of the non-human UL82 homologues appears to be shut off, and there 
is no evidence of continued low level expression of these homologues to unblock 
the remainder of the genome.  Evidence for this can be observed when infected 
cells are super-infected with tsK, unmasking the genomes that are still present in 
the cells but have become quiescent after short-term expression.  Therefore the 
non-human UL82 homologues may lack the positive feedback mechanism thought 
to be associated with pp71.  These data indicate that, like pp71, all the non-human 
UL82 homologues are able to stimulate short-term gene expression, possibly for 
the rapid initiation of the viral transcription program, but, unlike pp71, allow the 
genome to be completely shut off preventing long-term expression in these 
systems. 
 
Alternatively, it is possible that short-term and long-term gene expression directed 
by the UL82 homologues is linked to differing chromatin structures in both 
situations.  The intial short-term gene expression directed by all the non-human 
homologues investigated maybe indicative of an open chromatin formation around 
the HCMV MIEP, allowing the UL82 homologues to act on the HCMV MIEP to 
drive β-gal expression.  It maybe the case that, at late times post-infection, the 
HCMV MIEP beomes repressed  through the recruitment of HDACs resulting in a 
closed chromatin conformation.  Therefore, in cells infected with the in1312 
recombinant viruses expressing the non-human UL82 homologues, a state similar Tanya Chaudry 2008    Chapter 6  137
to latency is achieved at later times post-infection as the non-human UL82 
homologues are unable to relieve repression at the HCMV MIEP, and thus are 
unable to direct long-term gene expression.  In cells infected with in1310 pp71 
may act to relieve histone deactylation allowing access for other transcription 
factors to give long-term gene expression. 
 
Further work would needed to establish the state of chromatin around at the MIEP 
at early and late times post-infection 
 
6.1.3. Effects of the UL82 homologues on genome quiescence 
 
Preston and Nichol (2005) showed that pp71 could act in trans to reactivate 
quiescent genomes.  In this study, SEAP assays were carried out to investigate if 
the non-human homologue, Ch82, like pp71 could reactivate quiescent genomes.  
Results from the SEAP assays showed that upon super-infecting quiescent 
genomes with in1310 and in0146, only pp71 was able to provoke resumption of 
gene expression.  This confirmed work by Preston and Nichol (2005) and showed 
that pp71 appears to be unique in its ability to stimulate reactivation of quiescent 
genomes. 
 
As pp71 has been demonstrated to be able to reactivate quiescent genomes, this 
protein can be considered to have some similar functions to HSV-1 ICP0.  Various 
studies have shown that ICP0 is able to reactivate quiescent genomes (Harris & 
Preston, 1991, Preston & Nicholl, 1997, Russell et al., 1987, Samaniego et al., 
1998, Stow & Stow, 1989), however the rate at which pp71 can induce reactivation 
of a quiescent genome is slower than that of ICP0 (Preston & Nicholl, 2005).   
Reactivation by pp71 is believed to be less effective than ICP0 as only small 
amounts of ICP0 are required to reverse the quiescent state (Hobbs et al., 2001, 
Preston & Nicholl, 2005).  It has been suggested that ICP0 may counteract 
repression by stimulating the degradation of a number of cellular proteins via the 
ubiquitin proteasome pathway through the binding of its RING finger domain to 
USP7 (Boutell et al., 2002).  The protein pp71 lacks a RING finger domain, 
however, despite this, it can mediate proteasomal degradation of the Rb family of 
proteins which may result in pp71 stimulating quiescent cells back into the cell 
cycle (Kalejta & Shenk, 2003c).  Thus pp71, like ICP0, may utilise a proteasomal 
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quiescent cells.  Previous studies have shown that quiescent HSV-1 can be 
reactivated upon super-infection with HCMV (Russell & Preston, 1986, Stow & 
Stow, 1989) suggesting that HCMV gene products act as a substitute for the 
absence of ICP0.  It is possible that pp71 may have some effect upon this, as to 
date no additional HCMV gene products have been identified as playing a role in 
reactivation.   
 
6.1.4. Promoter analysis of the UL82 homologues 
 
The ability of pp71 to mediate long-term gene expression may be linked to the 
promoter stimulating activity of this protein.  Consequently, long-term gene 
expression may be directed by the non-human UL82 homologues but only when 
they are controlled by their own MIEP promoters.  The HCMV MIEP enhancer 
contains a number of interaction sites to which transcription factors can bind, to 
activate the MIEP.  These sites include three copies of a 21 bp repeat element and 
four copies of an 18 bp repeat element.  It also contains five copies of a 19 bp 
repeat element (CCCCATTGACGTCAATGGG) to which the cellular transcription 
factors ATF/CREB are known to bind.  Various studies have shown that pp71-
induced MIEP stimulation requires the presence of the ATF/CREB binding site 
within the enhancer region (Cherrington & Mocarski, 1989, Liu & Stinski, 1992).  
Deletion of the 19 bp repeat element containing the consensus ATF/CREB binding 
motif abolished responsiveness of the promoter to pp71 in co-transfection assays 
(Liu & Stinski, 1992).   
 
Sequence analysis of the ChCMV MIEP enhancer region (data not shown) 
showed conserved 19 bp, 18 bp, 21 bp and 17 bp repeat elements.  Four copies of 
the 19 bp repeat elements were found, one of which was a perfect match to the 19 
bp sequence in HCMV, two sequences contained two nucleotide mismatches the 
first at residues 704-747 (GCCCATTGACGTCAATGGT) and the second at 
residues 729-747 (TTCCATTGACGTCAATGGG).  The third sequence at residues 
809-829 had three mismatches (CCCTATTGACGTCAATGAC).  However, as the 
consensus sequence (TTGACGTCAA) to which the ATF/CREB proteins bind 
remains unaltered it seems unlikely that the mismatches would have any 
significant effect on activation.  Indeed, variations also exist within the 19 bp 
repeat in the HCMV MIEP.  Two copies of the 18 bp repeat sequence were found 
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were also found, one of which was a perfect match to that in HCMV while the other 
contained two mismatches.  Only one copy of the 17 bp repeat element was found 
conserved within the ChCMV sequence and contained one mismatched 
nucleotide. 
 
The 19 bp nucleotide repeat sequence is also believed to be highly conserved 
within the SCMV MIEP enhancer region, while the 18 and a 16 bp element are 
only marginally conserved (Thomsen et al., 1984).  The 19 bp repeat element is 
also conserved in RhCMV (data not shown).  Thus as these repeat elements 
appear to be conserved within both ChCMV, SCMV and RhCMV MIEPs, it is 
highly likely that they are also conserved within the BCMV MIEP.  It is possible 
that the non-human UL82 homologues, like pp71, activate the ATF/CREB 
sequences at the 19bp repeat elements in the HCMV MIEP because they are 
conserved throughout their own promoters, resulting in short-term gene 
expression.  This could provide an explanation as to why the non-human 
homologues were equally or more active than pp71 during short-term assays. The 
target promoter in all experiments was the HCMV MIEP, thus all the homologues 
were able to act on the conserved ATF/CREB sequences at the 19 bp repeat 
elements to drive short-term gene expression.  It is possible that during long-term 
gene expression pp71 acts on a different part of the promoter, possibly by binding 
to cellular factors which attach to other repeat elements.  Furthermore, this mode 
of action may also be the case for the non-human UL82 homologues acting on 
their own promoters. 
 
6.1.5. The LXCXD motif  
 
The LACSD motif within pp71 was found to induce the degradation of the Rb 
tumour suppressor protein family through a proteasome-dependent ubiquitin-
independent mechanism (Kalejta & Shenk, 2003c).  This motif was conserved in 
the S82 protein at residues 209-213 and in the B82 protein at residues 209-213.  
Within the Ch82 protein this motif is found as LSCSD at residues 212-216, while in 
Rh82 the motif appears as LACSN at residues 209-213 (figure 6.1a).  However 
work by Preston and Nicholl (2005) eliminated the theory that the LACSD motif in 
pp71 played a role in directing long-term gene expression.  Mutation of the central 
cysteine to glycine abolished the effect of pp71 on the degradation of the 
unphosphorylated Rb gene products but did not alter the ability of pp71 to mediate A Conservation of Rb interaction domains in the UL82 homologues
LEQLACSDPNT
VELLSCSDRNT
Simian(206)MDQLACSDADT
Baboon(205)MDQLACSDGYT
Rhesus(206)IDQLACSNGDT
Consensus     MDQLACSDG T
Chimp (210)
Human (213)
B
PLTLVDAL
PLRLVDAV
Simian(199)PLTVVDAM
Baboon(198)PLTVVDAM
Rhesus(199)PLTLVDAI
Consensus     PLTLVDAM
Chimp (203)
Human (206)
DID I
PGVSIEAGP
PGVSMEAGP
Simian(316)PGLSIEAGP
Baboon(315)PGLSIECGP
Rhesus(316)PGISMDAGP
Consensus     PGLSIEAGP
Chimp (321)
Human (324)
DID II
Conservation of DIDs in the UL82 homologues
Figure 6.1 Conservation of UL82 functional domains in 
homologous non-human CMV sequences
A: Conservation of the LASCD domain. B: Conservation of the 
DIDs.  For all domains, residues conserved across all sequences 
are shown in red.Tanya Chaudry 2008    Chapter 6  140
long-term activity of the promoter (Preston & Nicholl, 2005).  As changes to the 
LACSD motif in pp71 did not result in changes to long-term gene expression, it is 
unlikely that the conserved motifs within the non-human UL82 homologues are of 
any importance with regards to long-term gene expression.  However, it is not 
known if the conserved motifs within non-human UL82 homologues promote the 
degradation of the Rb proteins, or if the amino acid substitutions to the motifs in 
the Ch82 and Rh82 proteins have any significance. 
 
6.2. The significance of the DIDs in the UL82 homologues 
 
Sequencing of pp71 and the non-human UL82 homologues has revealed certain 
similarities and differences.  Hensel et al. (1996) showed that pp71 has a bi-partite 
nuclear localisation signal (NLS), however this region is not conserved in the non-
human homologues (Nicholson, 2004).  As the Ch82, S82, B82 and Rh82 proteins 
are all targeted to the nucleus it seems unlikely that the proposed NLS in pp71 has 
any significant role in targeting this protein to the nuclei of cells.  Hofmann et al. 
(2002) identified two putative DIDs (DID I at residues 206-213; DID II at residues 
324-331).  Deletion of either of these domains resulted in the pp71-hDaxx 
interaction being abolished.  Point mutations of these motifs failed to identify the 
amino acid residues essential for hDaxx binding.  As these DIDs are found within 
the most ordered region of pp71, deletion of these domains or mutations to 
individual residues may result in the disruption of the structure of pp71, resulting 
the inability of the protein to bind to hDaxx. 
 
Sequence analysis of the non-human homologues has revealed that that these 
DIDs are well conserved within the protein sequences of all the non-human 
homologues, with the greatest degree of conservation occurring in DID II (figure 
6.1b) (Nicholson, 2004).  It is possible that these conserved DIDs within the 
non-human UL82 homologue sequences are involved in the hDaxx interactions 
observed in this study. 
 
The role of the proposed pp71 DIDs in interactions with hDaxx (Hofmann et al., 
2002) is borne out by the observed pattern of co-localisation of hybrid F with both 
hDaxx and PML.  This indicated that this protein not only co-localises with hDaxx 
but also is trafficked to PML at ND10 domains.  This hybrid protein is likely to 
co-localise with hDaxx and PML as the DIDs in pp71 have remained intact, despite 
the change to the structure of pp71.  This suggests that as long as this highly Tanya Chaudry 2008    Chapter 6  141
ordered region of pp71 remains undisrupted it is still able to retain a certain degree 
of functionality in terms of localising to hDaxx and PML at ND10 domains.  In order 
to establish that the DIDs conserved in the Ch82 homologue are indeed functional, 
comparative experiments would have to be carried out using hybrid E which 
contains the middle region of Ch82 flanked by the N- and C- terminal regions of 
pp71. 
 
6.3. Conclusions 
 
This study has sought to characterise the non-human UL82 homologues of pp71 
in terms of their effects on gene expression, intracellular localisation and 
interactions with the cellular proteins hDaxx and PML.  Each UL82 homologue was 
shown to act in a similar way to pp71 with the exception that pp71 remains unique 
in its ability to direct long-term gene expression and reactivate quiescent 
genomes.  Moreover, the non-human UL82 homologues exhibited slightly different 
intracellular distribution patterns to pp71 over the time period examined.  Also 
hDaxx and PML interactions of the S82 homologue were different compared to 
that of pp71.  This work, in combination with further analysis of structure, 
sequence motifs and cellular interactions, will help to progress the continued 
elucidation of pp71 function. 
 
6.4. Future work 
 
•  Sequence analysis of the UL82 homologues has shown regions of highly 
conserved motifs including the DIDs and the LASCD motifs.  Further study 
is needed to establish if the conserved DIDs in the non-human UL82 
homologues are important in hDaxx interactions.  Further work is also 
required to establish if the conserved LASCD motifs in the non-human 
UL82 homologues cause proteasome-dependent ubiquitin-independent 
degradation of the Rb tumour protein families. 
 
•  Further analysis of pp71 and the proteasomal degradation of hDaxx is 
required to establish if pp71 alone degrades hDaxx or if any other cellular 
interactions occur. 
 
•  Further analysis of the non-human UL82 homologues is needed to establish 
if they degrade or disperse hDaxx to relieve transcriptional repression. Tanya Chaudry 2008    Chapter 6  142
 
•  Elucidation of the 3D structure of pp71 would be helpful investigate protein 
folding, and to establish how deletions or changes to the structure of pp71 
affect its other properties. 
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Appendices 
 
Appendix A: Recombinant Viruses 
 
EYP-tagged HSV-1 recombinant viruses 
 
Virus  Transgene locus  Mutations to HSV-
1 recombinats 
in1374 
Negative control 
E.coli lacZ inserted in to the 
UL43 locus 
VP16, ICP0. ICP4  
in1310 
HCMV EYFPpp71 inserted into 
the TK locus 
E.coli lacZ inserted in to the 
UL43 locus 
VP16, ICP0. ICP4 
in0150 
SCMV EYFPS82 inserted into the 
TK locus 
E.coli lacZ inserted in to the 
UL43 locus  
VP16, ICP0. ICP4 
in0146 
ChCMV EYFPCh82 inserted into 
the TK locus 
E.coli lacZ inserted in to the 
UL43 locus 
VP16, ICP0. ICP4 
in0144 
RhCMV EYFPRh82 inserted into 
the TK locus 
E.coli lacZ inserted in to the 
UL43 locus 
VP16, ICP0. ICP4 
in0145 
BCMV EYFPB82 inserted into the 
TK locus 
E.coli lacZ inserted in to the 
UL43 locus 
VP16, ICP0. ICP4 
 
myc-tagged HSV-1 recombinant viruses 
 
Virus  Transgene  locus  Mutations to HSV-
1 recombinats 
in0149 
ChCMV82 mycCh82 inserted into 
the TK locus 
E.coli lacZ inserted in to the 
UL43 locus 
VP16, ICP0. ICP4 
in0151 
HCMV mycpp71 inserted into the 
TK locus 
E.coli lacZ inserted in to the 
UL43 locus 
VP16, ICP0. ICP4 
 
Other HSV-1 recombinant viruses used in this study 
 
Virus  Transgene  locus  Mutations to HSV-
1 recombinats 
in1382  E.coli  lacZ  inserted in to 
the TK locus 
 
VP16, ICP0. ICP4 
in0156 
EYFPTC6 inserted into the TK 
locus 
E.coli  lacZ  inserted in to 
the UL43 locus 
 
VP16, ICP0. ICP4 
in1318 
Secreted alkaline phospatase 
(SEAP) inserted into the TK 
locus 
   
VP16, ICP0. ICP4 Tanya Chaudry 2008      164
 
All HSV-1 recombinant viruses used in this study were impaired for the 
transcriptional stimulating activity of VP16 the IE proteins ICP0 and ICP4 were 
rendered non-functional by deletion and temperature sensitive mutations 
respectively. 
 RING  
deleted
ICP0
VP16
(in1814)
ICP4 
(tsK)
ICP4 
(tsK)
HSV-1 multiple mutant in1312
A multiple mutant inactive for the functions of the three major HSV-1 transcription activators 
VP16, ICP0 and ICP4 at 38.5o but contains lacZ under the control of the HCMV MIEP. In1312 based recombinant expressing the EYFP/myc-tagged UL82 homologues or EYFP-tagged 
hybrid protein TC6
Thymidine kinase 
locus
MIEP
SV40 
Term
pp71
Ch82
S82
B82
Rh82
Hybrid TC6
HSV-1 HSV-1
lacZ
UL43 locus
The in1312 HSV-1 multiple mutant was used to construct the negative control in1374, which has lacZ inserted into the 
UL43 locus. In1374 was used as a vector to express the Ul82 homologues or hybrid protein TC6 by insertion of the 
appropriate DNA cassette into the TK locus.  All the HSV-1 recombinant viruses lack VP16, ICP0 and ICP4 function at 
38.50In1382
Thymidine 
kinase locus
HSV-1 HSV-1
MIEP SV40 
Term
E.coli lacZ
Thymidine 
kinase locus
HSV-1 HSV-1
MIEP SV40 
Term
SEAP
In1318
In1382 was constructed by inserting the E.coli lacZ reporter gene into the TK locus, in1318 was constructed by inserting 
the gene expressing SEAP into the TK locus.  Each HSV-1 mutant virus was impaired for the transcriptional activity of 
VP16, ICP0 and contained a temperature sensitive mutation at ICP4 rendering the viruses inactive at 38.50
Other HSV-1 in1312 based recombinant viruses used in this study 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix B 
Genome organisation of the HCMV Strain Merlin 
Coloured arrows indicate protein-coding regions and the name of each gene is 
indicated below. 
The Merlin image was kindly provided by Dr. Andrew Davison RL11 family UL14 family UL18 family US22 family UL25 family UL82 family UL146 family
US1 family US2 family US6 family US12 family GCPR family other non-core core
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